European Biotechnology - first and foremost in European biotech https://european-biotechnology.com/ For almost two decades, European Biotechnology has been the first and foremost information platform reporting on the life sciences in Europe. en-us AstraZeneca to acquire Amolyt Pharma for up to US$1.05bnhttps://european-biotechnology.com/up-to-date/latest-news/news/astrazeneca-to-acquire-amolyt-pharma-for-up-to-us105bn.html2024-03-14T11:51:03+01:00 Relation Therapeutics Ltd bags US$35m in seed financing.https://european-biotechnology.com/up-to-date/latest-news/news/relation-therapeutics-ltd-bags-us35m-in-seed-financing.html2024-03-14T11:24:19+01:00 Researcher find potential target for atherosclerosishttps://european-biotechnology.com/up-to-date/latest-news/news/researcher-find-potential-target-for-atherosclerosis.html2024-03-13T08:55:55+01:00 Obesity: Arecor Therapeutics partners with TRx Bioscienceshttps://european-biotechnology.com/up-to-date/latest-news/news/obesity-arecor-therapeutics-partners-with-trx-biosciences.html2024-03-12T09:04:19+01:00 Scientists create non-digestible aptamer https://european-biotechnology.com/up-to-date/latest-news/news/scientists-create-non-digestible-aptamer.html2024-03-08T11:28:00+01:00 SynaptixBio Ltd gets FDA ODD for leukodystrophyhttps://european-biotechnology.com/up-to-date/latest-news/news/synaptixbio-ltd-gets-fda-odd-for-leukodystrophy.html2024-03-05T15:34:27+01:00 Pierre Fabre SAS in US$31m licence deal with Kinnate Biopharma Inchttps://european-biotechnology.com/up-to-date/latest-news/news/pierre-fabre-sas-in-us31m-licence-deal-with-kinnate-biopharma-inc.html2024-03-04T16:05:00+01:00 Bayer SE secures rights to in €310m dealhttps://european-biotechnology.com/up-to-date/latest-news/news/bayer-se-secures-rights-to-in-eur310m-deal.html2024-03-04T08:50:00+01:00 PulseSight to disrupt AMD spacehttps://european-biotechnology.com/up-to-date/latest-news/news/pulsesight-to-disrupt-amd-space.html2024-02-29T08:00:00+01:00 Swiss vaccine developer Limma Tech get CARB-X granthttps://european-biotechnology.com/up-to-date/latest-news/news/swiss-vaccine-developer-limma-tech-get-carb-x-grant.html2024-02-28T16:00:45+01:00 Curve Therapeutics raises £40.5m in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/curve-therapeutics-raises-pound405m-in-series-a-financing.html2024-02-27T11:11:59+01:00 Pacifico Biolabs raises US$3.3m in pre-seed roundhttps://european-biotechnology.com/up-to-date/latest-news/news/pacifico-biolabs-raises-us33m-in-pre-seed-round.html2024-02-26T15:00:00+01:00 Gene therapy supplier MIP Discovery closes £7M Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/gene-therapy-supplier-mip-discovery-closes-pound7m-series-a-financing.html2024-02-20T10:13:48+01:00 Vidac Pharma Holding plc reports preclinical proof of principlehttps://european-biotechnology.com/up-to-date/latest-news/news/vidac-pharma-holding-plc-reports-preclinical-proof-of-principle.html2024-02-19T15:12:27+01:00 Roche leads Freenome Inc US$257m financinghttps://european-biotechnology.com/up-to-date/latest-news/news/roche-leads-freenome-inc-us257m-financing.html2024-02-16T09:14:35+01:00 Bioplastics production capacity to quadruple by 2028https://european-biotechnology.com/up-to-date/latest-news/news/bioplastics-production-capacity-to-quadruple-by-2028.html2024-02-15T10:27:14+01:00 AZmed closes €15m Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/azmed-closes-eur15m-series-a-financing.html2024-02-14T08:31:44+01:00 Bayer's Ask Bio unit starts Phase II heart failure gene therapyhttps://european-biotechnology.com/up-to-date/latest-news/news/bayers-ask-bio-unit-starts-phase-ii-heart-failure-gene-therapy.html2024-02-14T07:35:34+01:00 German companies to revolutionise lab plastics markethttps://european-biotechnology.com/up-to-date/latest-news/news/german-companies-to-revolutionise-lab-plastics-market.html2024-02-13T09:00:00+01:00 AMPLY Discovery Ltd bags £1.4m funding to tackle complex diseaseshttps://european-biotechnology.com/up-to-date/latest-news/news/amply-discovery-ltd-bags-pound14m-funding-to-tackle-complex-diseases.html2024-02-12T08:40:00+01:00 Cambridge university spin-out HutanBio Ltd bags £2.25m seed financinghttps://european-biotechnology.com/up-to-date/latest-news/news/cambridge-university-spin-out-hutanbio-ltd-bags-pound225m-seed-financing.html2024-02-09T11:08:42+01:00 EU parliament backs deregulation of New Genome Techniqueshttps://european-biotechnology.com/up-to-date/latest-news/news/eu-parliament-backs-deregulation-of-new-genome-techniques.html2024-02-07T17:21:00+01:00 Jazz Pharmaceuticals licences KRAS blocker from Redx Pharmahttps://european-biotechnology.com/up-to-date/latest-news/news/jazz-pharmaceuticals-licences-kras-blocker-from-redx-pharma.html2024-02-07T08:53:09+01:00 Spanish plant-based protein producer Heüra Foods closes Series B financinghttps://european-biotechnology.com/up-to-date/latest-news/news/spanish-plant-based-protein-producer-heuera-foods-closes-series-b-financing.html2024-02-05T13:40:47+01:00 Biovian and 3P Biopharmaceuticals join forces to create 3PBIOVIANhttps://european-biotechnology.com/up-to-date/latest-news/news/biovian-and-3p-biopharmaceuticals-join-forces-to-create-3pbiovian.html2024-02-05T12:03:42+01:00 Lonza and Oxford Nanopore collaborate to advance mRNA Therapeuticshttps://european-biotechnology.com/up-to-date/latest-news/news/lonza-and-oxford-nanopore-collaborate-to-advance-mrna-therapeutics.html2024-01-31T11:30:20+01:00 £26m for Cystic Fibrosis Drug Trialhttps://european-biotechnology.com/up-to-date/latest-news/news/pound26m-for-cystic-fibrosis-drug-trial.html2024-01-30T10:39:17+01:00 Alvotech Advances in Biosimilar Market with Successful AVT03 Studyhttps://european-biotechnology.com/up-to-date/latest-news/news/alvotech-advances-in-biosimilar-market-with-successful-avt03-study.html2024-01-29T15:13:07+01:00 Novozymes and Chr. Hansen Complete Merger, Forming Novonesishttps://european-biotechnology.com/up-to-date/latest-news/news/novozymes-and-chr-hansen-complete-merger-forming-novonesis.html2024-01-29T13:12:08+01:00 2:1 for new genomic techniqueshttps://european-biotechnology.com/up-to-date/latest-news/news/21-for-new-genomic-techniques.html2024-01-25T13:47:35+01:00 Innate immunity merger raises €75mhttps://european-biotechnology.com/up-to-date/latest-news/news/innate-immunity-merger-raises-eur75m.html2024-01-24T09:00:00+01:00 Roche jumps ship on AC Immunehttps://european-biotechnology.com/up-to-date/latest-news/news/roche-jumps-ship-on-ac-immune.html2024-01-23T07:00:00+01:00 Deregulation of new genomic techniques before decisionhttps://european-biotechnology.com/up-to-date/latest-news/news/deregulation-of-new-genomic-techniques-before-decision.html2024-01-22T09:44:48+01:00 Amsilk partners with 21st.BIOhttps://european-biotechnology.com/up-to-date/latest-news/news/amsilk-partners-with-21stbio.html2024-01-17T09:43:30+01:00 Onera Health raises US$32m in Series C roundhttps://european-biotechnology.com/up-to-date/latest-news/news/onera-health-raises-us32m-in-series-c-round.html2024-01-16T12:37:23+01:00 Spexis sells antibiotics programme to Basileahttps://european-biotechnology.com/up-to-date/latest-news/news/spexis-sells-antibiotics-programme-to-basilea.html2024-01-15T09:28:51+01:00 Finnish Enifer Oy secures €12m grant to scale up https://european-biotechnology.com/up-to-date/latest-news/news/finnish-enifer-oy-secures-eur12m-grant-to-scale-up.html2024-01-11T08:46:00+01:00 Mogu Srl raises €11m to scale mycelium technologyhttps://european-biotechnology.com/up-to-date/latest-news/news/mogu-srl-raises-eur11m-to-scale-mycelium-technology.html2024-01-09T13:09:39+01:00 Novo Nordisk Foundation in US$25m partnership with CARB-X https://european-biotechnology.com/up-to-date/latest-news/news/novo-nordisk-foundation-in-us25m-partnership-with-carb-x.html2024-01-09T06:01:00+01:00 Novartis AG to buy immunology specialist Calypso Biotech BVhttps://european-biotechnology.com/up-to-date/latest-news/news/novartis-ag-to-buy-immunology-specialist-calypso-biotech-bv.html2024-01-08T10:51:23+01:00 GLP1 agonists: FDA investigates suicide riskhttps://european-biotechnology.com/up-to-date/latest-news/news/glp1-agonists-fda-investigates-suicide-risk.html2024-01-05T15:25:31+01:00 Boehringer Ingelheim enters €410m licence deal with Kyowa Kirin Co., Ltd.https://european-biotechnology.com/up-to-date/latest-news/news/boehringer-ingelheim-enters-eur410m-licence-deal-with-kyowa-kirin-co-ltd.html2024-01-05T12:36:58+01:00 miRNA specialist Resalis Therapeutics Srl raises €10m in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/mirna-specialist-resalis-therapeutics-srl-raises-eur10m-in-series-a-financing.html2024-01-04T13:33:00+01:00 Roche presents restistance-breaking antibiotichttps://european-biotechnology.com/up-to-date/latest-news/news/roche-presents-restistance-breaking-antibiotic.html2024-01-03T08:56:00+01:00 Alfasigma SpA signs €170m deal with Galapagos NVhttps://european-biotechnology.com/up-to-date/latest-news/news/alfasigma-spa-signs-eur170m-deal-with-galapagos-nv.html2024-01-02T08:39:56+01:00 AstraZeneca buys Chinese Gracell Biotechnologies for $1.2bnhttps://european-biotechnology.com/up-to-date/latest-news/news/astrazeneca-buys-chinese-gracell-biotechnologies-for-12bn.html2023-12-28T08:37:32+01:00 Metrion Biosciences closes £3.7m equity financinghttps://european-biotechnology.com/up-to-date/latest-news/news/metrion-biosciences-closes-pound37m-equity-financing.html2023-12-20T11:16:15+01:00 LimmaTech Biologics acquires licence option for AbVacc vaccine LBT-SA7 https://european-biotechnology.com/up-to-date/latest-news/news/limmatech-biologics-acquires-licence-option-for-abvacc-vaccine-lbt-sa7.html2023-12-19T10:33:00+01:00 French parliamentarians against cell-based meat https://european-biotechnology.com/up-to-date/latest-news/news/french-parliamentarians-against-cell-based-meat.html2023-12-18T11:32:20+01:00 Vandria SA bags CHF18m in Series A financing https://european-biotechnology.com/up-to-date/latest-news/news/vandria-sa-bags-chf18m-in-series-a-financing.html2023-12-14T11:59:45+01:00 Antabio SAS raises €25 m in Series B financinghttps://european-biotechnology.com/up-to-date/latest-news/news/antabio-sas-raises-eur25-m-in-series-b-financing.html2023-12-12T13:11:11+01:00 Production process for cell-based coffee publishedhttps://european-biotechnology.com/up-to-date/latest-news/news/production-process-for-cell-based-coffee-published.html2023-12-12T13:00:18+01:00 Germany blocks deregulation of NGT breedshttps://european-biotechnology.com/up-to-date/latest-news/news/germany-blocks-deregulation-of-ngt-breeds.html2023-12-11T21:59:00+01:00 Cathera SA closes Series B round at €42mhttps://european-biotechnology.com/up-to-date/latest-news/news/cathera-sa-closes-series-b-round-at-eur42m.html2023-12-11T15:22:05+01:00 UK publishes £2bn vision for engineering biologyhttps://european-biotechnology.com/up-to-date/latest-news/news/uk-publishes-pound2bn-vision-for-engineering-biology.html2023-12-06T18:18:25+01:00 Valnevas Lyme vaccine trial complets recruitmenthttps://european-biotechnology.com/up-to-date/latest-news/news/valnevas-lyme-vaccine-trial-complets-recruitment.html2023-12-06T10:00:39+01:00 Unveiling prostate cancer's Achilles' heelhttps://european-biotechnology.com/up-to-date/latest-news/news/unveiling-prostate-cancers-achilles-heel.html2023-12-05T12:30:28+01:00 $30m for genetic medicine advancementshttps://european-biotechnology.com/up-to-date/latest-news/news/30m-for-genetic-medicine-advancements.html2023-12-05T11:13:08+01:00 Takeover in ADC space: Abbvie snags ImmunoGenhttps://european-biotechnology.com/up-to-date/latest-news/news/takeover-in-adc-space-abbvie-snags-immunogen.html2023-11-30T15:20:00+01:00 AI protein specialist Cradle raises US$24m in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/ai-protein-specialist-cradle-raises-us24m-in-series-a-financing.html2023-11-28T09:44:08+01:00 Repairing MS-caused damage with stem cellshttps://european-biotechnology.com/up-to-date/latest-news/news/repairing-ms-caused-damage-with-stem-cells.html2023-11-28T07:59:36+01:00 Breakthrough in COPD treatmenthttps://european-biotechnology.com/up-to-date/latest-news/news/breakthrough-in-copd-treatment.html2023-11-27T11:09:08+01:00 Novo Nordisk invests €2.1bn in production expansionhttps://european-biotechnology.com/up-to-date/latest-news/news/novo-nordisk-invests-eur21bn-in-production-expansion.html2023-11-24T09:07:57+01:00 Quotient Therapeutics kicks-off with US$50m financinghttps://european-biotechnology.com/up-to-date/latest-news/news/quotient-therapeutics-kicks-off-with-us50m-financing.html2023-11-21T21:55:47+01:00 Solar Foods raises €8m in Series B financinghttps://european-biotechnology.com/up-to-date/latest-news/news/solar-foods-raises-eur8m-in-series-b-financing.html2023-11-21T09:36:40+01:00 Germany boosts protein transition with €38mhttps://european-biotechnology.com/up-to-date/latest-news/news/germany-boosts-protein-transition-with-eur38m.html2023-11-20T08:52:59+01:00 Microharvest GmbH launches SCP-Pilot plant in Lissabon https://european-biotechnology.com/up-to-date/latest-news/news/microharvest-gmbh-launches-scp-pilot-plant-in-lissabon.html2023-11-18T14:59:33+01:00 AMR: Partnership set to improve in vivo antibiotics testinghttps://european-biotechnology.com/up-to-date/latest-news/news/amr-partnership-set-to-improve-in-vivo-antibiotics-testing.html2023-11-15T06:36:00+01:00 VectorY Therapeutics raises €129m in Series A roundhttps://european-biotechnology.com/up-to-date/latest-news/news/vectory-therapeutics-raises-eur129m-in-series-a-round.html2023-11-13T20:37:19+01:00 ViaNautis Bio Ltd closes US$25m Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/vianautis-bio-ltd-closes-us25m-series-a-financing.html2023-11-13T08:48:33+01:00 Recordbreaking BIO-Europe in Munich, but: back to 2019https://european-biotechnology.com/up-to-date/latest-news/news/recordbreaking-bio-europe-in-munich-but-back-to-2019.html2023-11-09T10:35:31+01:00 Amyl Therapeutics bags €11m Series A extensionhttps://european-biotechnology.com/up-to-date/latest-news/news/amyl-therapeutics-bags-eur11m-series-a-extension.html2023-11-08T17:23:36+01:00 Evotech screens cancer candidates for Dewpoint Therapeuticshttps://european-biotechnology.com/up-to-date/latest-news/news/evotech-screens-cancer-candidates-for-dewpoint-therapeutics.html2023-11-07T08:54:21+01:00 Pierre Fabre SA licences immunotherapy from Atara Biotherapeuticshttps://european-biotechnology.com/up-to-date/latest-news/news/pierre-fabre-sa-licences-immunotherapy-from-atara-biotherapeutics.html2023-11-06T20:16:05+01:00 Scotland boosts bio-based manufacturing with £75m fundhttps://european-biotechnology.com/up-to-date/latest-news/news/scotland-boosts-bio-based-manufacturing-with-pound75m-fund.html2023-11-05T19:16:35+01:00 Memo Therapeutics AG raises CHF25m https://european-biotechnology.com/up-to-date/latest-news/news/memo-therapeutics-ag-raises-chf25m.html2023-11-02T11:33:12+01:00 microRNA could offer a safe target in atherosclerosishttps://european-biotechnology.com/up-to-date/latest-news/news/microrna-could-offer-a-safe-target-in-atherosclerosis.html2023-11-02T10:59:00+01:00 Cellectis and AstraZeneca in US$2.2bn dealhttps://european-biotechnology.com/up-to-date/latest-news/news/cellectis-and-astrazeneca-in-us22bn-deal.html2023-11-01T09:30:40+01:00 Alfasigma SpA set to take over Galapagos programmehttps://european-biotechnology.com/up-to-date/latest-news/news/alfasigma-spa-set-to-take-over-galapagos-programme.html2023-10-31T13:27:03+01:00 Abingworth raises $356m for new CCD fund https://european-biotechnology.com/up-to-date/latest-news/news/abingworth-raises-356m-for-new-ccd-fund.html2023-10-30T11:24:43+01:00 Study links TCM with effects on protein networkshttps://european-biotechnology.com/up-to-date/latest-news/news/study-links-tcm-with-effects-on-protein-networks.html2023-10-28T10:58:00+02:00 BioNtech reports Car-T/mRNA booster study results at ESMOhttps://european-biotechnology.com/up-to-date/latest-news/news/biontech-reports-car-tmrna-booster-study-results-at-esmo.html2023-10-24T21:13:58+02:00 Roche acquires Telavant Holdings to win TLA1 racehttps://european-biotechnology.com/up-to-date/latest-news/news/roche-acquires-telavant-holdings-to-win-tla1-race.html2023-10-24T11:37:22+02:00 UK boosts AMR defenses with £30m PACE initiativehttps://european-biotechnology.com/up-to-date/latest-news/news/uk-boosts-amr-defenses-with-pound30m-pace-initiative.html2023-10-23T10:00:00+02:00 CPHI: Trends shaping pharma's pathhttps://european-biotechnology.com/up-to-date/latest-news/news/cphi-trends-shaping-pharmas-path.html2023-10-20T17:17:53+02:00 Xlife Sciences AG acquires 20% stake in 4D Lifetec AGhttps://european-biotechnology.com/up-to-date/latest-news/news/xlife-sciences-ag-acquires-20-stake-in-4d-lifetec-ag.html2023-10-18T15:53:51+02:00 SpliceBio has made up a US $216m alliance with Spark Therapeuticshttps://european-biotechnology.com/up-to-date/latest-news/news/splicebio-has-made-up-a-us-216m-alliance-with-spark-therapeutics.html2023-10-18T08:40:12+02:00 Antiverse and GlobalBio Inc. extend collaborationhttps://european-biotechnology.com/up-to-date/latest-news/news/antiverse-and-globalbio-inc-extend-collaboration.html2023-10-18T07:01:00+02:00 SOTIO Biotech licenses ADCs from Lonza subsidiary Synaffix BVhttps://european-biotechnology.com/up-to-date/latest-news/news/sotio-biotech-licenses-adcs-from-lonza-subsidiary-synaffix-bv.html2023-10-16T06:16:00+02:00 World Health Summit opened in Berlinhttps://european-biotechnology.com/up-to-date/latest-news/news/world-health-summit-opened-in-berlin.html2023-10-15T20:29:23+02:00 Synerkine Pharma BV secures EUR 12.1m in Series A extensionhttps://european-biotechnology.com/up-to-date/latest-news/news/synerkine-pharma-bv-secures-eur-121m-in-series-a-extension.html2023-10-13T14:07:00+02:00 AI helps classifying brain tumours during surgeryhttps://european-biotechnology.com/up-to-date/latest-news/news/ai-helps-classifying-brain-tumours-during-surgery.html2023-10-12T20:35:00+02:00 Agomab Therapeutics NV raises US$100m in Series C financinghttps://european-biotechnology.com/up-to-date/latest-news/news/agomab-therapeutics-nv-raises-us100m-in-series-c-financing.html2023-10-11T09:31:33+02:00 AstronauTx closes £48m Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/astronautx-closes-pound48m-series-a-financing.html2023-10-10T06:45:00+02:00 French team BioAroma awarded with BISC-E 2023 prizehttps://european-biotechnology.com/up-to-date/latest-news/news/french-team-bioaroma-awarded-with-bisc-e-2023-prize.html2023-10-09T08:37:00+02:00 Breakthrough in microtia treatmenthttps://european-biotechnology.com/up-to-date/latest-news/news/breakthrough-in-microtia-treatment.html2023-10-05T12:08:54+02:00 Orakl Oncology SA raises €3m to advance tumour modellinghttps://european-biotechnology.com/up-to-date/latest-news/news/orakl-oncology-sa-raises-eur3m-to-advance-tumour-modelling.html2023-10-04T11:10:26+02:00 Sanofi licences vaccine against bacterial sepsishttps://european-biotechnology.com/up-to-date/latest-news/news/sanofi-licences-vaccine-against-bacterial-sepsis.html2023-10-03T07:46:07+02:00 Spain set to unveil the potential of the biologisation of medicine and food productionhttps://european-biotechnology.com/up-to-date/latest-news/news/spain-set-to-unveil-the-potential-of-the-biologisation-of-medicine-and-food-production.html2023-10-03T04:10:00+02:00 Mogrify Ltd extends Series A financing to $46m https://european-biotechnology.com/up-to-date/latest-news/news/mogrify-ltd-extends-series-a-financing-to-46m.html2023-10-02T12:39:49+02:00 Joining forces for mRNA breakthroughhttps://european-biotechnology.com/up-to-date/latest-news/news/joining-forces-for-mrna-breakthrough.html2023-09-27T15:50:00+02:00 SeaBeLife secures €1.2m in fundinghttps://european-biotechnology.com/up-to-date/latest-news/news/seabelife-secures-eur12m-in-funding.html2023-09-26T16:42:31+02:00 BioSpain breaking recordshttps://european-biotechnology.com/up-to-date/latest-news/news/biospain-breaking-records.html2023-09-26T12:02:59+02:00 Pierre Fabre Laboratories collaborate with Vernalishttps://european-biotechnology.com/up-to-date/latest-news/news/pierre-fabre-laboratories-collaborate-with-vernalis.html2023-09-26T10:25:45+02:00 Crucible Therapeutics spins out with £5mhttps://european-biotechnology.com/up-to-date/latest-news/news/crucible-therapeutics-spins-out-with-pound5m.html2023-09-25T10:26:00+02:00 Oxford Biomedica acquires ABL Europe for €15m https://european-biotechnology.com/up-to-date/latest-news/news/oxford-biomedica-acquires-abl-europe-for-eur15m.html2023-09-25T09:54:15+02:00 Austrian Kern Tec raises €12m in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/austrian-kern-tec-raises-eur12m-in-series-a-financing.html2023-09-23T07:31:57+02:00 BenevolentAI Ltd inks US$594m partnership with Merck KGaA https://european-biotechnology.com/up-to-date/latest-news/news/benevolentai-ltd-inks-us594m-partnership-with-merck-kgaa.html2023-09-20T07:07:30+02:00 Aboleris Pharma bags €27.3m in Series A Financing https://european-biotechnology.com/up-to-date/latest-news/news/aboleris-pharma-bags-eur273m-in-series-a-financing.html2023-09-19T07:14:00+02:00 German company aims for the first EU approval for cell-cultured meathttps://european-biotechnology.com/up-to-date/latest-news/news/german-company-aims-for-the-first-eu-approval-for-cell-cultured-meat.html2023-09-17T20:59:00+02:00 Researchers stop brain cell death in Alzheimer’s micehttps://european-biotechnology.com/up-to-date/latest-news/news/researchers-stop-brain-cell-death-in-alzheimers-mice.html2023-09-15T10:20:28+02:00 Pierre Fabre Laboratories acquires Vertical Biohttps://european-biotechnology.com/up-to-date/latest-news/news/pierre-fabre-laboratories-acquires-vertical-bio.html2023-09-14T08:23:00+02:00 BioLamina AB bags €19m funding for expansionhttps://european-biotechnology.com/up-to-date/latest-news/news/biolamina-ab-bags-eur19m-funding-for-expansion.html2023-09-12T08:58:32+02:00 Radiotherapy R&D partnershiphttps://european-biotechnology.com/up-to-date/latest-news/news/radiotherapy-rd-partnership.html2023-09-11T11:30:00+02:00 BioInnovation Institute Boosts Six Life Science Companieshttps://european-biotechnology.com/up-to-date/latest-news/news/bioinnovation-institute-boosts-six-life-science-companies.html2023-09-06T10:30:00+02:00 Majority of EU agri-council supports NGT deregulation https://european-biotechnology.com/up-to-date/latest-news/news/majority-of-eu-agri-council-supports-ngt-deregulation.html2023-09-06T09:30:28+02:00 New detection method for protein degraders https://european-biotechnology.com/up-to-date/latest-news/news/new-detection-method-for-protein-degraders-1.html2023-09-04T13:27:38+02:00 Study: New breeding methods hardly contribute to climate protection https://european-biotechnology.com/up-to-date/latest-news/news/study-new-breeding-methods-hardly-contribute-to-climate-protection.html2023-09-01T12:11:37+02:00 CEPI commits up to US$80m to University of Oxford to develop vaccineshttps://european-biotechnology.com/up-to-date/latest-news/news/cepi-commits-up-to-us80m-to-university-of-oxford-to-develop-vaccines.html2023-08-30T08:46:38+02:00 Pairwise and Bayer collaborate to CRISPR short-stem maizehttps://european-biotechnology.com/up-to-date/latest-news/news/pairwise-and-bayer-collaborate-to-crispr-short-stem-maize.html2023-08-29T08:09:00+02:00 Mystery solved: Mysthera Theapeutics launches with $3.5mhttps://european-biotechnology.com/up-to-date/latest-news/news/mystery-solved-mysthera-theapeutics-launches-with-35m.html2023-08-28T14:35:00+02:00 Mithra raises €20m through private placementhttps://european-biotechnology.com/up-to-date/latest-news/news/mithra-raises-eur20m-through-private-placement.html2023-08-28T07:15:53+02:00 Dutch researchers and Novobiotics Inc present weapon vs AMRhttps://european-biotechnology.com/up-to-date/latest-news/news/dutch-researchers-and-novobiotics-inc-present-weapon-vs-amr.html2023-08-25T09:06:00+02:00 UK invests in biopharma manufacturershttps://european-biotechnology.com/up-to-date/latest-news/news/uk-invests-in-biopharma-manufacturers.html2023-08-24T09:09:00+02:00 Synbio experts develop cells that hearhttps://european-biotechnology.com/up-to-date/latest-news/news/synbio-experts-develop-cells-that-hear.html2023-08-23T14:54:27+02:00 Oxford Biomedica expands agreement with Cabaletta Biohttps://european-biotechnology.com/up-to-date/latest-news/news/oxford-biomedica-expands-agreement-with-cabaletta-bio.html2023-08-22T10:00:00+02:00 Researchers decipher mystery of oil-eating microbeshttps://european-biotechnology.com/up-to-date/latest-news/news/researchers-decipher-mystery-of-oil-eating-microbes.html2023-08-19T18:14:00+02:00 Valneva announces extension of existing loan agreementhttps://european-biotechnology.com/up-to-date/latest-news/news/valneva-announces-extension-of-existing-loan-agreement.html2023-08-17T08:08:33+02:00 Spexis AG bags money for pivotal Phase III trialhttps://european-biotechnology.com/up-to-date/latest-news/news/spexis-ag-bags-money-for-pivotal-phase-iii-trial.html2023-08-15T08:45:22+02:00 Novo Nordisk takes over Inversago Pharma Inc.https://european-biotechnology.com/up-to-date/latest-news/news/novo-nordisk-takes-over-inversago-pharma-inc.html2023-08-11T15:48:00+02:00 Promising viral gene therapy for genetic kidney diseasehttps://european-biotechnology.com/up-to-date/latest-news/news/promising-viral-gene-therapy-for-genetic-kidney-disease.html2023-08-10T07:39:00+02:00 Alianza Team invests in microbial oil maker Clean Food Group https://european-biotechnology.com/up-to-date/latest-news/news/alianza-team-invests-in-microbial-oil-maker-clean-food-group.html2023-08-08T10:38:59+02:00 More marine plastics than expectedhttps://european-biotechnology.com/up-to-date/latest-news/news/more-marine-plastics-than-expected.html2023-08-07T16:21:00+02:00 Sygnature Discovery Ltd acquires leading Canadian CROhttps://european-biotechnology.com/up-to-date/latest-news/news/sygnature-discovery-ltd-acquires-leading-canadian-cro.html2023-08-04T09:30:00+02:00 Enzyme foams morer active and stablehttps://european-biotechnology.com/up-to-date/latest-news/news/enzyme-foams-morer-active-and-stable.html2023-08-03T08:41:00+02:00 Bavarian Nordic A/S bags US$120m for smallpox vaccinehttps://european-biotechnology.com/up-to-date/latest-news/news/bavarian-nordic-as-bags-us120m-for-smallpox-vaccine.html2023-08-03T08:17:00+02:00 PureTech Health gets US$11.4m to advance LYT-300https://european-biotechnology.com/up-to-date/latest-news/news/puretech-health-gets-us114m-to-advance-lyt-300.html2023-08-02T09:04:00+02:00 Neuraxpharm pays US$650m for MS drug commercialisationhttps://european-biotechnology.com/up-to-date/latest-news/news/neuraxpharm-pays-us650m-for-ms-drug-commercialisation.html2023-08-01T16:10:46+02:00 Mithra Pharmaceuticals SA in €17m licencing dealhttps://european-biotechnology.com/up-to-date/latest-news/news/mithra-pharmaceuticals-sa-in-eur17m-licencing-deal.html2023-07-31T08:33:31+02:00 Bacterial-fungal consortium denitrifies wastewater by 100%https://european-biotechnology.com/up-to-date/latest-news/news/bacterial-fungal-consortium-denitrifies-wastewater-by-100.html2023-07-28T09:32:00+02:00 Retinopathy: Golgi and Breye join forceshttps://european-biotechnology.com/up-to-date/latest-news/news/retinopathy-golgi-and-breye-join-forces.html2023-07-26T12:00:00+02:00 NK cell therapy company NK:IO raises seed moneyhttps://european-biotechnology.com/up-to-date/latest-news/news/nk-cell-therapy-company-nkio-raises-seed-money.html2023-07-25T09:33:00+02:00 Alnylam in US$2.8bn biobucks deal with Rochehttps://european-biotechnology.com/up-to-date/latest-news/news/alnylam-in-us28bn-biobucks-deal-with-roche.html2023-07-24T10:15:00+02:00 Resistance blocker of immune checkpoint inhibitors gets patentedhttps://european-biotechnology.com/up-to-date/latest-news/news/resistance-blocker-of-immune-checkpoint-inhibitors-gets-patented.html2023-07-20T09:26:16+02:00 Lilly presents impressing results for Alzheimer's drug donanemabhttps://european-biotechnology.com/up-to-date/latest-news/news/lilly-presents-impressing-results-for-alzheimers-drug-donanemab.html2023-07-19T13:35:31+02:00 Biomethane fuel offers negative carbon footprinthttps://european-biotechnology.com/up-to-date/latest-news/news/biomethane-fuel-offers-negative-carbon-footprint.html2023-07-17T11:05:00+02:00 Carbios raises €141m to boost enzymatic PET recyclinghttps://european-biotechnology.com/up-to-date/latest-news/news/carbios-raises-eur141m-to-boost-enzymatic-pet-recycling.html2023-07-13T10:49:33+02:00 EG 427 expands Series A closing to €18mhttps://european-biotechnology.com/up-to-date/latest-news/news/eg-427-expands-series-a-closing-to-eur18m.html2023-07-13T10:11:50+02:00 Seed money for unique topical hair growth inducer https://european-biotechnology.com/up-to-date/latest-news/news/seed-money-for-unique-topical-hair-growth-inducer.html2023-07-11T10:18:25+02:00 Evotec earns US$40m in global licence deal with BMShttps://european-biotechnology.com/up-to-date/latest-news/news/evotec-earns-us40m-in-global-licence-deal-with-bms.html2023-07-11T09:11:05+02:00 Nanobiotix SA licences NBTXR3 to J&Jhttps://european-biotechnology.com/up-to-date/latest-news/news/nanobiotix-sa-licences-nbtxr3-to-jj.html2023-07-10T12:47:59+02:00 Living therapy: Microbial immunotherapy of Exeliom Biosciences gets a boosthttps://european-biotechnology.com/up-to-date/latest-news/news/living-therapy-microbial-immunotherapy-of-exeliom-biosciences-gets-a-boost.html2023-07-07T10:42:44+02:00 Dutch go first: pre-approval tastings of cultivated meat & seafood in the Netherlandshttps://european-biotechnology.com/up-to-date/latest-news/news/dutch-go-first-pre-approval-tastings-of-cultivated-meat-seafood-in-the-netherlands.html2023-07-06T10:18:00+02:00 EU Regulation of Genome Editing in Plants – not yet a lawhttps://european-biotechnology.com/up-to-date/latest-news/news/eu-regulation-of-genome-editing-in-plants-not-yet-a-law.html2023-07-05T11:15:32+02:00 Dutch NLC has €20m in first close of new Health Impact Fundhttps://european-biotechnology.com/up-to-date/latest-news/news/dutch-nlc-has-eur20m-in-first-close-of-new-health-impact-fund.html2023-07-05T10:52:55+02:00 French Carthera closes €37.5m Series B financing roundhttps://european-biotechnology.com/up-to-date/latest-news/news/french-carthera-closes-eur375m-series-b-financing-round.html2023-07-03T13:21:00+02:00 Donaldson Acquires Belgian Univercells Technologies for €138mhttps://european-biotechnology.com/up-to-date/latest-news/news/donaldson-acquires-belgian-univercells-technologies-for-eur138m.html2023-06-30T13:51:00+02:00 Gleamer raises €27m in Series B funding round https://european-biotechnology.com/up-to-date/latest-news/news/gleamer-raises-eur27m-in-series-b-funding-round.html2023-06-28T15:48:15+02:00 Centogene and Lifera kick-off joint venturehttps://european-biotechnology.com/up-to-date/latest-news/news/centogene-and-lifera-kick-off-joint-venture.html2023-06-27T13:56:17+02:00 Astraveus SAS bags €16.5m in seed financinghttps://european-biotechnology.com/up-to-date/latest-news/news/astraveus-sas-bags-eur165m-in-seed-financing.html2023-06-27T09:19:35+02:00 New BIOTECH insight newsletter outhttps://european-biotechnology.com/up-to-date/latest-news/news/new-biotech-insight-newsletter-out.html2023-06-27T07:48:14+02:00 Fresh money for Carbioshttps://european-biotechnology.com/up-to-date/latest-news/news/fresh-money-for-carbios.html2023-06-25T17:38:00+02:00 Smarter, faster, cheaper: Veeva shows howhttps://european-biotechnology.com/up-to-date/latest-news/news/smarter-faster-cheaper-veeva-shows-how.html2023-06-20T17:01:39+02:00 Santhera licences vamorolone rights to Catalyst Pharmaceuticalshttps://european-biotechnology.com/up-to-date/latest-news/news/santhera-licences-vamorolone-rights-to-catalyst-pharmaceuticals.html2023-06-20T09:21:19+02:00 BioSenic halts ALLOB developmenthttps://european-biotechnology.com/up-to-date/latest-news/news/biosenic-halts-allob-development.html2023-06-19T22:14:00+02:00 Neogap fully takes over TCER Oncology shareshttps://european-biotechnology.com/up-to-date/latest-news/news/neogap-fully-takes-over-tcer-oncology-shares.html2023-06-19T22:10:56+02:00 Antibody provides broad protection vs hantaviruseshttps://european-biotechnology.com/up-to-date/latest-news/news/antibody-provides-broad-protection-vs-hantaviruses.html2023-06-15T12:19:22+02:00 Syncona launches new gene therapy company Beacon Therapeuticshttps://european-biotechnology.com/up-to-date/latest-news/news/syncona-launches-new-gene-therapy-company-beacon-therapeutics.html2023-06-12T08:09:11+02:00 Roche to file MAA for eculizumab competitorhttps://european-biotechnology.com/up-to-date/latest-news/news/roche-to-file-maa-for-eculizumab-competitor.html2023-06-09T19:05:00+02:00 CGT Catapult expanding with Scotch facilityhttps://european-biotechnology.com/up-to-date/latest-news/news/cgt-catapult-expanding-with-scotch-facility.html2023-06-08T08:33:40+02:00 Bayer AG is joining forces with Acuitas Therapeutics, Inchttps://european-biotechnology.com/up-to-date/latest-news/news/bayer-ag-is-joining-forces-with-acuitas-therapeutics-inc.html2023-06-06T07:39:00+02:00 Cytovation ASA raises US$8m in Series Ahttps://european-biotechnology.com/up-to-date/latest-news/news/cytovation-asa-raises-us8m-in-series-a.html2023-06-05T10:01:00+02:00 The innovative power of the chemical industry assembledhttps://european-biotechnology.com/up-to-date/latest-news/news/the-innovative-power-of-the-chemical-industry-assembled.html2023-06-02T09:12:49+02:00 Stem cell gene transfer treats IL-1 immune diseases https://european-biotechnology.com/up-to-date/latest-news/news/stem-cell-gene-transfer-treats-il-1-immune-diseases.html2023-05-31T19:00:00+02:00 eXmoor Pharma Ltd raises US$35mhttps://european-biotechnology.com/up-to-date/latest-news/news/exmoor-pharma-ltd-raises-us35m.html2023-05-30T14:10:17+02:00 VarmX BV raises €30m in Series B2 financinghttps://european-biotechnology.com/up-to-date/latest-news/news/varmx-bv-raises-eur30m-in-series-b2-financing.html2023-05-29T11:01:20+02:00 Glioma drug combo turns tumours hothttps://european-biotechnology.com/up-to-date/latest-news/news/glioma-drug-combo-turns-tumours-hot.html2023-05-25T07:27:00+02:00 VectivBio taken over in $1bn acquisitionhttps://european-biotechnology.com/up-to-date/latest-news/news/vectivbio-taken-over-in-1bn-acquisition.html2023-05-24T09:13:16+02:00 AI predicts an enzyme’s substratehttps://european-biotechnology.com/up-to-date/latest-news/news/ai-predicts-an-enzymes-substrate.html2023-05-23T04:00:00+02:00 LanzaTech and Plastipak produce greener PEThttps://european-biotechnology.com/up-to-date/latest-news/news/lanzatech-and-plastipak-produce-greener-pet.html2023-05-19T10:52:00+02:00 Roche’s meets endpoints in relapsing multiple sclerosis https://european-biotechnology.com/up-to-date/latest-news/news/roches-meets-endpoints-in-relapsing-multiple-sclerosis.html2023-05-17T07:51:05+02:00 uniQure sells royalty interest in gene therapy for $400mhttps://european-biotechnology.com/up-to-date/latest-news/news/uniqure-sells-royalty-interest-in-gene-therapy-for-400m.html2023-05-15T13:13:37+02:00 Dualyx NV raises €40m in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/dualyx-nv-raises-eur40m-in-series-a-financing.html2023-05-15T10:59:50+02:00 Sanofi's/Astazeneca's anti-RSV antibody highly effectivehttps://european-biotechnology.com/up-to-date/latest-news/news/sanofisastazenecas-anti-rsv-antibody-highly-effective.html2023-05-12T14:26:00+02:00 Mainz Biomed Partners with Microba Life Scienceshttps://european-biotechnology.com/up-to-date/latest-news/news/mainz-biomed-partners-with-microba-life-sciences.html2023-05-10T12:50:46+02:00 DiogenX SA raises €27.5M in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/diogenx-sa-raises-eur275m-in-series-a-financing.html2023-05-10T11:42:12+02:00 Wacker AG expands biotech business through €100m acquisitionhttps://european-biotechnology.com/up-to-date/latest-news/news/wacker-ag-expands-biotech-business-through-eur100m-acquisition.html2023-05-08T10:58:07+02:00 Neogap Therapeutics A/S partners with Cellerys AGhttps://european-biotechnology.com/up-to-date/latest-news/news/neogap-therapeutics-as-partners-with-cellerys-ag.html2023-05-04T10:33:39+02:00 Dutch State to sell share capital of Intravacc BVhttps://european-biotechnology.com/up-to-date/latest-news/news/dutch-state-to-sell-share-capital-of-intravacc-bv.html2023-05-03T10:06:05+02:00 Tay Therapeutics in licensing deal with VYNE Therapeutics https://european-biotechnology.com/up-to-date/latest-news/news/tay-therapeutics-in-licensing-deal-with-vyne-therapeutics.html2023-05-02T10:06:00+02:00 Medigene licences CD40L-CD28 costimulatory switch receptor https://european-biotechnology.com/up-to-date/latest-news/news/medigene-licences-cd40l-cd28-costimulatory-switch-receptor.html2023-05-02T09:27:15+02:00 EU to decarbonise aviation sector through green fuel targetshttps://european-biotechnology.com/up-to-date/latest-news/news/eu-to-decarbonise-aviation-sector-through-green-fuel-targets.html2023-04-27T09:28:00+02:00 Swiss Biotech Report: Sunrise, not sunset, is the feeling of the hourhttps://european-biotechnology.com/up-to-date/latest-news/news/swiss-biotech-report-sunrise-not-sunset-is-the-feeling-of-the-hour.html2023-04-26T09:11:59+02:00 Novartis in US$465m deal with 3B Pharmaceuticals GmbH https://european-biotechnology.com/up-to-date/latest-news/news/novartis-in-us465m-deal-with-3b-pharmaceuticals-gmbh.html2023-04-25T09:06:50+02:00 Syngenta partners with Biotalyshttps://european-biotechnology.com/up-to-date/latest-news/news/syngenta-partners-with-biotalys.html2023-04-24T08:57:29+02:00 Phialogics AG bags pre-seed financing https://european-biotechnology.com/up-to-date/latest-news/news/phialogics-ag-bags-pre-seed-financing.html2023-04-20T08:19:45+02:00 Forbion raises €1.35bn across two fundshttps://european-biotechnology.com/up-to-date/latest-news/news/forbion-raises-eur135bn-across-two-funds.html2023-04-19T09:14:19+02:00 Ariceum Therapeutics extends Series A to €47.75mhttps://european-biotechnology.com/up-to-date/latest-news/news/ariceum-therapeutics-extends-series-a-to-eur4775m.html2023-04-18T14:16:46+02:00 Genmab and argenx combine antibody know-howhttps://european-biotechnology.com/up-to-date/latest-news/news/genmab-and-argenx-combine-antibody-know-how.html2023-04-17T14:39:30+02:00 Adaptyv Biosytems launches protein engineering foundryhttps://european-biotechnology.com/up-to-date/latest-news/news/adaptyv-biosytems-launches-protein-engineering-foundry.html2023-04-13T07:30:42+02:00 Researchers activate chemotherapeutics by ultrasoundhttps://european-biotechnology.com/up-to-date/latest-news/news/researchers-activate-chemotherapeutics-by-ultrasound.html2023-04-12T09:07:00+02:00 FAO presents food safety assessment on cell-based protein productshttps://european-biotechnology.com/up-to-date/latest-news/news/fao-presents-food-safety-assessment-on-cell-based-protein-products.html2023-04-10T12:09:00+02:00 Mosaic Therapeutics closes $28m series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/mosaic-therapeutics-closes-28m-series-a-financing.html2023-04-05T07:08:00+02:00 Carbios SAS set to licence and expand PET recyclinghttps://european-biotechnology.com/up-to-date/latest-news/news/carbios-sas-set-to-licence-and-expand-pet-recycling.html2023-04-04T09:31:06+02:00 Insempra and Axxence launch alpha-iononehttps://european-biotechnology.com/up-to-date/latest-news/news/insempra-and-axxence-launch-alpha-ionone.html2023-04-04T08:47:27+02:00 German-Chinese ADC collaborationhttps://european-biotechnology.com/up-to-date/latest-news/news/german-chinese-adc-collaboration.html2023-04-03T14:38:00+02:00 Nomi Biotech presents natural additive to preserve probioticshttps://european-biotechnology.com/up-to-date/latest-news/news/nomi-biotech-presents-natural-additive-to-preserve-probiotics.html2023-04-03T08:18:02+02:00 Algal enzyme synthesizes gasoline building blockshttps://european-biotechnology.com/up-to-date/latest-news/news/algal-enzyme-synthesizes-gasoline-building-blocks.html2023-03-31T14:37:00+02:00 LSP Dementia Fund closes at €260mhttps://european-biotechnology.com/up-to-date/latest-news/news/lsp-dementia-fund-closes-at-eur260m.html2023-03-30T08:58:00+02:00 Secarna Pharmaceuticals partners with SciNeuro Pharmaceuticals https://european-biotechnology.com/up-to-date/latest-news/news/secarna-pharmaceuticals-partners-with-scineuro-pharmaceuticals.html2023-03-27T16:17:39+02:00 Hot of the press: new issue of BIOTECH Insighthttps://european-biotechnology.com/up-to-date/latest-news/news/hot-of-the-press-new-issue-of-biotech-insight.html2023-03-27T15:45:04+02:00 Macomics licences macrophage modulator to Ono https://european-biotechnology.com/up-to-date/latest-news/news/macomics-licences-macrophage-modulator-to-ono.html2023-03-26T07:38:00+02:00 mbiomics GmbH cashes in €13m in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/mbiomics-gmbh-cashes-in-eur13m-in-series-a-financing.html2023-03-25T12:57:15+01:00 Upscaling AAV gene therapyhttps://european-biotechnology.com/up-to-date/latest-news/news/upscaling-aav-gene-therapy.html2023-03-22T11:10:16+01:00 500 experts at the 7th AMR Conference in Baselhttps://european-biotechnology.com/up-to-date/latest-news/news/500-experts-at-the-7th-amr-conference-in-basel.html2023-03-21T14:17:35+01:00 Vitestro raises €12m in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/vitestro-raises-eur12m-in-series-a-financing.html2023-03-21T10:23:18+01:00 European VCs join US$105m financing of US Mediar Thxhttps://european-biotechnology.com/up-to-date/latest-news/news/european-vcs-join-us105m-financing-of-us-mediar-thx.html2023-03-15T09:34:01+01:00 Neurodegenerative disorders are being fought with €28mhttps://european-biotechnology.com/up-to-date/latest-news/news/neurodegenerative-disorders-are-being-fought-with-eur28m.html2023-03-14T15:40:00+01:00 Pfizer-Seagen: Acquisition in the workshttps://european-biotechnology.com/up-to-date/latest-news/news/pfizer-seagen-acquisition-in-the-works.html2023-03-14T13:12:12+01:00 Iktos SA raises €15.5m in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/iktos-sa-raises-eur155m-in-series-a-financing.html2023-03-09T13:18:13+01:00 Collaboration to fight cancerhttps://european-biotechnology.com/up-to-date/latest-news/news/collaboration-to-fight-cancer.html2023-03-09T11:38:12+01:00 Noema Pharma AG closes Series B financinghttps://european-biotechnology.com/up-to-date/latest-news/news/noema-pharma-ag-closes-series-b-financing.html2023-03-08T16:28:00+01:00 Oculis lists at Nasdaq through SPAC mergerhttps://european-biotechnology.com/up-to-date/latest-news/news/oculis-lists-at-nasdaq-through-spac-merger.html2023-03-05T18:52:39+01:00 Money for AI-powered drug discoveryhttps://european-biotechnology.com/up-to-date/latest-news/news/money-for-ai-powered-drug-discovery.html2023-03-02T16:33:01+01:00 Confo Therapeutics and Lilly partner to advance CFTX-1554https://european-biotechnology.com/up-to-date/latest-news/news/confo-therapeutics-and-lilly-partner-to-advance-cftx-1554.html2023-03-02T14:47:00+01:00 German HTGF IV fund closes at €493mhttps://european-biotechnology.com/up-to-date/latest-news/news/german-htgf-iv-fund-closes-at-eur493m.html2023-03-01T10:08:48+01:00 5 Alarm Bio Ltd raises £500K in seed roundhttps://european-biotechnology.com/up-to-date/latest-news/news/5-alarm-bio-ltd-raises-pound500k-in-seed-round.html2023-02-28T09:46:00+01:00 High blood pressure reprograms immune systemhttps://european-biotechnology.com/up-to-date/latest-news/news/high-blood-pressure-reprograms-immune-system.html2023-02-27T08:10:00+01:00 Abivax SA raises €130m to advance obefazimod to Phase III https://european-biotechnology.com/up-to-date/latest-news/news/abivax-sa-raises-eur130m-to-advance-obefazimod-to-phase-iii.html2023-02-22T21:48:13+01:00 Paleo raised € 12 m in Series A financing roundhttps://european-biotechnology.com/up-to-date/latest-news/news/paleo-raised-eur-12-m-in-series-a-financing-round.html2023-02-21T15:27:36+01:00 Minaris and LIfT BioSciences collaborate in cell therapy developmenthttps://european-biotechnology.com/up-to-date/latest-news/news/minaris-and-lift-biosciences-collaborate-in-cell-therapy-development.html2023-02-21T09:30:42+01:00 PVH Corp joins fiber-to-fiber consortiumhttps://european-biotechnology.com/up-to-date/latest-news/news/pvh-corp-joins-fiber-to-fiber-consortium.html2023-02-20T09:26:27+01:00 Free sugar linked to higher cardiovascular diseasehttps://european-biotechnology.com/up-to-date/latest-news/news/free-sugar-linked-to-higher-cardiovascular-disease.html2023-02-16T14:31:00+01:00 AMsilk scaling up through Evonik collaborationhttps://european-biotechnology.com/up-to-date/latest-news/news/amsilk-scaling-up-through-evonik-collaboration.html2023-02-15T06:01:00+01:00 HOOKIPA bags US$10m cancer milestonehttps://european-biotechnology.com/up-to-date/latest-news/news/hookipa-bags-us10m-cancer-milestone.html2023-02-14T10:17:01+01:00 Cydar Medical Ltd raises €10.5m in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/cydar-medical-ltd-raises-eur105m-in-series-a-financing.html2023-02-13T09:24:04+01:00 Upping sustainability in pharma packaginghttps://european-biotechnology.com/up-to-date/latest-news/news/upping-sustainability-in-pharma-packaging.html2023-02-09T16:40:00+01:00 Evonetix extends Series B financing to US$54mhttps://european-biotechnology.com/up-to-date/latest-news/news/evonetix-extends-series-b-financing-to-us54m.html2023-02-07T17:13:43+01:00 Germany’s Curevac offers common shareshttps://european-biotechnology.com/up-to-date/latest-news/news/germanys-curevac-offers-common-shares.html2023-02-07T09:20:57+01:00 Chong Kun Dang Pharm licences Synaffix ADC platformhttps://european-biotechnology.com/up-to-date/latest-news/news/chong-kun-dang-pharm-licences-synaffix-adc-platform.html2023-02-06T12:47:26+01:00 New EU stakeholder platform to speed up clinical trialshttps://european-biotechnology.com/up-to-date/latest-news/news/new-eu-stakeholder-platform-to-speed-up-clinical-trials.html2023-02-06T12:13:06+01:00 Ultra-processed foods increase risk for cancerhttps://european-biotechnology.com/up-to-date/latest-news/news/ultra-processed-foods-increase-risk-for-cancer.html2023-01-31T12:40:07+01:00 Lonza collaborates with Asher Biotherapeutics Inchttps://european-biotechnology.com/up-to-date/latest-news/news/lonza-collaborates-with-asher-biotherapeutics-inc.html2023-01-31T12:21:59+01:00 Evotec and Janssen team up in immunooncology https://european-biotechnology.com/up-to-date/latest-news/news/evotec-and-janssen-team-up-in-immunooncology.html2023-01-30T11:50:00+01:00 Evidence of deliberate climate damagehttps://european-biotechnology.com/up-to-date/latest-news/news/evidence-of-deliberate-climate-damage.html2023-01-27T08:39:00+01:00 Rewind Therapeutics extends Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/rewind-therapeutics-extends-series-a-financing.html2023-01-26T08:35:00+01:00 New polymer can stop biofilm formationhttps://european-biotechnology.com/up-to-date/latest-news/news/new-polymer-can-stop-biofilm-formation.html2023-01-25T16:14:00+01:00 Henkel buys FDCA from Avantium NVhttps://european-biotechnology.com/up-to-date/latest-news/news/henkel-buys-fdca-from-avantium-nv.html2023-01-25T06:09:00+01:00 New partnerships push InDevR for Series B financing https://european-biotechnology.com/up-to-date/latest-news/news/new-partnerships-push-indevr-for-series-b-financing.html2023-01-18T11:27:40+01:00 Vésale Bioscience wins R&D grant https://european-biotechnology.com/up-to-date/latest-news/news/vesale-bioscience-wins-rd-grant.html2023-01-17T12:09:39+01:00 Abionyx Pharma announces success in fighting sepsis-triggered AKIhttps://european-biotechnology.com/up-to-date/latest-news/news/abionyx-pharma-announces-success-in-fighting-sepsis-triggered-aki.html2023-01-16T08:29:00+01:00 BioNTech bags Instadeep for £562mhttps://european-biotechnology.com/up-to-date/latest-news/news/biontech-bags-instadeep-for-pound562m.html2023-01-11T18:14:31+01:00 Roche withdraws checkpoint blocker from the markethttps://european-biotechnology.com/up-to-date/latest-news/news/roche-withdraws-checkpoint-blocker-from-the-market.html2023-01-10T13:17:55+01:00 Novo Holdings invests into standardisation of LC-MS-based proteomicshttps://european-biotechnology.com/up-to-date/latest-news/news/novo-holdings-invests-into-standardisation-of-lc-ms-based-proteomics.html2023-01-09T15:26:01+01:00 ExeVir receives EIB risk finance for multiple COVID-19 nanobodyhttps://european-biotechnology.com/up-to-date/latest-news/news/exevir-receives-eib-risk-finance-for-multiple-covid-19-nanobody.html2023-01-09T11:54:56+01:00 Hummingbird and Synaffix in $150m ADC dealhttps://european-biotechnology.com/up-to-date/latest-news/news/hummingbird-and-synaffix-in-150m-adc-deal.html2023-01-05T07:25:26+01:00 Ethris inks €15m deal with Indian Ciplashttps://european-biotechnology.com/up-to-date/latest-news/news/ethris-inks-eur15m-deal-with-indian-ciplas.html2023-01-03T15:23:04+01:00 First hints for leukopenia diagnostic in MShttps://european-biotechnology.com/up-to-date/latest-news/news/first-hints-for-leukopenia-diagnostic-in-ms.html2023-01-02T10:14:00+01:00 Collaboration to develop mRNA vaccine against betacoronaviruseshttps://european-biotechnology.com/up-to-date/latest-news/news/collaboration-to-develop-mrna-vaccine-against-betacoronaviruses.html2022-12-21T14:18:47+01:00 First allogeneic cancer immunotherapy hits markethttps://european-biotechnology.com/up-to-date/latest-news/news/first-allogeneic-cancer-immunotherapy-hits-market.html2022-12-20T15:41:31+01:00 Numares AG cashes in €20m from EIBhttps://european-biotechnology.com/up-to-date/latest-news/news/numares-ag-cashes-in-eur20m-from-eib.html2022-12-20T09:50:23+01:00 INDUSTRIA BIOTEC 2023 with a broader perspectivehttps://european-biotechnology.com/up-to-date/latest-news/news/industria-biotec-2023-with-a-broader-perspective.html2022-12-19T18:10:58+01:00 €72M from Novo´s REPAIR Impact Fund for Group B Streptococcus vaccineshttps://european-biotechnology.com/up-to-date/latest-news/news/eur72m-from-novos-repair-impact-fund-for-group-b-streptococcus-vaccines.html2022-12-15T16:02:44+01:00 A ray of hope in leukaemiahttps://european-biotechnology.com/up-to-date/latest-news/news/a-ray-of-hope-in-leukaemia.html2022-12-13T13:00:00+01:00 Amgen wins race of top `22 deals with $26bn for Horizon thxhttps://european-biotechnology.com/up-to-date/latest-news/news/amgen-wins-race-of-top-22-deals-with-26bn-for-horizon-thx.html2022-12-13T11:59:43+01:00 Step Pharma presents promising cancer treatmenthttps://european-biotechnology.com/up-to-date/latest-news/news/step-pharma-presents-promising-cancer-treatment.html2022-12-12T13:04:22+01:00 Partnering revitalized at the BioFit2022 – in Strasbourg and onlinehttps://european-biotechnology.com/up-to-date/latest-news/news/partnering-revitalized-at-the-biofit2022-in-strasbourg-and-online.html2022-12-08T14:29:15+01:00 European Commission calls for reversal of Illumina's $7bn Grail mergerhttps://european-biotechnology.com/up-to-date/latest-news/news/european-commission-calls-for-reversal-of-illuminas-7bn-grail-merger.html2022-12-06T09:07:00+01:00 BioNTech and Ryvu Therapeutics enter into global collaborationhttps://european-biotechnology.com/up-to-date/latest-news/news/biontech-and-ryvu-therapeutics-enter-into-global-collaboration.html2022-12-04T08:41:00+01:00 Amsterdam Neogene Therapeutics aquired by AstraZenecahttps://european-biotechnology.com/up-to-date/latest-news/news/amsterdam-neogene-therapeutics-aquired-by-astrazeneca.html2022-12-02T08:20:00+01:00 Novo Nordisk funds API manufacturing with €726mhttps://european-biotechnology.com/up-to-date/latest-news/news/novo-nordisk-funds-api-manufacturing-with-eur726m.html2022-11-30T16:09:12+01:00 SOTIO licences first cancer ADC from LegoChem Bioscienceshttps://european-biotechnology.com/up-to-date/latest-news/news/sotio-licences-first-cancer-adc-from-legochem-biosciences.html2022-11-29T17:50:01+01:00 British AI provider raises $33m in Series A financing https://european-biotechnology.com/up-to-date/latest-news/news/british-ai-provider-raises-33m-in-series-a-financing.html2022-11-29T11:51:53+01:00 Growing investor interest in biotechnologyhttps://european-biotechnology.com/up-to-date/latest-news/news/growing-investor-interest-in-biotechnology.html2022-11-29T10:08:00+01:00 C4X Discovery Holdings inks $402m deal with AstraZenecahttps://european-biotechnology.com/up-to-date/latest-news/news/c4x-discovery-holdings-inks-402m-deal-with-astrazeneca.html2022-11-28T12:59:04+01:00 CatalYm GmbH raises €50m to push visugromab development https://european-biotechnology.com/up-to-date/latest-news/news/catalym-gmbh-raises-eur50m-to-push-visugromab-development.html2022-11-22T16:41:28+01:00 Cultimate Foods UG raises €700.000 in pre-seed financinghttps://european-biotechnology.com/up-to-date/latest-news/news/cultimate-foods-ug-raises-eur700000-in-pre-seed-financing.html2022-11-21T12:01:19+01:00 Cradle BV bags €5.4m in seed financinghttps://european-biotechnology.com/up-to-date/latest-news/news/cradle-bv-bags-eur54m-in-seed-financing.html2022-11-18T14:35:39+01:00 Standing Ovation inks exlusive partnership with Bel Grouphttps://european-biotechnology.com/up-to-date/latest-news/news/standing-ovation-inks-exlusive-partnership-with-bel-group.html2022-11-15T14:57:02+01:00 EpiEndo Pharmaceuticals pushes COPD candidatehttps://european-biotechnology.com/up-to-date/latest-news/news/epiendo-pharmaceuticals-pushes-copd-candidate.html2022-11-14T15:34:00+01:00 Novo Nordisk Foundation funds Plant2Food with €27mhttps://european-biotechnology.com/up-to-date/latest-news/news/novo-nordisk-foundation-funds-plant2food-with-eur27m.html2022-11-11T12:08:17+01:00 Neotiv GmbH closes €10m seed financinghttps://european-biotechnology.com/up-to-date/latest-news/news/neotiv-gmbh-closes-eur10m-seed-financing.html2022-11-09T10:04:10+01:00 Jolt Capital boosts BC Platforms with $20mhttps://european-biotechnology.com/up-to-date/latest-news/news/jolt-capital-boosts-bc-platforms-with-20m.html2022-11-08T10:55:45+01:00 Fungal skin replaces plastics in electronicshttps://european-biotechnology.com/up-to-date/latest-news/news/fungal-skin-replaces-plastics-in-electronics.html2022-11-07T15:12:53+01:00 Novadip Biosciences SA raises €40m https://european-biotechnology.com/up-to-date/latest-news/news/novadip-biosciences-sa-raises-eur40m.html2022-11-07T10:44:27+01:00 Benefits of booster campaigns questionablehttps://european-biotechnology.com/up-to-date/latest-news/news/benefits-of-booster-campaigns-questionable.html2022-11-04T16:07:00+01:00 Memo Therapeutics and Ono Pharmaceutical enter partnershiphttps://european-biotechnology.com/up-to-date/latest-news/news/memo-therapeutics-and-ono-pharmaceutical-enter-partnership.html2022-11-01T16:17:59+01:00 Healthcare investments in Catalonia at record highhttps://european-biotechnology.com/up-to-date/latest-news/news/healthcare-investments-in-catalonia-at-record-high.html2022-11-01T10:07:07+01:00 EU Health Union ignoring cardiologyhttps://european-biotechnology.com/up-to-date/latest-news/news/eu-health-union-ignoring-cardiology.html2022-10-31T20:13:00+01:00 Audi and Krajete create CO2 air capture planthttps://european-biotechnology.com/up-to-date/latest-news/news/audi-and-krajete-create-co2-air-capture-plant.html2022-10-28T10:19:38+02:00 Solar Food’s protein from carbon dioxide gets authorisationhttps://european-biotechnology.com/up-to-date/latest-news/news/solar-foods-protein-from-carbon-dioxide-gets-authorisation.html2022-10-26T08:30:49+02:00 Bone Therapeutics merges with Medsenic and changes namehttps://european-biotechnology.com/up-to-date/latest-news/news/bone-therapeutics-merges-with-medsenic-and-changes-name.html2022-10-25T09:26:43+02:00 Resolve Biosciences secures US$71m in fundinghttps://european-biotechnology.com/up-to-date/latest-news/news/resolve-biosciences-secures-us71m-in-funding.html2022-10-24T10:20:00+02:00 Enhanc3D Genomics raises £10m in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/enhanc3d-genomics-raises-pound10m-in-series-a-financing.html2022-10-20T09:30:09+02:00 Univercells SA raises €44m in first close of its Series Dhttps://european-biotechnology.com/up-to-date/latest-news/news/univercells-sa-raises-eur44m-in-first-close-of-its-series-d.html2022-10-19T14:50:00+02:00 Adrenomed set to start pivotal trial in sepsishttps://european-biotechnology.com/up-to-date/latest-news/news/adrenomed-set-to-start-pivotal-trial-in-sepsis.html2022-10-18T21:50:45+02:00 Mablink raises $31m in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/mablink-raises-31m-in-series-a-financing.html2022-10-16T21:46:16+02:00 Experts showcase next-gen biotech solutions to climate crisishttps://european-biotechnology.com/up-to-date/latest-news/news/experts-showcase-next-gen-biotech-solutions-to-climate-crisis.html2022-10-12T11:46:46+02:00 Stalicla SA and Evgen Pharma plc ink $160.5m licensing deal for SFX-01https://european-biotechnology.com/up-to-date/latest-news/news/stalicla-sa-and-evgen-pharma-plc-ink-1605m-licensing-deal-for-sfx-01.html2022-10-12T11:15:28+02:00 Clinical Microbiomics A/S bags €10m financinghttps://european-biotechnology.com/up-to-date/latest-news/news/clinical-microbiomics-as-bags-eur10m-financing.html2022-10-11T08:54:17+02:00 EU starts largest study on factors affecting mental health https://european-biotechnology.com/up-to-date/latest-news/news/eu-starts-largest-study-on-factors-affecting-mental-health.html2022-10-10T09:35:10+02:00 Standing Ovation wins Industria Biotec’s start-up pitchhttps://european-biotechnology.com/up-to-date/latest-news/news/standing-ovation-wins-industria-biotecs-start-up-pitch.html2022-10-06T10:33:34+02:00 Araris Biotech closes $24m Series A financing roundhttps://european-biotechnology.com/up-to-date/latest-news/news/araris-biotech-closes-24m-series-a-financing-round.html2022-10-04T18:42:06+02:00 New Protein Fund I supports 17 alternative protein start-ups https://european-biotechnology.com/up-to-date/latest-news/news/new-protein-fund-i-supports-17-alternative-protein-start-ups.html2022-10-04T17:58:33+02:00 Sibylla Biotech raises €23m Series Ahttps://european-biotechnology.com/up-to-date/latest-news/news/sibylla-biotech-raises-eur23m-series-a.html2022-10-04T11:06:19+02:00 AI expert XUND GmbH bags €6m seed financinghttps://european-biotechnology.com/up-to-date/latest-news/news/ai-expert-xund-gmbh-bags-eur6m-seed-financing.html2022-10-03T12:36:00+02:00 ADC makeer Pheon Therapeutics raises $68mhttps://european-biotechnology.com/up-to-date/latest-news/news/adc-makeer-pheon-therapeutics-raises-68m.html2022-09-28T11:06:01+02:00 Kupando raises €13m to push TLR4/7 agonisthttps://european-biotechnology.com/up-to-date/latest-news/news/kupando-raises-eur13m-to-push-tlr47-agonist.html2022-09-26T18:41:16+02:00 DAMAN P/S enters personal RA medicine projecthttps://european-biotechnology.com/up-to-date/latest-news/news/daman-ps-enters-personal-ra-medicine-project.html2022-09-26T18:34:52+02:00 AI specialist Quinten Health bags €14m financinghttps://european-biotechnology.com/up-to-date/latest-news/news/ai-specialist-quinten-health-bags-eur14m-financing.html2022-09-21T14:47:38+02:00 Bavarian Nordic expands vaccine contract by $234m https://european-biotechnology.com/up-to-date/latest-news/news/bavarian-nordic-expands-vaccine-contract-by-234m.html2022-09-21T14:23:50+02:00 Genfit swallows Versantis in €105m dealhttps://european-biotechnology.com/up-to-date/latest-news/news/genfit-swallows-versantis-in-eur105m-deal.html2022-09-19T07:51:09+02:00 Food specialist Standing Ovation SA raises €12mhttps://european-biotechnology.com/up-to-date/latest-news/news/food-specialist-standing-ovation-sa-raises-eur12m.html2022-09-14T15:36:52+02:00 HeartBeat.bio inks partnership with Molecular Deviceshttps://european-biotechnology.com/up-to-date/latest-news/news/heartbeatbio-inks-partnership-with-molecular-devices.html2022-09-12T13:22:47+02:00 Mobile app recognises COVID-19 infectionhttps://european-biotechnology.com/up-to-date/latest-news/news/mobile-app-recognises-covid-19-infection.html2022-09-08T07:54:05+02:00 Pleco Therapeutics raises €17.3m in Series Ahttps://european-biotechnology.com/up-to-date/latest-news/news/pleco-therapeutics-raises-eur173m-in-series-a.html2022-09-06T13:31:05+02:00 Emergence Therapeutics licences Synaffix platformhttps://european-biotechnology.com/up-to-date/latest-news/news/emergence-therapeutics-licences-synaffix-platform.html2022-09-06T12:51:37+02:00 Abivax SA bags €49.2m to push ABX-464 https://european-biotechnology.com/up-to-date/latest-news/news/abivax-sa-bags-eur492m-to-push-abx-464.html2022-09-02T10:35:20+02:00 BioEcho Life Sciences launches US subsidiaryhttps://european-biotechnology.com/up-to-date/latest-news/news/bioecho-life-sciences-launches-us-subsidiary.html2022-09-02T09:34:00+02:00 Belgian researchers create extraembryonic mesoderm cellshttps://european-biotechnology.com/up-to-date/latest-news/news/belgian-researchers-create-extraembryonic-mesoderm-cells.html2022-09-01T19:59:39+02:00 SARS-CoV-2 infection triggers chronic fatigue syndromehttps://european-biotechnology.com/up-to-date/latest-news/news/sars-cov-2-infection-triggers-chronic-fatigue-syndrome.html2022-08-31T12:35:32+02:00 Danish Bactolife A/S grabs fundinghttps://european-biotechnology.com/up-to-date/latest-news/news/danish-bactolife-as-grabs-funding.html2022-08-30T17:35:16+02:00 Moderna launches patent dispute with BioNTech/Pfizerhttps://european-biotechnology.com/up-to-date/latest-news/news/moderna-launches-patent-dispute-with-biontechpfizer.html2022-08-29T07:44:00+02:00 Belgian eTheRNA raises €39m in Series B2 financinghttps://european-biotechnology.com/up-to-date/latest-news/news/belgian-etherna-raises-eur39m-in-series-b2-financing.html2022-08-24T10:44:39+02:00 Kinarus announces CHF 20 million convertible bond issuehttps://european-biotechnology.com/up-to-date/latest-news/news/kinarus-announces-chf-20-million-convertible-bond-issue.html2022-08-23T16:56:00+02:00 Cancer: Western life style is a killerhttps://european-biotechnology.com/up-to-date/latest-news/news/cancer-western-life-style-is-a-killer.html2022-08-22T12:39:00+02:00 Ryvu Therapeutics bags €22m from EIBhttps://european-biotechnology.com/up-to-date/latest-news/news/ryvu-therapeutics-bags-eur22m-from-eib.html2022-08-18T10:53:59+02:00 Largest beer brewer to use sustainable PEF bottleshttps://european-biotechnology.com/up-to-date/latest-news/news/largest-beer-brewer-to-use-sustainable-pef-bottles.html2022-08-17T11:28:01+02:00 Vector Biopharma kicks of with CHF30m Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/vector-biopharma-kicks-of-with-chf30m-series-a-financing.html2022-08-16T07:18:00+02:00 Two deaths with Novartis gene therapyhttps://european-biotechnology.com/up-to-date/latest-news/news/two-deaths-with-novartis-gene-therapy.html2022-08-15T07:09:00+02:00 Azenta set to acquire B Medical Systemshttps://european-biotechnology.com/up-to-date/latest-news/news/azenta-set-to-acquire-b-medical-systems.html2022-08-09T15:46:27+02:00 Sartorius pays £415m for Albumedix Ltdhttps://european-biotechnology.com/up-to-date/latest-news/news/sartorius-pays-pound415m-for-albumedix-ltd.html2022-08-09T07:45:09+02:00 BioNtech SE expands collab with Genmab A/Shttps://european-biotechnology.com/up-to-date/latest-news/news/biontech-se-expands-collab-with-genmab-as.html2022-08-08T07:14:33+02:00 F2G to use $70m financing to advance olorofilmhttps://european-biotechnology.com/up-to-date/latest-news/news/f2g-to-use-70m-financing-to-advance-olorofilm.html2022-08-04T09:05:31+02:00 Sosei announces $1.2bn R&D collaboration with Abbvie https://european-biotechnology.com/up-to-date/latest-news/news/sosei-announces-12bn-rd-collaboration-with-abbvie.html2022-08-02T09:38:20+02:00 UK-Spanish team to optimise efficacy of microbial production processeshttps://european-biotechnology.com/up-to-date/latest-news/news/uk-spanish-team-to-optimise-efficacy-of-microbial-production-processes.html2022-08-01T14:51:00+02:00 InflaRX set to file for MAA for vilobelimabhttps://european-biotechnology.com/up-to-date/latest-news/news/inflarx-set-to-file-for-maa-for-vilobelimab.html2022-07-26T15:06:17+02:00 New Amsterdam Pharma merges with Frazier Lifesciences Acquisition Corp.https://european-biotechnology.com/up-to-date/latest-news/news/new-amsterdam-pharma-merges-with-frazier-lifesciences-acquisition-corp.html2022-07-26T06:57:40+02:00 New antibody cocktail might fight all corona variantshttps://european-biotechnology.com/up-to-date/latest-news/news/new-antibody-cocktail-might-fight-all-corona-variants.html2022-07-25T20:22:00+02:00 French-German Novasep-PharmaZell Group invests EUR7.3M at Mourenx sitehttps://european-biotechnology.com/up-to-date/latest-news/news/french-german-novasep-pharmazell-group-invests-eur73m-at-mourenx-site.html2022-07-22T11:06:53+02:00 Oxford Science Enterprises raised a further £250 million ($300 million) in fundinghttps://european-biotechnology.com/up-to-date/latest-news/news/oxford-science-enterprises-raised-a-further-pound250-million-300-million-in-funding.html2022-07-21T07:47:00+02:00 Swedish Bioinvent issues shares worth SEK299m (USD28m)https://european-biotechnology.com/up-to-date/latest-news/news/swedish-bioinvent-issues-shares-worth-sek299m-usd28m.html2022-07-20T09:24:00+02:00 Immunocore has a sip with USD140m private placementhttps://european-biotechnology.com/up-to-date/latest-news/news/immunocore-has-a-sip-with-usd140m-private-placement.html2022-07-19T09:53:52+02:00 GSK splits off consumer health as Haleon - first stock listing today https://european-biotechnology.com/up-to-date/latest-news/news/gsk-splits-off-consumer-health-as-haleon-first-stock-listing-today.html2022-07-18T09:18:38+02:00 Polpharma Biologics Announces EMA Acceptance for Proposed Biosimilar Natalizumab (Tysabri)https://european-biotechnology.com/up-to-date/latest-news/news/polpharma-biologics-announces-ema-acceptance-for-proposed-biosimilar-natalizumab-tysabri.html2022-07-15T11:05:55+02:00 Agomab extenses Series B with USD40m Bringing Total Amount to USD114mhttps://european-biotechnology.com/up-to-date/latest-news/news/agomab-extenses-series-b-with-usd40m-bringing-total-amount-to-usd114m.html2022-07-13T11:28:29+02:00 Spatial Biology Company Navinci (Olink) closes EUR9m Series Ahttps://european-biotechnology.com/up-to-date/latest-news/news/spatial-biology-company-navinci-olink-closes-eur9m-series-a.html2022-07-12T10:14:00+02:00 Swedish SOBI awarded rights to market Zynlonta from ADC therapeuticshttps://european-biotechnology.com/up-to-date/latest-news/news/swedish-sobi-awarded-rights-to-market-zynlonta-from-adc-therapeutics.html2022-07-11T12:10:00+02:00 ECBF joins Novo Seeds and Sofinnova Partners in EUR11.5m round in Biosyntiahttps://european-biotechnology.com/up-to-date/latest-news/news/ecbf-joins-novo-seeds-and-sofinnova-partners-in-eur115m-round-in-biosyntia.html2022-07-08T10:43:51+02:00 Lonza invests CHF500m in Large-Scale Facility in Stein (CH)https://european-biotechnology.com/up-to-date/latest-news/news/lonza-invests-chf500m-in-large-scale-facility-in-stein-ch.html2022-07-07T09:48:00+02:00 Evotec, Boehringer Ingelheim, and bioMérieux launch Aurobachttps://european-biotechnology.com/up-to-date/latest-news/news/evotec-boehringer-ingelheim-and-biomerieux-launch-aurobac.html2022-07-06T10:38:46+02:00 Urovant Sciences cashes in $75m in licence deal from Pierre Fabrehttps://european-biotechnology.com/up-to-date/latest-news/news/urovant-sciences-cashes-in-75m-in-licence-deal-from-pierre-fabre.html2022-07-05T17:10:00+02:00 CureVac NV sues BioNTech for IP infringementhttps://european-biotechnology.com/up-to-date/latest-news/news/curevac-nv-sues-biontech-for-ip-infringement.html2022-07-04T23:31:00+02:00 French Ipsen falls after Epizyme take-over announcementhttps://european-biotechnology.com/up-to-date/latest-news/news/french-ipsen-falls-after-epizyme-take-over-announcement.html2022-06-28T15:11:00+02:00 TWB announces winners in industrial biotech start-up contesthttps://european-biotechnology.com/up-to-date/latest-news/news/twb-announces-winners-in-industrial-biotech-start-up-contest.html2022-06-27T09:22:00+02:00 BIONTech breaks ground for manufacturing site in Rwandahttps://european-biotechnology.com/up-to-date/latest-news/news/biontech-breaks-ground-for-manufacturing-site-in-rwanda.html2022-06-23T12:31:12+02:00 Cannabis players Canify AS and Bavaria Weed merge to form Canify AGhttps://european-biotechnology.com/up-to-date/latest-news/news/cannabis-players-canify-as-and-bavaria-weed-merge-to-form-canify-ag.html2022-06-22T12:06:30+02:00 Unilever launches $120m venture with Genomatica https://european-biotechnology.com/up-to-date/latest-news/news/unilever-launches-120m-venture-with-genomatica.html2022-06-17T08:42:03+02:00 Roche obtains special authorisation for bispecific antibodyhttps://european-biotechnology.com/up-to-date/latest-news/news/roche-obtains-special-authorisation-for-bispecific-antibody.html2022-06-14T10:39:00+02:00 French ImCheck get´s a USD103m check by Pfizer and a pack of VCshttps://european-biotechnology.com/up-to-date/latest-news/news/french-imcheck-gets-a-usd103m-check-by-pfizer-and-a-pack-of-vcs.html2022-06-13T15:17:07+02:00 $50m for London CHARM Therapeutics for deep minded folding expertisehttps://european-biotechnology.com/up-to-date/latest-news/news/50m-for-london-charm-therapeutics-for-deep-minded-folding-expertise.html2022-06-10T14:27:00+02:00 Biotalys’ first proteinbased biocontrol shows up in vineyardshttps://european-biotechnology.com/up-to-date/latest-news/news/biotalys-first-proteinbased-biocontrol-shows-up-in-vineyards.html2022-06-09T13:44:00+02:00 Andera Partners co-leads $118m Series B of Mineralys thx (USA)https://european-biotechnology.com/up-to-date/latest-news/news/andera-partners-co-leads-118m-series-b-of-mineralys-thx-usa.html2022-06-08T17:09:53+02:00 From waste to sugar - demonstration plant opens in Waleshttps://european-biotechnology.com/up-to-date/latest-news/news/from-waste-to-sugar-demonstration-plant-opens-in-wales.html2022-06-06T16:47:00+02:00 International Vaccine Institute – IVI – will locate its European office in Stockholmhttps://european-biotechnology.com/up-to-date/latest-news/news/international-vaccine-institute-ivi-will-locate-its-european-office-in-stockholm.html2022-06-03T16:28:00+02:00 Abliva decides on a SEK200m financing to fund Phase 2/3 studyhttps://european-biotechnology.com/up-to-date/latest-news/news/abliva-decides-on-a-sek200m-financing-to-fund-phase-23-study.html2022-06-02T15:54:00+02:00 Transine Therapeutics Ltd closes £13.7m seed financinghttps://european-biotechnology.com/up-to-date/latest-news/news/transine-therapeutics-ltd-closes-pound137m-seed-financing.html2022-06-01T19:49:32+02:00 Orphan drug developer Minoryx raises €51mhttps://european-biotechnology.com/up-to-date/latest-news/news/orphan-drug-developer-minoryx-raises-eur51m.html2022-05-31T10:21:00+02:00 G7 heads call for decarbonisation of industryhttps://european-biotechnology.com/up-to-date/latest-news/news/g7-heads-call-for-decarbonisation-of-industry.html2022-05-30T08:51:34+02:00 Ellipses Pharma licences SRB22 from SunRock Biopharma https://european-biotechnology.com/up-to-date/latest-news/news/ellipses-pharma-licences-srb22-from-sunrock-biopharma.html2022-05-25T10:12:39+02:00 Evotec signs contracts with Almirall and Sernovahttps://european-biotechnology.com/up-to-date/latest-news/news/evotec-signs-contracts-with-almirall-and-sernova.html2022-05-22T11:46:00+02:00 Avantium gets EU grant https://european-biotechnology.com/up-to-date/latest-news/news/avantium-gets-eu-grant.html2022-05-18T13:46:49+02:00 Enzymaster raises $45m in Series C roundhttps://european-biotechnology.com/up-to-date/latest-news/news/enzymaster-raises-45m-in-series-c-round.html2022-05-15T08:56:00+02:00 EU starts consultation on novel plant breeding methods https://european-biotechnology.com/up-to-date/latest-news/news/eu-starts-consultation-on-novel-plant-breeding-methods.html2022-05-11T13:05:18+02:00 Evotec and BMS intensify R&D on protein degradershttps://european-biotechnology.com/up-to-date/latest-news/news/evotec-and-bms-intensify-rd-on-protein-degraders.html2022-05-10T12:24:00+02:00 Replacing beef with cellular protein halves deforestationhttps://european-biotechnology.com/up-to-date/latest-news/news/replacing-beef-with-cellular-protein-halves-deforestation.html2022-05-05T23:23:00+02:00 Hot of the press: BIOTECH Insight Newsletterhttps://european-biotechnology.com/up-to-date/latest-news/news/hot-of-the-press-biotech-insight-newsletter.html2022-05-04T06:25:00+02:00 Engimmune Therapeutics raises CHF15.5m in seed financinghttps://european-biotechnology.com/up-to-date/latest-news/news/engimmune-therapeutics-raises-chf155m-in-seed-financing.html2022-05-04T05:10:00+02:00 Switzerland shows sustained growth of biotech sectorhttps://european-biotechnology.com/up-to-date/latest-news/news/switzerland-shows-sustained-growth-of-biotech-sector.html2022-05-02T22:16:35+02:00 Commission to establish EU health data spacehttps://european-biotechnology.com/up-to-date/latest-news/news/commission-to-establish-eu-health-data-space.html2022-05-01T21:04:32+02:00 Four new autoantigens trigger multiple sclerosishttps://european-biotechnology.com/up-to-date/latest-news/news/four-new-autoantigens-trigger-multiple-sclerosis.html2022-04-27T18:26:00+02:00 TWB partners with Processium and Syngulonhttps://european-biotechnology.com/up-to-date/latest-news/news/twb-partners-with-processium-and-syngulon.html2022-04-27T12:21:01+02:00 Meat consumption must fall by at least 75 percenthttps://european-biotechnology.com/up-to-date/latest-news/news/meat-consumption-must-fall-by-at-least-75-percent.html2022-04-27T05:56:00+02:00 Vigeneron updates gene therapy collab with Daiichi Sankyohttps://european-biotechnology.com/up-to-date/latest-news/news/vigeneron-updates-gene-therapy-collab-with-daiichi-sankyo.html2022-04-26T15:38:36+02:00 Single-use market to reach $20.8bn by 2026https://european-biotechnology.com/up-to-date/latest-news/news/single-use-market-to-reach-208bn-by-2026.html2022-04-26T15:22:12+02:00 Study shows advantages of cellular agriculturehttps://european-biotechnology.com/up-to-date/latest-news/news/study-shows-advantages-of-cellular-agriculture.html2022-04-25T20:31:55+02:00 EMA delays Valneva vaccine approvalhttps://european-biotechnology.com/up-to-date/latest-news/news/ema-delays-valneva-vaccine-approval.html2022-04-25T08:03:00+02:00 Mimetas BV participating in €325m cancer fundinghttps://european-biotechnology.com/up-to-date/latest-news/news/mimetas-bv-participating-in-eur325m-cancer-funding.html2022-04-20T09:24:43+02:00 Hansa Biopharma’s imlifidase advances to Phase III testing https://european-biotechnology.com/up-to-date/latest-news/news/hansa-biopharmas-imlifidase-advances-to-phase-iii-testing.html2022-04-19T09:51:00+02:00 GSK acquires Sierra Oncology for 1.9bnhttps://european-biotechnology.com/up-to-date/latest-news/news/gsk-acquires-sierra-oncology-for-19bn.html2022-04-15T07:20:00+02:00 Scientists print 3D cancer modelhttps://european-biotechnology.com/up-to-date/latest-news/news/scientists-print-3d-cancer-model.html2022-04-14T12:06:26+02:00 Affimed prices public offering to finance NK cell trialshttps://european-biotechnology.com/up-to-date/latest-news/news/affimed-prices-public-offering-to-finance-nk-cell-trials.html2022-04-13T10:10:34+02:00 GeNeuro finds biologic against post-COVID syndromehttps://european-biotechnology.com/up-to-date/latest-news/news/geneuro-finds-biologic-against-post-covid-syndrome.html2022-04-13T09:48:25+02:00 Catalent swallows VMIC Ltdhttps://european-biotechnology.com/up-to-date/latest-news/news/catalent-swallows-vmic-ltd.html2022-04-06T20:01:59+02:00 AXA launches €440 m private equity healthcare strategyhttps://european-biotechnology.com/up-to-date/latest-news/news/axa-launches-eur440-m-private-equity-healthcare-strategy.html2022-04-05T14:36:16+02:00 Bayer Leaps to invests €1.3bn externallyhttps://european-biotechnology.com/up-to-date/latest-news/news/bayer-leaps-to-invests-eur13bn-externally.html2022-04-05T07:51:49+02:00 Avantium closes financing for FDCA planthttps://european-biotechnology.com/up-to-date/latest-news/news/avantium-closes-financing-for-fdca-plant.html2022-04-01T16:32:26+02:00 Novo Holdings co-leads €40m Qure.ai financinghttps://european-biotechnology.com/up-to-date/latest-news/news/novo-holdings-co-leads-eur40m-qureai-financing.html2022-03-29T13:02:53+02:00 Sanofi and IGM Biosciences Inc. in $6.15bn dealhttps://european-biotechnology.com/up-to-date/latest-news/news/sanofi-and-igm-biosciences-inc-in-615bn-deal.html2022-03-29T08:54:52+02:00 XNK Therapeutics AB raises €12.75mhttps://european-biotechnology.com/up-to-date/latest-news/news/xnk-therapeutics-ab-raises-eur1275m.html2022-03-29T08:16:00+02:00 CSL Behring files for MAA of haemophilia B gene therapyhttps://european-biotechnology.com/up-to-date/latest-news/news/csl-behring-files-for-maa-of-haemophilia-b-gene-therapy.html2022-03-27T06:28:00+02:00 Argenx SE to raise €637m https://european-biotechnology.com/up-to-date/latest-news/news/argenx-se-to-raise-eur637m.html2022-03-24T11:29:30+01:00 Bayer invests into synthetic TCRs for cell therapyhttps://european-biotechnology.com/up-to-date/latest-news/news/bayer-invests-into-synthetic-tcrs-for-cell-therapy.html2022-03-22T20:12:05+01:00 Bavarian Nordic bags $225m for licence to RSV vaccinehttps://european-biotechnology.com/up-to-date/latest-news/news/bavarian-nordic-bags-225m-for-licence-to-rsv-vaccine.html2022-03-22T16:39:37+01:00 Switzerland paves the way for genome editinghttps://european-biotechnology.com/up-to-date/latest-news/news/switzerland-paves-the-way-for-genome-editing.html2022-03-20T15:34:00+01:00 Gilde Healthcare Private Equity IV launches €517m https://european-biotechnology.com/up-to-date/latest-news/news/gilde-healthcare-private-equity-iv-launches-eur517m.html2022-03-16T17:02:06+01:00 Precirix NV raises €80m in Series B financinghttps://european-biotechnology.com/up-to-date/latest-news/news/precirix-nv-raises-eur80m-in-series-b-financing.html2022-03-16T08:01:19+01:00 Sanofi bags €300m from US investor Blackstonehttps://european-biotechnology.com/up-to-date/latest-news/news/sanofi-bags-eur300m-from-us-investor-blackstone.html2022-03-16T06:55:14+01:00 Join 900 US CEOs protest against Ukraine invasionhttps://european-biotechnology.com/up-to-date/latest-news/news/join-900-us-ceos-protest-against-ukraine-invasion.html2022-03-15T09:20:51+01:00 Scenic Biotech BV announces $31m financinghttps://european-biotechnology.com/up-to-date/latest-news/news/scenic-biotech-bv-announces-31m-financing.html2022-03-09T13:21:58+01:00 Kurma Partners closes growth fund at €160mhttps://european-biotechnology.com/up-to-date/latest-news/news/kurma-partners-closes-growth-fund-at-eur160m.html2022-03-09T12:55:16+01:00 mRNA for Africahttps://european-biotechnology.com/up-to-date/latest-news/news/mrna-for-africa.html2022-03-07T18:57:01+01:00 Epsilogen raise £30.75m in Series B financinghttps://european-biotechnology.com/up-to-date/latest-news/news/epsilogen-raise-pound3075m-in-series-b-financing.html2022-03-02T14:19:13+01:00 Syndesi swallowed by Abbviehttps://european-biotechnology.com/up-to-date/latest-news/news/syndesi-swallowed-by-abbvie.html2022-03-01T17:39:27+01:00 Chinese Huadong snaps up Heidelberg Pharma.https://european-biotechnology.com/up-to-date/latest-news/news/chinese-huadong-snaps-up-heidelberg-pharma.html2022-03-01T17:10:49+01:00 Meletios Therapeutics licences antiviral patent https://european-biotechnology.com/up-to-date/latest-news/news/meletios-therapeutics-licences-antiviral-patent.html2022-02-28T09:13:00+01:00 ECBF oversubscribed closing at €300mhttps://european-biotechnology.com/up-to-date/latest-news/news/ecbf-oversubscribed-closing-at-eur300m.html2022-02-25T09:23:15+01:00 TargED Biopharmaceuticals BV raises €39m in Series A financing https://european-biotechnology.com/up-to-date/latest-news/news/targed-biopharmaceuticals-bv-raises-eur39m-in-series-a-financing.html2022-02-22T16:34:31+01:00 Finnish VTT spin-out Onego Bio Ltd raises €10mhttps://european-biotechnology.com/up-to-date/latest-news/news/finnish-vtt-spin-out-onego-bio-ltd-raises-eur10m.html2022-02-22T15:18:46+01:00 Moderna wants to extent its European footprinthttps://european-biotechnology.com/up-to-date/latest-news/news/moderna-wants-to-extent-its-european-footprint.html2022-02-21T17:03:00+01:00 Centauri Therapeutics starting with £24m financinghttps://european-biotechnology.com/up-to-date/latest-news/news/centauri-therapeutics-starting-with-pound24m-financing.html2022-02-16T11:11:11+01:00 Curve Therapeutics in US$1.7bn deal with MSDhttps://european-biotechnology.com/up-to-date/latest-news/news/curve-therapeutics-in-us17bn-deal-with-msd.html2022-02-16T09:57:05+01:00 Newton Biocapital launches new NBC III fund https://european-biotechnology.com/up-to-date/latest-news/news/newton-biocapital-launches-new-nbc-iii-fund.html2022-02-15T08:26:20+01:00 New funds to boost European life scienceshttps://european-biotechnology.com/up-to-date/latest-news/news/new-funds-to-boost-european-life-sciences.html2022-02-13T17:11:00+01:00 Aicuris licences antisense RNA know-how from Hybridize Therapeuticshttps://european-biotechnology.com/up-to-date/latest-news/news/aicuris-licences-antisense-rna-know-how-from-hybridize-therapeutics.html2022-02-10T14:11:41+01:00 BioNTech collaborates with AGC Biologicshttps://european-biotechnology.com/up-to-date/latest-news/news/biontech-collaborates-with-agc-biologics.html2022-02-09T13:17:47+01:00 EU Council confirms European Scale-up Initiativehttps://european-biotechnology.com/up-to-date/latest-news/news/eu-council-confirms-european-scale-up-initiative.html2022-02-09T12:12:14+01:00 Protix raises €50m for expansionhttps://european-biotechnology.com/up-to-date/latest-news/news/protix-raises-eur50m-for-expansion.html2022-02-08T13:00:00+01:00 Viennese Ribbon Biolabs closes €18m Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/viennese-ribbon-biolabs-closes-eur18m-series-a-financing.html2022-02-02T13:59:00+01:00 mRNA specalist Ethris raises $26m in Series B financinghttps://european-biotechnology.com/up-to-date/latest-news/news/mrna-specalist-ethris-raises-26m-in-series-b-financing.html2022-02-01T11:22:00+01:00 Evotec and Boehringer Ingelheim enter drug discovery dealhttps://european-biotechnology.com/up-to-date/latest-news/news/evotec-and-boehringer-ingelheim-enter-drug-discovery-deal.html2022-01-26T17:31:24+01:00 BioNTech and Pfizer evaluate Omicron-specific vaccinehttps://european-biotechnology.com/up-to-date/latest-news/news/biontech-and-pfizer-evaluate-omicron-specific-vaccine.html2022-01-26T09:49:01+01:00 Cytovation AS kicks-off with $20m Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/cytovation-as-kicks-off-with-20m-series-a-financing.html2022-01-25T08:06:48+01:00 Valneva vaccine neutralises Omicron varianthttps://european-biotechnology.com/up-to-date/latest-news/news/valneva-vaccine-neutralises-omicron-variant.html2022-01-21T13:06:00+01:00 Neurimmune expands drug discovery collaboration with Ono Pharmaceuticalhttps://european-biotechnology.com/up-to-date/latest-news/news/neurimmune-expands-drug-discovery-collaboration-with-ono-pharmaceutical.html2022-01-18T10:06:41+01:00 Evotec and Lilly to collaborate in metabolic diseaseshttps://european-biotechnology.com/up-to-date/latest-news/news/evotec-and-lilly-to-collaborate-in-metabolic-diseases.html2022-01-18T09:54:12+01:00 Protagen, BioAnalytix and GeneWerk launch ProtaGenehttps://european-biotechnology.com/up-to-date/latest-news/news/protagen-bioanalytix-and-genewerk-launch-protagene.html2022-01-13T10:34:32+01:00 BioNTech SE licences Cresendo Bio’s Humabody technologyhttps://european-biotechnology.com/up-to-date/latest-news/news/biontech-se-licences-cresendo-bios-humabody-technology.html2022-01-10T15:34:38+01:00 Novartis AG executes licence option with Molecular Partnershttps://european-biotechnology.com/up-to-date/latest-news/news/novartis-ag-executes-licence-option-with-molecular-partners.html2022-01-10T09:04:07+01:00 Neurimmune inks US-$760 deal with AstraZeneca https://european-biotechnology.com/up-to-date/latest-news/news/neurimmune-inks-us-760-deal-with-astrazeneca.html2022-01-09T19:18:00+01:00 Santhera finds Chinese marketing partner for vamorolonehttps://european-biotechnology.com/up-to-date/latest-news/news/santhera-finds-chinese-marketing-partner-for-vamorolone.html2022-01-05T07:26:52+01:00 DNA Script bags US$200m financinghttps://european-biotechnology.com/up-to-date/latest-news/news/dna-script-bags-us200m-financing.html2022-01-04T13:07:03+01:00 Sound Bioventures Fund I AB closes at €110mhttps://european-biotechnology.com/up-to-date/latest-news/news/sound-bioventures-fund-i-ab-closes-at-eur110m.html2022-01-04T10:54:55+01:00 Omicron variant more harmless than Deltahttps://european-biotechnology.com/up-to-date/latest-news/news/omicron-variant-more-harmless-than-delta.html2022-01-01T09:00:00+01:00 Novo Holdings invests €86m in 21st.BIOhttps://european-biotechnology.com/up-to-date/latest-news/news/novo-holdings-invests-eur86m-in-21stbio.html2021-12-23T08:42:00+01:00 Novartis AG snags Gyroscope for US$1.5bnhttps://european-biotechnology.com/up-to-date/latest-news/news/novartis-ag-snags-gyroscope-for-us15bn.html2021-12-22T09:55:32+01:00 NorthSea Therapeutics completes US$80m Series C financinghttps://european-biotechnology.com/up-to-date/latest-news/news/northsea-therapeutics-completes-us80m-series-c-financing.html2021-12-20T11:32:27+01:00 Depixus raises €30.6m in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/depixus-raises-eur306m-in-series-a-financing.html2021-12-15T08:42:13+01:00 Ichnos Sciences in licence deal with Almirall https://european-biotechnology.com/up-to-date/latest-news/news/ichnos-sciences-in-licence-deal-with-almirall.html2021-12-14T09:25:51+01:00 Vifor Pharma Ltd to be acquired for CHF10.9bnhttps://european-biotechnology.com/up-to-date/latest-news/news/vifor-pharma-ltd-to-be-acquired-for-chf109bn.html2021-12-14T08:49:20+01:00 Apogenix gets €25.8m cash injection for asunercepthttps://european-biotechnology.com/up-to-date/latest-news/news/apogenix-gets-eur258m-cash-injection-for-asunercept.html2021-12-09T12:47:17+01:00 British Adendra Therapeutics closes $53m financinghttps://european-biotechnology.com/up-to-date/latest-news/news/british-adendra-therapeutics-closes-53m-financing.html2021-12-08T08:03:00+01:00 Recordati bags EUSA to strengthen rare disease franchisehttps://european-biotechnology.com/up-to-date/latest-news/news/recordati-bags-eusa-to-strengthen-rare-disease-franchise.html2021-12-06T12:45:00+01:00 Sanofi acquires therapeutic acne vaccinehttps://european-biotechnology.com/up-to-date/latest-news/news/sanofi-acquires-therapeutic-acne-vaccine.html2021-12-02T00:45:00+01:00 US-Greek Venture gets €32m cash injectionhttps://european-biotechnology.com/up-to-date/latest-news/news/us-greek-venture-gets-eur32m-cash-injection.html2021-12-01T11:10:27+01:00 Early-stage ventures fighting AMR wanted!https://european-biotechnology.com/up-to-date/latest-news/news/early-stage-ventures-fighting-amr-wanted.html2021-11-30T00:45:00+01:00 Quell raises US$156m for Treg cell therapy programmehttps://european-biotechnology.com/up-to-date/latest-news/news/quell-raises-us156m-for-treg-cell-therapy-programme.html2021-11-29T21:17:00+01:00 Vaccibody – now Nykode – in vaccine deal with Regeneronhttps://european-biotechnology.com/up-to-date/latest-news/news/vaccibody-now-nykode-in-vaccine-deal-with-regeneron.html2021-11-25T11:17:00+01:00 EC signs prepurchase agreement with Valnevahttps://european-biotechnology.com/up-to-date/latest-news/news/ec-signs-prepurchase-agreement-with-valneva.html2021-11-24T09:42:10+01:00 Vifor buys out one-drug wonder Sanifithttps://european-biotechnology.com/up-to-date/latest-news/news/vifor-buys-out-one-drug-wonder-sanifit.html2021-11-23T07:17:00+01:00 Novo Nordisk snatches Dicernahttps://european-biotechnology.com/up-to-date/latest-news/news/novo-nordisk-snatches-dicerna.html2021-11-18T20:19:48+01:00 Pfizer licences Paxlovid to poor countrieshttps://european-biotechnology.com/up-to-date/latest-news/news/pfizer-licences-paxlovid-to-poor-countries.html2021-11-17T08:06:07+01:00 Synthace bags US$35m for R&D cloud platformhttps://european-biotechnology.com/up-to-date/latest-news/news/synthace-bags-us35m-for-rd-cloud-platform.html2021-11-16T21:17:00+01:00 EU orders up Valneva’s inactivated Covid-19 vaccinehttps://european-biotechnology.com/up-to-date/latest-news/news/eu-orders-up-valnevas-inactivated-covid-19-vaccine.html2021-11-10T21:17:00+01:00 LSP and EQT merge to create top-10 investment firmhttps://european-biotechnology.com/up-to-date/latest-news/news/lsp-and-eqt-merge-to-create-top-10-investment-firm.html2021-11-10T09:53:57+01:00 Stock market boom: Two biotechs go publichttps://european-biotechnology.com/up-to-date/latest-news/news/stock-market-boom-two-biotechs-go-public.html2021-11-08T21:17:00+01:00 LSP raises a whopping €850m for the European life scienceshttps://european-biotechnology.com/up-to-date/latest-news/news/lsp-raises-a-whopping-eur850m-for-the-european-life-sciences.html2021-11-04T21:17:00+01:00 Novartis inks US-$1.3bn deal with Dunad Therapeutics https://european-biotechnology.com/up-to-date/latest-news/news/novartis-inks-us-13bn-deal-with-dunad-therapeutics.html2021-11-03T10:43:25+01:00 AstraZeneca unloads respiratory drugs to Covishttps://european-biotechnology.com/up-to-date/latest-news/news/astrazeneca-unloads-respiratory-drugs-to-covis.html2021-11-01T22:17:00+01:00 Agomab Therapeutics to acquire Origo Biopharmahttps://european-biotechnology.com/up-to-date/latest-news/news/agomab-therapeutics-to-acquire-origo-biopharma.html2021-10-28T06:51:42+02:00 Evotec goes for massive IPO on Nasdaqhttps://european-biotechnology.com/up-to-date/latest-news/news/evotec-goes-for-massive-ipo-on-nasdaq.html2021-10-27T22:17:00+02:00 €40m for Treg starver start-uphttps://european-biotechnology.com/up-to-date/latest-news/news/eur40m-for-treg-starver-start-up.html2021-10-26T12:17:00+02:00 From make-up to jet fuel: Breakthrough for Global Bioenergieshttps://european-biotechnology.com/up-to-date/latest-news/news/from-make-up-to-jet-fuel-breakthrough-for-global-bioenergies.html2021-10-21T07:17:00+02:00 Sofinnova Capital X Fund closed at €472mhttps://european-biotechnology.com/up-to-date/latest-news/news/sofinnova-capital-x-fund-closed-at-eur472m.html2021-10-20T10:23:55+02:00 BICO raises €600m and acquires QInstrumentshttps://european-biotechnology.com/up-to-date/latest-news/news/bico-raises-eur600m-and-acquires-qinstruments.html2021-10-19T07:17:00+02:00 European sustainability fund raises €200mhttps://european-biotechnology.com/up-to-date/latest-news/news/european-sustainability-fund-raises-eur200m.html2021-10-13T19:17:00+02:00 Curevac withdraws MAA of CVnCoV https://european-biotechnology.com/up-to-date/latest-news/news/curevac-withdraws-maa-of-cvncov.html2021-10-13T11:56:22+02:00 Idorsia: Failure in Phase IIIhttps://european-biotechnology.com/up-to-date/latest-news/news/idorsia-failure-in-phase-iii.html2021-10-12T07:17:00+02:00 Delivering on Europe´s Green Deal – EFIB 2021 in Viennahttps://european-biotechnology.com/up-to-date/latest-news/news/delivering-on-europes-green-deal-efib-2021-in-vienna.html2021-10-06T13:44:03+02:00 COVID-19 immunisation set to get FDA EUA https://european-biotechnology.com/up-to-date/latest-news/news/covid-19-immunisation-set-to-get-fda-eua.html2021-10-05T17:19:08+02:00 Thermo Fisher opens Swiss biologics manufacturing planthttps://european-biotechnology.com/up-to-date/latest-news/news/thermo-fisher-opens-swiss-biologics-manufacturing-plant.html2021-10-05T07:17:00+02:00 BioNTech investigates cancer vaccine BNT122 in Phase II trialhttps://european-biotechnology.com/up-to-date/latest-news/news/biontech-investigates-cancer-vaccine-bnt122-in-phase-ii-trial.html2021-10-01T07:17:33+02:00 Advent France Biotechnology launches €86m fundhttps://european-biotechnology.com/up-to-date/latest-news/news/advent-france-biotechnology-launches-eur86m-fund.html2021-09-30T16:34:00+02:00 UK clears the way for gene-edited cropshttps://european-biotechnology.com/up-to-date/latest-news/news/uk-clears-the-way-for-gene-edited-crops.html2021-09-30T07:16:00+02:00 Team identifies factors for COVID-19 vaccine protectionhttps://european-biotechnology.com/up-to-date/latest-news/news/team-identifies-factors-for-covid-19-vaccine-protection.html2021-09-29T13:43:58+02:00 AstraZeneca invests in saRNA platformhttps://european-biotechnology.com/up-to-date/latest-news/news/astrazeneca-invests-in-sarna-platform.html2021-09-28T07:16:00+02:00 EIF supports translational med with €25mhttps://european-biotechnology.com/up-to-date/latest-news/news/eif-supports-translational-med-with-eur25m.html2021-09-24T10:40:00+02:00 Boehringer Ingelheim: Takeover in immunooncology https://european-biotechnology.com/up-to-date/latest-news/news/boehringer-ingelheim-takeover-in-immunooncology.html2021-09-23T07:16:00+02:00 AstraZeneca puts €307m in Irish Alexion planthttps://european-biotechnology.com/up-to-date/latest-news/news/astrazeneca-puts-eur307m-in-irish-alexion-plant.html2021-09-22T09:16:44+02:00 Bayer: Peptide deal with Gubrahttps://european-biotechnology.com/up-to-date/latest-news/news/bayer-peptide-deal-with-gubra.html2021-09-21T07:55:00+02:00 Foundation launches Harvard research hubhttps://european-biotechnology.com/up-to-date/latest-news/news/foundation-launches-harvard-research-hub.html2021-09-16T07:55:00+02:00 Touchlight extends funding round to boost DNA vector manufacturehttps://european-biotechnology.com/up-to-date/latest-news/news/touchlight-extends-funding-round-to-boost-dna-vector-manufacture.html2021-09-15T07:35:00+02:00 Meatable teams up with Royal DSMhttps://european-biotechnology.com/up-to-date/latest-news/news/meatable-teams-up-with-royal-dsm.html2021-09-14T07:55:00+02:00 US$21m for microbiome therapieshttps://european-biotechnology.com/up-to-date/latest-news/news/us21m-for-microbiome-therapies.html2021-09-09T07:55:00+02:00 Swiss Biotech Day shows great biopharma ambitionshttps://european-biotechnology.com/up-to-date/latest-news/news/swiss-biotech-day-shows-great-biopharma-ambitions.html2021-09-08T08:55:29+02:00 Owlstone: US$59m for breath biopsy developmenthttps://european-biotechnology.com/up-to-date/latest-news/news/owlstone-us59m-for-breath-biopsy-development.html2021-09-07T09:17:00+02:00 EU ends litigation with AstraZenecahttps://european-biotechnology.com/up-to-date/latest-news/news/eu-ends-litigation-with-astrazeneca.html2021-09-03T12:17:00+02:00 EuropaBio lobbies for better Orphan Drug ruleshttps://european-biotechnology.com/up-to-date/latest-news/news/europabio-lobbies-for-better-orphan-drug-rules.html2021-09-01T10:55:20+02:00 VectivBio expands rare disease pipelinehttps://european-biotechnology.com/up-to-date/latest-news/news/vectivbio-expands-rare-disease-pipeline.html2021-08-31T17:17:00+02:00 Call for pull incentives to get startedhttps://european-biotechnology.com/up-to-date/latest-news/news/call-for-pull-incentives-to-get-started.html2021-08-30T05:46:00+02:00 ADC Therapeutics: US$325m for ADC royaltieshttps://european-biotechnology.com/up-to-date/latest-news/news/adc-therapeutics-us325m-for-adc-royalties.html2021-08-26T17:17:00+02:00 Cardior bags €64m in Series B Financinghttps://european-biotechnology.com/up-to-date/latest-news/news/cardior-bags-eur64m-in-series-b-financing.html2021-08-24T10:17:17+02:00 Yet another blow to Merck’s cancer hopefulhttps://european-biotechnology.com/up-to-date/latest-news/news/yet-another-blow-to-mercks-cancer-hopeful.html2021-08-24T10:00:00+02:00 Beckley Psytech: €68m for psychedelic medshttps://european-biotechnology.com/up-to-date/latest-news/news/beckley-psytech-eur68m-for-psychedelic-meds.html2021-08-19T07:00:00+02:00 ERS Genomics and Cellular Engineering Technologies collaboratinghttps://european-biotechnology.com/up-to-date/latest-news/news/ers-genomics-and-cellular-engineering-technologies-collaborating.html2021-08-18T08:53:31+02:00 Boehringer walks away from CureVac dealhttps://european-biotechnology.com/up-to-date/latest-news/news/boehringer-walks-away-from-curevac-deal.html2021-08-17T07:00:00+02:00 New vaccine trial targets Covid variantshttps://european-biotechnology.com/up-to-date/latest-news/news/new-vaccine-trial-targets-covid-variants.html2021-08-12T07:00:00+02:00 Visus Therapeutics cashes in €20m from LSP https://european-biotechnology.com/up-to-date/latest-news/news/visus-therapeutics-cashes-in-eur20m-from-lsp.html2021-08-11T06:20:00+02:00 Protein may help control cancer cellshttps://european-biotechnology.com/up-to-date/latest-news/news/protein-may-help-control-cancer-cells.html2021-08-10T08:00:00+02:00 British drug developer Mission Therapeutics plc earns $20m milestone https://european-biotechnology.com/up-to-date/latest-news/news/british-drug-developer-mission-therapeutics-plc-earns-20m-milestone.html2021-08-09T08:12:31+02:00 Bayer takes over Vividionhttps://european-biotechnology.com/up-to-date/latest-news/news/bayer-takes-over-vividion.html2021-08-05T10:00:00+02:00 Spectricity raises €14m in Series B roundhttps://european-biotechnology.com/up-to-date/latest-news/news/spectricity-raises-eur14m-in-series-b-round.html2021-08-04T07:58:31+02:00 Sanofi snaps up mRNA partner for US$3.2bnhttps://european-biotechnology.com/up-to-date/latest-news/news/sanofi-snaps-up-mrna-partner-for-us32bn.html2021-08-03T07:40:00+02:00 Abcam to acquire BioVision for $340mhttps://european-biotechnology.com/up-to-date/latest-news/news/abcam-to-acquire-biovision-for-340m.html2021-08-02T08:40:06+02:00 Byondis and Glycotope merge platforms to target carbohydrateshttps://european-biotechnology.com/up-to-date/latest-news/news/byondis-and-glycotope-merge-platforms-to-target-carbohydrates.html2021-07-29T07:00:00+02:00 Artios Pharma Ltd raises US-$153m Series C financinghttps://european-biotechnology.com/up-to-date/latest-news/news/artios-pharma-ltd-raises-us-153m-series-c-financing.html2021-07-27T19:13:00+02:00 AXA IM Alts raises €1.9bn European Life Sciences Fundhttps://european-biotechnology.com/up-to-date/latest-news/news/axa-im-alts-raises-eur19bn-european-life-sciences-fund.html2021-07-27T11:05:33+02:00 Synaffix inks $246m deal with ProfoundBiohttps://european-biotechnology.com/up-to-date/latest-news/news/synaffix-inks-246m-deal-with-profoundbio.html2021-07-24T10:12:56+02:00 Panakès expands into biotech with €150m fundhttps://european-biotechnology.com/up-to-date/latest-news/news/panakes-expands-into-biotech-with-eur150m-fund.html2021-07-22T08:00:00+02:00 BioNTech takes over cancer immunotherapy platformhttps://european-biotechnology.com/up-to-date/latest-news/news/biontech-takes-over-cancer-immunotherapy-platform.html2021-07-20T08:00:00+02:00 Nanosyrinx raises £6.2m to validate drug delivery platformhttps://european-biotechnology.com/up-to-date/latest-news/news/nanosyrinx-raises-pound62m-to-validate-drug-delivery-platform.html2021-07-19T19:40:07+02:00 €26m financing for ISA Pharmaceuticalshttps://european-biotechnology.com/up-to-date/latest-news/news/eur26m-financing-for-isa-pharmaceuticals.html2021-07-15T07:00:00+02:00 Unilever licences Arzeda Inc.‘s enzyme technologyhttps://european-biotechnology.com/up-to-date/latest-news/news/unilever-licences-arzeda-incs-enzyme-technology.html2021-07-14T05:41:00+02:00 Novo Nordisk invests in amyloidosis pipelinehttps://european-biotechnology.com/up-to-date/latest-news/news/novo-nordisk-invests-in-amyloidosis-pipeline.html2021-07-13T08:00:00+02:00 Sanofi invests heavily in multiple myeloma pipelinehttps://european-biotechnology.com/up-to-date/latest-news/news/sanofi-invests-heavily-in-multiple-myeloma-pipeline.html2021-07-08T11:00:00+02:00 Bio-Me raises NOK10mhttps://european-biotechnology.com/up-to-date/latest-news/news/bio-me-raises-nok10m.html2021-07-07T09:13:19+02:00 NFL Biosciences goes public, raises €5mhttps://european-biotechnology.com/up-to-date/latest-news/news/nfl-biosciences-goes-public-raises-eur5m.html2021-07-06T08:00:00+02:00 Promethera bags €20m for liver failure treatmenthttps://european-biotechnology.com/up-to-date/latest-news/news/promethera-bags-eur20m-for-liver-failure-treatment.html2021-07-01T07:30:00+02:00 Novalis Biotech closes biotech fund at €25mhttps://european-biotechnology.com/up-to-date/latest-news/news/novalis-biotech-closes-biotech-fund-at-eur25m.html2021-06-30T08:55:04+02:00 Cellink AB to take-over Discover Echo Inchttps://european-biotechnology.com/up-to-date/latest-news/news/cellink-ab-to-take-over-discover-echo-inc.html2021-06-26T11:56:45+02:00 Rheincell set to be acquired by Catalenthttps://european-biotechnology.com/up-to-date/latest-news/news/rheincell-set-to-be-acquired-by-catalent.html2021-06-25T09:04:37+02:00 Data protection rules may block medical progresshttps://european-biotechnology.com/up-to-date/latest-news/news/data-protection-rules-may-block-medical-progress.html2021-06-23T11:17:39+02:00 NeuVasQ Biotechnologies bags €20m in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/neuvasq-biotechnologies-bags-eur20m-in-series-a-financing.html2021-06-22T09:01:02+02:00 Coriolis Pharma expands its ATMP development facilitieshttps://european-biotechnology.com/up-to-date/latest-news/news/coriolis-pharma-expands-its-atmp-development-facilities.html2021-06-21T18:17:16+02:00 mRNA: Evonik cooperates with Stanford Universityhttps://european-biotechnology.com/up-to-date/latest-news/news/mrna-evonik-cooperates-with-stanford-university.html2021-06-14T15:33:00+02:00 COVAX: Pfizer and Biontech to provide 500 Million Doses of COVID-19 Vaccinehttps://european-biotechnology.com/up-to-date/latest-news/news/covax-pfizer-and-biontech-to-provide-500-million-doses-of-covid-19-vaccine.html2021-06-10T14:16:50+02:00 Iksuda Therapeutics closes $47m financing roundhttps://european-biotechnology.com/up-to-date/latest-news/news/iksuda-therapeutics-closes-47m-financing-round.html2021-06-07T13:21:40+02:00 Lonza expands EU production capacity for Moderna vaccinehttps://european-biotechnology.com/up-to-date/latest-news/news/lonza-expands-eu-production-capacity-for-moderna-vaccine.html2021-06-02T08:12:04+02:00 EU approves Biontech/Pfizer vaccine for adolescentshttps://european-biotechnology.com/up-to-date/latest-news/news/eu-approves-biontechpfizer-vaccine-for-adolescents.html2021-06-01T14:45:13+02:00 Senti Bio and Bluerock ink Regmed collaborationhttps://european-biotechnology.com/up-to-date/latest-news/news/senti-bio-and-bluerock-ink-regmed-collaboration.html2021-05-26T14:29:10+02:00 Pieris in $1.4bn deal with Rochehttps://european-biotechnology.com/up-to-date/latest-news/news/pieris-in-14bn-deal-with-roche.html2021-05-26T09:41:25+02:00 Associations call for acceleration of ATMP trials in Europehttps://european-biotechnology.com/up-to-date/latest-news/news/associations-call-for-acceleration-of-atmp-trials-in-europe.html2021-05-25T08:04:00+02:00 COVID-19 med APN01 selected to be tested in ACTIV studyhttps://european-biotechnology.com/up-to-date/latest-news/news/covid-19-med-apn01-selected-to-be-tested-in-activ-study.html2021-05-20T07:02:59+02:00 Hummingbird Bioscience raises $125m in Series C financinghttps://european-biotechnology.com/up-to-date/latest-news/news/hummingbird-bioscience-raises-125m-in-series-c-financing.html2021-05-18T23:32:31+02:00 BD installs production hub in Zaraogzahttps://european-biotechnology.com/up-to-date/latest-news/news/bd-installs-production-hub-in-zaraogza.html2021-05-18T12:45:32+02:00 COVID-19 therapeutics: Germany launches €300m fundinghttps://european-biotechnology.com/up-to-date/latest-news/news/covid-19-therapeutics-germany-launches-eur300m-funding.html2021-05-13T19:59:18+02:00 Recombinant silk producer AMSilk raises €29mhttps://european-biotechnology.com/up-to-date/latest-news/news/recombinant-silk-producer-amsilk-raises-eur29m.html2021-05-11T18:27:59+02:00 SARS-CoV-2-antibodies may promote severe COVID-19https://european-biotechnology.com/up-to-date/latest-news/news/sars-cov-2-antibodies-may-promote-severe-covid-19.html2021-05-11T17:10:26+02:00 Abingworth raises $582m for late-stage fund ACCD 2https://european-biotechnology.com/up-to-date/latest-news/news/abingworth-raises-582m-for-late-stage-fund-accd-2.html2021-05-10T11:07:35+02:00 USA supports to temporarily waive IP of COVID-19 vaccineshttps://european-biotechnology.com/up-to-date/latest-news/news/usa-supports-to-temporarily-waive-ip-of-covid-19-vaccines.html2021-05-06T06:41:00+02:00 Swiss Oculis SA raises $57m in Series Chttps://european-biotechnology.com/up-to-date/latest-news/news/swiss-oculis-sa-raises-57m-in-series-c.html2021-05-06T06:31:00+02:00 Mogrifiy completes Series A financing roundhttps://european-biotechnology.com/up-to-date/latest-news/news/mogrifiy-completes-series-a-financing-round.html2021-05-04T13:32:33+02:00 COVID-19 vaccine for poor countrieshttps://european-biotechnology.com/up-to-date/latest-news/news/covid-19-vaccine-for-poor-countries.html2021-05-03T13:32:42+02:00 ADCendo ApS raises €51m in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/adcendo-aps-raises-eur51m-in-series-a-financing.html2021-04-29T10:08:16+02:00 DNA Script bags DARPA fundinghttps://european-biotechnology.com/up-to-date/latest-news/news/dna-script-bags-darpa-funding.html2021-04-27T13:39:04+02:00 First malaria vaccine meets WHO efficacy criteriahttps://european-biotechnology.com/up-to-date/latest-news/news/first-malaria-vaccine-meets-who-efficacy-criteria.html2021-04-26T20:02:01+02:00 European COVID-19 antibody enters Phase III testinghttps://european-biotechnology.com/up-to-date/latest-news/news/european-covid-19-antibody-enters-phase-iii-testing.html2021-04-23T08:02:00+02:00 J&J starts European COVID-19 vaccine roll-outhttps://european-biotechnology.com/up-to-date/latest-news/news/jj-starts-european-covid-19-vaccine-roll-out.html2021-04-22T07:26:40+02:00 Endeavour Medtech Growth II LP closes at $375m https://european-biotechnology.com/up-to-date/latest-news/news/endeavour-medtech-growth-ii-lp-closes-at-375m.html2021-04-21T10:11:00+02:00 Record year for Swiss biotech industryhttps://european-biotechnology.com/up-to-date/latest-news/news/record-year-for-swiss-biotech-industry.html2021-04-20T19:46:48+02:00 EU orders 100 million additional doses from Biontechhttps://european-biotechnology.com/up-to-date/latest-news/news/eu-orders-100-million-additional-doses-from-biontech.html2021-04-20T06:25:00+02:00 COVID-19: Study finds neutralising antibodies to disappear rapidlyhttps://european-biotechnology.com/up-to-date/latest-news/news/covid-19-study-finds-neutralising-antibodies-to-disappear-rapidly.html2021-04-15T10:11:00+02:00 BioVersys gets €20m EIB loan to develop novel antibioticshttps://european-biotechnology.com/up-to-date/latest-news/news/bioversys-gets-eur20m-eib-loan-to-develop-novel-antibiotics.html2021-04-14T08:44:00+02:00 C4X Discovery and Sanofi ink €414m IL-17A blocker R&D contract https://european-biotechnology.com/up-to-date/latest-news/news/c4x-discovery-and-sanofi-ink-eur414m-il-17a-blocker-rd-contract.html2021-04-13T11:33:00+02:00 Next-gen COVID-19 vaccine good in preclinical testshttps://european-biotechnology.com/up-to-date/latest-news/news/next-gen-covid-19-vaccine-good-in-preclinical-tests.html2021-04-08T07:51:00+02:00 EMA: AZD1222 causes serious rare ADEshttps://european-biotechnology.com/up-to-date/latest-news/news/ema-azd1222-causes-serious-rare-ades.html2021-04-07T20:16:33+02:00 Targeting SARS-CoV-2 differentlyhttps://european-biotechnology.com/up-to-date/latest-news/news/targeting-sars-cov-2-differently.html2021-04-04T11:27:00+02:00 miRNAs unmask vulnerability in breast cancer stem cellshttps://european-biotechnology.com/up-to-date/latest-news/news/mirnas-unmask-vulnerability-in-breast-cancer-stem-cells.html2021-04-03T07:22:00+02:00 Janssen to pledge COVID-19 vaccine to African Unionhttps://european-biotechnology.com/up-to-date/latest-news/news/janssen-to-pledge-covid-19-vaccine-to-african-union.html2021-03-30T08:15:38+02:00 Bispecific IgG switch off SARS-CoV-2 escape variants https://european-biotechnology.com/up-to-date/latest-news/news/bispecific-igg-switch-off-sars-cov-2-escape-variants.html2021-03-25T15:30:19+01:00 Step Pharma SAS raises €35m in Series B https://european-biotechnology.com/up-to-date/latest-news/news/step-pharma-sas-raises-eur35m-in-series-b.html2021-03-24T09:39:24+01:00 AZD1222 claims 79% effecacy in pivotal US studyhttps://european-biotechnology.com/up-to-date/latest-news/news/azd1222-claims-79-effecacy-in-pivotal-us-study.html2021-03-23T07:19:00+01:00 EMA recommends to continue AZD1222 vaccinationshttps://european-biotechnology.com/up-to-date/latest-news/news/ema-recommends-to-continue-azd1222-vaccinations.html2021-03-18T18:16:00+01:00 Novel COVID antibody enters clinical testinghttps://european-biotechnology.com/up-to-date/latest-news/news/novel-covid-antibody-enters-clinical-testing.html2021-03-17T10:08:13+01:00 B.1.1.7 variant associated with higher mortalityhttps://european-biotechnology.com/up-to-date/latest-news/news/b117-variant-associated-with-higher-mortality.html2021-03-15T12:35:33+01:00 Roche in take-over deal with GenMark Diagnosticshttps://european-biotechnology.com/up-to-date/latest-news/news/roche-in-take-over-deal-with-genmark-diagnostics.html2021-03-15T07:47:21+01:00 Media hype on Denmark’s decision to halt AZD1222 vaccinationhttps://european-biotechnology.com/up-to-date/latest-news/news/media-hype-on-denmarks-decision-to-halt-azd1222-vaccination.html2021-03-11T15:26:50+01:00 Roche Phase III study misses COVID-19 endpointhttps://european-biotechnology.com/up-to-date/latest-news/news/roche-phase-iii-study-misses-covid-19-endpoint.html2021-03-11T10:15:18+01:00 BioPhero A/S raises US$17m in Series A fundinghttps://european-biotechnology.com/up-to-date/latest-news/news/biophero-as-raises-us17m-in-series-a-funding.html2021-03-10T07:36:28+01:00 PCR-test reveals risk of genotoxity of genome editinghttps://european-biotechnology.com/up-to-date/latest-news/news/pcr-test-reveals-risk-of-genotoxity-of-genome-editing.html2021-03-07T16:58:00+01:00 EMA starts rolling review for Sputnik V vaccinehttps://european-biotechnology.com/up-to-date/latest-news/news/ema-starts-rolling-review-for-sputnik-v-vaccine.html2021-03-04T11:53:37+01:00 CAC builds biofuel plant for OMVhttps://european-biotechnology.com/up-to-date/latest-news/news/cac-builds-biofuel-plant-for-omv.html2021-03-03T11:46:15+01:00 French biotech investors launch spin-out alliancehttps://european-biotechnology.com/up-to-date/latest-news/news/french-biotech-investors-launch-spin-out-alliance.html2021-03-02T14:43:54+01:00 Oxular Ltd raises US$37m https://european-biotechnology.com/up-to-date/latest-news/news/oxular-ltd-raises-us37m.html2021-03-01T19:14:55+01:00 EU life science PPPs face less budget in Horizon Europehttps://european-biotechnology.com/up-to-date/latest-news/news/eu-life-science-ppps-face-less-budget-in-horizon-europe.html2021-02-24T18:03:28+01:00 MosaMeat BV closes US$85m Series B financinghttps://european-biotechnology.com/up-to-date/latest-news/news/mosameat-bv-closes-us85m-series-b-financing.html2021-02-24T15:02:03+01:00 Biomarker identifies high-risk COVID-19 patientshttps://european-biotechnology.com/up-to-date/latest-news/news/biomarker-identifies-high-risk-covid-19-patients.html2021-02-23T08:32:27+01:00 MaxiVAX and Minaris Regenerative Medicine ink contracthttps://european-biotechnology.com/up-to-date/latest-news/news/maxivax-and-minaris-regenerative-medicine-ink-contract.html2021-02-22T14:44:00+01:00 EU orders additional COVID-19 vaccine doseshttps://european-biotechnology.com/up-to-date/latest-news/news/eu-orders-additional-covid-19-vaccine-doses.html2021-02-17T14:30:59+01:00 Novel strategy targets chronic liver diseaseshttps://european-biotechnology.com/up-to-date/latest-news/news/novel-strategy-targets-chronic-liver-diseases.html2021-02-16T19:57:49+01:00 Cellectis and Cytovia in US$760m licence dealhttps://european-biotechnology.com/up-to-date/latest-news/news/cellectis-and-cytovia-in-us760m-licence-deal.html2021-02-16T08:00:24+01:00 Cellink AB acquires Ginolis Oy for €70mhttps://european-biotechnology.com/up-to-date/latest-news/news/cellink-ab-acquires-ginolis-oy-for-eur70m.html2021-02-15T08:26:56+01:00 Rentschler Biopharma launches gene therapy subsidiaryhttps://european-biotechnology.com/up-to-date/latest-news/news/rentschler-biopharma-launches-gene-therapy-subsidiary.html2021-02-11T11:00:52+01:00 InteRNA Technologies secures €18.5m in Series B financinghttps://european-biotechnology.com/up-to-date/latest-news/news/interna-technologies-secures-eur185m-in-series-b-financing.html2021-02-09T14:07:33+01:00 German Health Ministry to invest €6.2bn in vaccineshttps://european-biotechnology.com/up-to-date/latest-news/news/german-health-ministry-to-invest-eur62bn-in-vaccines.html2021-02-09T09:26:45+01:00 V-Bio Ventures launches second fund at €78mhttps://european-biotechnology.com/up-to-date/latest-news/news/v-bio-ventures-launches-second-fund-at-eur78m.html2021-02-07T17:35:45+01:00 Abingworth raises US-$465m for new life sciences fundhttps://european-biotechnology.com/up-to-date/latest-news/news/abingworth-raises-us-465m-for-new-life-sciences-fund.html2021-02-03T12:44:12+01:00 Two companies aim for 2nd-gen COVID vaccineshttps://european-biotechnology.com/up-to-date/latest-news/news/two-companies-aim-for-2nd-gen-covid-vaccines.html2021-02-03T10:05:03+01:00 Rentschler Biopharma to produce 100m doses of CureVac vaccinehttps://european-biotechnology.com/up-to-date/latest-news/news/rentschler-biopharma-to-produce-100m-doses-of-curevac-vaccine.html2021-02-02T06:00:57+01:00 Italian Enthera Pharma raise €35m in Series A extensionhttps://european-biotechnology.com/up-to-date/latest-news/news/italian-enthera-pharma-raise-eur35m-in-series-a-extension.html2021-01-28T16:47:43+01:00 German antibodies in demand in USAhttps://european-biotechnology.com/up-to-date/latest-news/news/german-antibodies-in-demand-in-usa.html2021-01-27T08:57:15+01:00 Omnix Medical bags €10.8m from EIC Accerator Fundhttps://european-biotechnology.com/up-to-date/latest-news/news/omnix-medical-bags-eur108m-from-eic-accerator-fund.html2021-01-25T11:46:40+01:00 Germany orders antibody therapies from USAhttps://european-biotechnology.com/up-to-date/latest-news/news/germany-orders-antibody-therapies-from-usa.html2021-01-25T10:23:50+01:00 Servier and MiNA Therapeutics sign €220m dealhttps://european-biotechnology.com/up-to-date/latest-news/news/servier-and-mina-therapeutics-sign-eur220m-deal.html2021-01-21T19:14:57+01:00 LSP leads €21m round into Neurent Medicalhttps://european-biotechnology.com/up-to-date/latest-news/news/lsp-leads-eur21m-round-into-neurent-medical.html2021-01-20T14:54:52+01:00 Janssen presents one-shot COVID-19 vaccine datahttps://european-biotechnology.com/up-to-date/latest-news/news/janssen-presents-one-shot-covid-19-vaccine-data.html2021-01-19T09:27:37+01:00 German researchers find reason for remdesivir's inefficiencyhttps://european-biotechnology.com/up-to-date/latest-news/news/german-researchers-find-reason-for-remdesivirs-inefficiency.html2021-01-14T08:33:38+01:00 LSP reports first closing of dementia fundhttps://european-biotechnology.com/up-to-date/latest-news/news/lsp-reports-first-closing-of-dementia-fund.html2021-01-13T08:49:00+01:00 Valneva in talks with EU about 60 million vaccine doseshttps://european-biotechnology.com/up-to-date/latest-news/news/valneva-in-talks-with-eu-about-60-million-vaccine-doses.html2021-01-12T12:55:50+01:00 Immunocore bags US$75m in Series C roundhttps://european-biotechnology.com/up-to-date/latest-news/news/immunocore-bags-us75m-in-series-c-round.html2021-01-12T08:14:00+01:00 EU approves second COVID-19 vaccinehttps://european-biotechnology.com/up-to-date/latest-news/news/eu-approves-second-covid-19-vaccine.html2021-01-07T08:30:00+01:00 Angelini Pharma to take over Arvelle Therapeuticshttps://european-biotechnology.com/up-to-date/latest-news/news/angelini-pharma-to-take-over-arvelle-therapeutics.html2021-01-06T07:26:00+01:00 COVID-19 test gives results within minutes https://european-biotechnology.com/up-to-date/latest-news/news/covid-19-test-gives-results-within-minutes.html2021-01-05T10:55:33+01:00 Merry Christmas and a Happy New Yearhttps://european-biotechnology.com/up-to-date/latest-news/news/merry-christmas-and-a-happy-new-year-2.html2020-12-26T08:42:31+01:00 EMA greenlights BioNtech's COVID-19 vaccinehttps://european-biotechnology.com/up-to-date/latest-news/news/ema-greenlights-biontechs-covid-19-vaccine.html2020-12-22T09:06:05+01:00 European Circular Bioeconomy Fund growinghttps://european-biotechnology.com/up-to-date/latest-news/news/european-circular-bioeconomy-fund-growing.html2020-12-16T13:24:52+01:00 Novo Holdings creates Hemabhttps://european-biotechnology.com/up-to-date/latest-news/news/novo-holdings-creates-hemab.html2020-12-15T07:56:35+01:00 Biotech companies launch Biotech Austriahttps://european-biotechnology.com/up-to-date/latest-news/news/biotech-companies-launch-biotech-austria.html2020-12-10T17:05:23+01:00 How microplastic particles get into the bodyhttps://european-biotechnology.com/up-to-date/latest-news/news/how-microplastic-particles-get-into-the-body.html2020-12-10T07:19:00+01:00 Centogene and Anylam launch clinical programmehttps://european-biotechnology.com/up-to-date/latest-news/news/centogene-and-anylam-launch-clinical-programme.html2020-12-09T07:51:00+01:00 Avantium NV bags money for demo planthttps://european-biotechnology.com/up-to-date/latest-news/news/avantium-nv-bags-money-for-demo-plant.html2020-12-08T08:11:00+01:00 How stress brings cancer to life againhttps://european-biotechnology.com/up-to-date/latest-news/news/how-stress-brings-cancer-to-life-again.html2020-12-04T06:39:00+01:00 UK approves Biontech/Pfizer Covid-19 vaccine https://european-biotechnology.com/up-to-date/latest-news/news/uk-approves-biontechpfizer-covid-19-vaccine.html2020-12-02T13:06:38+01:00 Swiss Noema Pharma raises CHF54m in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/swiss-noema-pharma-raises-chf54m-in-series-a-financing.html2020-12-02T06:16:00+01:00 Germany first EU country to launch COVID-19 therapy offensive?https://european-biotechnology.com/up-to-date/latest-news/news/germany-first-eu-country-to-launch-covid-19-therapy-offensive.html2020-12-01T12:29:13+01:00 Moderna to file for EU approval of mRNA-1273 vaccinehttps://european-biotechnology.com/up-to-date/latest-news/news/moderna-to-file-for-eu-approval-of-mrna-1273-vaccine.html2020-11-30T14:07:37+01:00 Drug set to rescue COVID-19 patients at ICUshttps://european-biotechnology.com/up-to-date/latest-news/news/drug-set-to-rescue-covid-19-patients-at-icus.html2020-11-26T19:27:04+01:00 Polyphor AG bags funding for murepavadinhttps://european-biotechnology.com/up-to-date/latest-news/news/polyphor-ag-bags-funding-for-murepavadin.html2020-11-25T11:55:40+01:00 Global bioeconomy in the spotlighthttps://european-biotechnology.com/up-to-date/latest-news/news/global-bioeconomy-in-the-spotlight.html2020-11-23T05:58:00+01:00 3,000+ experts discuss bioeconomy globallyhttps://european-biotechnology.com/up-to-date/latest-news/news/3000-experts-discuss-bioeconomy-globally.html2020-11-19T05:58:00+01:00 EU COVID-19 antibody ready for clinical trialshttps://european-biotechnology.com/up-to-date/latest-news/news/eu-covid-19-antibody-ready-for-clinical-trials.html2020-11-18T12:33:46+01:00 COVID-19: Moderna reports promising interim resultshttps://european-biotechnology.com/up-to-date/latest-news/news/covid-19-moderna-reports-promising-interim-results.html2020-11-17T08:01:01+01:00 Evotec expanding at Milton Park campushttps://european-biotechnology.com/up-to-date/latest-news/news/evotec-expanding-at-milton-park-campus.html2020-11-12T12:37:31+01:00 Pfizer/BioNTech sign vaccine contract with EC https://european-biotechnology.com/up-to-date/latest-news/news/pfizerbiontech-sign-vaccine-contract-with-ec.html2020-11-11T14:26:33+01:00 1,800+ experts will join the Global Bioeconomy Summithttps://european-biotechnology.com/up-to-date/latest-news/news/1800-experts-will-join-the-global-bioeconomy-summit.html2020-11-11T05:58:00+01:00 BioNTech reports high efficacy of COVID-19 vaccinehttps://european-biotechnology.com/up-to-date/latest-news/news/biontech-reports-high-efficacy-of-covid-19-vaccine.html2020-11-10T12:46:00+01:00 Vifor Pharma inks $340m deal with Angion Biomedica Inc.https://european-biotechnology.com/up-to-date/latest-news/news/vifor-pharma-inks-340m-deal-with-angion-biomedica-inc.html2020-11-09T09:09:00+01:00 Cell and gene therapy specialist Minaris expandinghttps://european-biotechnology.com/up-to-date/latest-news/news/cell-and-gene-therapy-specialist-minaris-expanding.html2020-11-03T18:35:17+01:00 Protein Brewery raise €22m in Series Ahttps://european-biotechnology.com/up-to-date/latest-news/news/protein-brewery-raise-eur22m-in-series-a.html2020-11-03T13:43:24+01:00 Galecto raise US$85m in Nasdaq IPOhttps://european-biotechnology.com/up-to-date/latest-news/news/galecto-raise-us85m-in-nasdaq-ipo.html2020-10-30T07:02:19+01:00 BI initiates Phase II testing of COVID-19 drughttps://european-biotechnology.com/up-to-date/latest-news/news/bi-initiates-phase-ii-testing-of-covid-19-drug.html2020-10-28T14:46:55+01:00 3P Bio to manufacture SpyBiotech vaccinehttps://european-biotechnology.com/up-to-date/latest-news/news/3p-bio-to-manufacture-spybiotech-vaccine.html2020-10-28T09:28:52+01:00 Bioinvent AB licences BI-1206 to CASI Pharmaceuticalshttps://european-biotechnology.com/up-to-date/latest-news/news/bioinvent-ab-licences-bi-1206-to-casi-pharmaceuticals.html2020-10-28T06:03:00+01:00 Transgene reports clinical results of TG4001 plus avelumabhttps://european-biotechnology.com/up-to-date/latest-news/news/transgene-reports-clinical-results-of-tg4001-plus-avelumab.html2020-10-27T08:09:58+01:00 Roche licences antiviral nucleoside from Ateahttps://european-biotechnology.com/up-to-date/latest-news/news/roche-licences-antiviral-nucleoside-from-atea.html2020-10-24T10:10:00+02:00 ADC company Araris Biotech raises CHF15.2mhttps://european-biotechnology.com/up-to-date/latest-news/news/adc-company-araris-biotech-raises-chf152m.html2020-10-22T08:23:59+02:00 Vifor Pharma in US$100m licence deal with Cara Therapeuticshttps://european-biotechnology.com/up-to-date/latest-news/news/vifor-pharma-in-us100m-licence-deal-with-cara-therapeutics.html2020-10-21T09:33:00+02:00 Atriva Therapeutics gets €24m from EIBhttps://european-biotechnology.com/up-to-date/latest-news/news/atriva-therapeutics-gets-eur24m-from-eib.html2020-10-20T11:06:57+02:00 Topas raises €22m in Series B financininghttps://european-biotechnology.com/up-to-date/latest-news/news/topas-raises-eur22m-in-series-b-financining.html2020-10-19T14:00:15+02:00 Siemens launches COVID-19 antigen lateral flow testhttps://european-biotechnology.com/up-to-date/latest-news/news/siemens-launches-covid-19-antigen-lateral-flow-test.html2020-10-14T10:16:34+02:00 Priothera closes €30m Series A financing https://european-biotechnology.com/up-to-date/latest-news/news/priothera-closes-eur30m-series-a-financing.html2020-10-13T08:14:32+02:00 COVID-19 jab: EU signs contract with JNJhttps://european-biotechnology.com/up-to-date/latest-news/news/covid-19-jab-eu-signs-contract-with-jnj.html2020-10-09T07:52:53+02:00 Santhera ends development of idebenonehttps://european-biotechnology.com/up-to-date/latest-news/news/santhera-ends-development-of-idebenone.html2020-10-06T07:54:02+02:00 Nobel Prize in Physiology for HCV pioneershttps://european-biotechnology.com/up-to-date/latest-news/news/nobel-prize-in-physiology-for-hcv-pioneers.html2020-10-05T20:41:51+02:00 Swiss Sophia Genetics to expand globallyhttps://european-biotechnology.com/up-to-date/latest-news/news/swiss-sophia-genetics-to-expand-globally.html2020-10-02T10:11:57+02:00 EIB and EC launch circular bioeconomy fundhttps://european-biotechnology.com/up-to-date/latest-news/news/eib-and-ec-launch-circular-bioeconomy-fund.html2020-10-01T12:24:43+02:00 Dewpoint Therapeutics raise $77m in Series B financinghttps://european-biotechnology.com/up-to-date/latest-news/news/dewpoint-therapeutics-raise-77m-in-series-b-financing.html2020-09-30T14:01:52+02:00 Kurma Partners close diagnostics fund at €50mhttps://european-biotechnology.com/up-to-date/latest-news/news/kurma-partners-close-diagnostics-fund-at-eur50m.html2020-09-29T08:26:00+02:00 Danish Galecto Inc. secures US$64m equity financinghttps://european-biotechnology.com/up-to-date/latest-news/news/danish-galecto-inc-secures-us64m-equity-financing.html2020-09-28T05:46:00+02:00 MosaMeat NV bags US$55m financinghttps://european-biotechnology.com/up-to-date/latest-news/news/mosameat-nv-bags-us55m-financing.html2020-09-25T13:02:19+02:00 Pureos Bioventures closes US$170m fundhttps://european-biotechnology.com/up-to-date/latest-news/news/pureos-bioventures-closes-us170m-fund.html2020-09-23T10:19:16+02:00 Biotechs request money for COVID therapeuticshttps://european-biotechnology.com/up-to-date/latest-news/news/biotechs-request-money-for-covid-therapeutics.html2020-09-22T10:43:50+02:00 Polyneuron Pharmaceuticals AG extends Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/polyneuron-pharmaceuticals-ag-extends-series-a-financing.html2020-09-17T07:26:00+02:00 Mabion to licence COVID-19 jab from Vaxine Pty Ltdhttps://european-biotechnology.com/up-to-date/latest-news/news/mabion-to-licence-covid-19-jab-from-vaxine-pty-ltd.html2020-09-16T08:11:00+02:00 4SC and Maruho end collaboration on Kv1.3 blockershttps://european-biotechnology.com/up-to-date/latest-news/news/4sc-and-maruho-end-collaboration-on-kv13-blockers.html2020-09-15T08:37:00+02:00 MiNA Therapeutic bags £23m financinghttps://european-biotechnology.com/up-to-date/latest-news/news/mina-therapeutic-bags-pound23m-financing.html2020-09-10T11:00:00+02:00 Vaccine developers unite to stand with sciencehttps://european-biotechnology.com/up-to-date/latest-news/news/vaccine-developers-unite-to-stand-with-science.html2020-09-08T18:11:38+02:00 Scope Fluidics gets EIB loan for infection diagnosticshttps://european-biotechnology.com/up-to-date/latest-news/news/scope-fluidics-gets-eib-loan-for-infection-diagnostics.html2020-09-07T16:38:11+02:00 COVID-19: Roche AG launches antigen rapid testhttps://european-biotechnology.com/up-to-date/latest-news/news/covid-19-roche-ag-launches-antigen-rapid-test.html2020-09-03T06:08:26+02:00 Unilever to replace fossil carbon in cleaning productshttps://european-biotechnology.com/up-to-date/latest-news/news/unilever-to-replace-fossil-carbon-in-cleaning-products.html2020-09-02T08:24:00+02:00 Stakeholders push for further pull incentiveshttps://european-biotechnology.com/up-to-date/latest-news/news/stakeholders-push-for-further-pull-incentives.html2020-09-01T12:33:00+02:00 Bioversys bags €17.7m financinghttps://european-biotechnology.com/up-to-date/latest-news/news/bioversys-bags-eur177m-financing.html2020-09-01T09:29:21+02:00 Sotio licences Unum Therapeutics’ CAR-T cell portfoliohttps://european-biotechnology.com/up-to-date/latest-news/news/sotio-licences-unum-therapeutics-car-t-cell-portfolio.html2020-08-31T14:42:37+02:00 Polyphor partners with Fosun Pharmahttps://european-biotechnology.com/up-to-date/latest-news/news/polyphor-partners-with-fosun-pharma.html2020-08-31T08:36:28+02:00 Engitix Ltd. lands US$500m deal with Takeda in fibrosishttps://european-biotechnology.com/up-to-date/latest-news/news/engitix-ltd-lands-us500m-deal-with-takeda-in-fibrosis.html2020-08-26T08:11:00+02:00 Moderna set to deliver COVID-19 jab to the EUhttps://european-biotechnology.com/up-to-date/latest-news/news/moderna-set-to-deliver-covid-19-jab-to-the-eu.html2020-08-25T08:18:00+02:00 Scientists map ulcerative colitis https://european-biotechnology.com/up-to-date/latest-news/news/scientists-map-ulcerative-colitis.html2020-08-24T08:01:30+02:00 COVID-19: Roche and Regeneron join forceshttps://european-biotechnology.com/up-to-date/latest-news/news/covid-19-roche-and-regeneron-join-forces.html2020-08-20T07:00:00+02:00 Aicuris to launch AiCubator to fight AMRhttps://european-biotechnology.com/up-to-date/latest-news/news/aicuris-to-launch-aicubator-to-fight-amr.html2020-08-18T07:06:00+02:00 AI predicts mutations underlying neurological diseaseshttps://european-biotechnology.com/up-to-date/latest-news/news/ai-predicts-mutations-underlying-neurological-diseases.html2020-08-12T18:00:00+02:00 F2G bags €50.8m financing to advance olorofimhttps://european-biotechnology.com/up-to-date/latest-news/news/f2g-bags-eur508m-financing-to-advance-olorofim.html2020-08-12T09:03:39+02:00 Evotec receives $8.4m CARB-X fundinghttps://european-biotechnology.com/up-to-date/latest-news/news/evotec-receives-84m-carb-x-funding.html2020-08-11T10:25:11+02:00 BioNTech and Fosun Pharma kick off Chinese COVID-19 trialshttps://european-biotechnology.com/up-to-date/latest-news/news/biontech-and-fosun-pharma-kick-off-chinese-covid-19-trials.html2020-08-06T06:35:42+02:00 Evotec partners with Secarna to develop LNA drugshttps://european-biotechnology.com/up-to-date/latest-news/news/evotec-partners-with-secarna-to-develop-lna-drugs.html2020-08-05T07:53:51+02:00 EC secures 300 million doses of COVID-19 vaccinehttps://european-biotechnology.com/up-to-date/latest-news/news/ec-secures-300-million-doses-of-covid-19-vaccine.html2020-08-04T07:14:25+02:00 Roche's IL-6 receptor blocker fails in Phase IIIhttps://european-biotechnology.com/up-to-date/latest-news/news/roches-il-6-receptor-blocker-fails-in-phase-iii.html2020-07-30T07:37:27+02:00 Enthera Pharmaceuticals Srl raises €28m in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/enthera-pharmaceuticals-srl-raises-eur28m-in-series-a-financing.html2020-07-29T07:55:29+02:00 Polyphor AG bags CHF19.3 in equity financinghttps://european-biotechnology.com/up-to-date/latest-news/news/polyphor-ag-bags-chf193-in-equity-financing.html2020-07-28T09:02:58+02:00 A plucked chicken named Horizon Europehttps://european-biotechnology.com/up-to-date/latest-news/news/a-plucked-chicken-named-horizon-europe.html2020-07-23T15:12:56+02:00 Quantro: Seed capital by Evotec and Boehringerhttps://european-biotechnology.com/up-to-date/latest-news/news/quantro-seed-capital-by-evotec-and-boehringer.html2020-07-21T14:26:00+02:00 COVID-19: Siemens’ assay outperforms antibody tests from competitorshttps://european-biotechnology.com/up-to-date/latest-news/news/covid-19-siemens-assay-outperforms-antibody-tests-from-competitors.html2020-07-15T13:23:00+02:00 AMR: Big Pharma sets up US$1bn Fundhttps://european-biotechnology.com/up-to-date/latest-news/news/amr-big-pharma-sets-up-us1bn-fund.html2020-07-13T10:59:00+02:00 VarmX bags €32m in Series B roundhttps://european-biotechnology.com/up-to-date/latest-news/news/varmx-bags-eur32m-in-series-b-round.html2020-07-09T09:47:00+02:00 APEIRON Biologics licences MaxCyte’s electroporation platform https://european-biotechnology.com/up-to-date/latest-news/news/apeiron-biologics-licences-maxcytes-electroporation-platform.html2020-07-08T08:29:09+02:00 Immatics launches US$250m Nasdaq-IPOhttps://european-biotechnology.com/up-to-date/latest-news/news/immatics-launches-us250m-nasdaq-ipo.html2020-07-07T06:31:00+02:00 New insulin formulation allows faster blood sugar managementhttps://european-biotechnology.com/up-to-date/latest-news/news/new-insulin-formulation-allows-faster-blood-sugar-management.html2020-07-01T18:01:01+02:00 COVID-19: Lopinavir-ritonavir failedhttps://european-biotechnology.com/up-to-date/latest-news/news/covid-19-lopinavir-ritonavir-failed.html2020-07-01T09:17:52+02:00 EC pledges €4.9bn to grant access to medicineshttps://european-biotechnology.com/up-to-date/latest-news/news/ec-pledges-eur49bn-to-grant-access-to-medicines.html2020-06-30T07:22:37+02:00 BioGeneration Ventures closes BGV IV Fund at €105mhttps://european-biotechnology.com/up-to-date/latest-news/news/biogeneration-ventures-closes-bgv-iv-fund-at-eur105m.html2020-06-24T07:00:00+02:00 LSP leads €11m Series A round in OneProjecthttps://european-biotechnology.com/up-to-date/latest-news/news/lsp-leads-eur11m-series-a-round-in-oneproject.html2020-06-24T06:15:00+02:00 Illumina and Epidarex Capital invest in post-Brexit UKhttps://european-biotechnology.com/up-to-date/latest-news/news/illumina-and-epidarex-capital-invest-in-post-brexit-uk.html2020-06-22T10:59:26+02:00 Novel adjuvant teases T cells to respond to HCVhttps://european-biotechnology.com/up-to-date/latest-news/news/novel-adjuvant-teases-t-cells-to-respond-to-hcv.html2020-06-18T06:24:00+02:00 First drug found to reduce COVID-19-mortalityhttps://european-biotechnology.com/up-to-date/latest-news/news/first-drug-found-to-reduce-covid-19-mortality.html2020-06-17T09:08:43+02:00 Germany puts €300m in CureVac AG for COVID-19 vaccinehttps://european-biotechnology.com/up-to-date/latest-news/news/germany-puts-eur300m-in-curevac-ag-for-covid-19-vaccine.html2020-06-16T08:32:09+02:00 Abbvie and Genmab team up in oncologyhttps://european-biotechnology.com/up-to-date/latest-news/news/abbvie-and-genmab-team-up-in-oncology.html2020-06-10T12:45:03+02:00 Evox Therapeutics signs US$1.2bn deal with Eli Lillyhttps://european-biotechnology.com/up-to-date/latest-news/news/evox-therapeutics-signs-us12bn-deal-with-eli-lilly.html2020-06-10T07:30:21+02:00 Calliditas Therapeutics raise US$90m in Nasdaq IPOhttps://european-biotechnology.com/up-to-date/latest-news/news/calliditas-therapeutics-raise-us90m-in-nasdaq-ipo.html2020-06-09T08:28:59+02:00 Hyloris Pharmaceuticals prepared to go publichttps://european-biotechnology.com/up-to-date/latest-news/news/hyloris-pharmaceuticals-prepared-to-go-public.html2020-06-03T12:59:42+02:00 NodThera bags US$55m in Series B roundhttps://european-biotechnology.com/up-to-date/latest-news/news/nodthera-bags-us55m-in-series-b-round.html2020-06-03T11:01:24+02:00 Bacterial colonisation differs by tumour typehttps://european-biotechnology.com/up-to-date/latest-news/news/bacterial-colonisation-differs-by-tumour-type.html2020-06-02T05:07:00+02:00 New algorithm predicts rheumatoid arthritishttps://european-biotechnology.com/up-to-date/latest-news/news/new-algorithm-predicts-rheumatoid-arthritis.html2020-05-28T07:30:00+02:00 Novo Holdings invests into AI CRO ExScientiahttps://european-biotechnology.com/up-to-date/latest-news/news/novo-holdings-invests-into-ai-cro-exscientia.html2020-05-27T08:40:28+02:00 Poxel SA raises €17.7m through capital increasehttps://european-biotechnology.com/up-to-date/latest-news/news/poxel-sa-raises-eur177m-through-capital-increase.html2020-05-26T06:47:00+02:00 British scientists start Phase II on COVID-19 vaccinehttps://european-biotechnology.com/up-to-date/latest-news/news/british-scientists-start-phase-ii-on-covid-19-vaccine.html2020-05-25T09:49:04+02:00 SARS-CoV2 antibody tests: not suited for individual diagnosis?https://european-biotechnology.com/up-to-date/latest-news/news/sars-cov2-antibody-tests-not-suited-for-individual-diagnosis.html2020-05-20T06:23:00+02:00 Vaccine to protect from any viral infectionhttps://european-biotechnology.com/up-to-date/latest-news/news/vaccine-to-protect-from-any-viral-infection.html2020-05-19T09:07:57+02:00 Abivax bags €36m fund for COVID-19 programmehttps://european-biotechnology.com/up-to-date/latest-news/news/abivax-bags-eur36m-fund-for-covid-19-programme.html2020-05-18T10:04:11+02:00 4Teen4’s DPP3 predicts burn mortality https://european-biotechnology.com/up-to-date/latest-news/news/4teen4s-dpp3-predicts-burn-mortality.html2020-05-14T14:26:13+02:00 IMI ramps up COVID fundhttps://european-biotechnology.com/up-to-date/latest-news/news/imi-ramps-up-covid-fund.html2020-05-13T05:28:00+02:00 S-Protein: Glycosylation pattern revealedhttps://european-biotechnology.com/up-to-date/latest-news/news/s-protein-glycosylation-pattern-revealed.html2020-05-06T01:28:21+02:00 Newron terminates sarizotan development in Rett syndromehttps://european-biotechnology.com/up-to-date/latest-news/news/newron-terminates-sarizotan-development-in-rett-syndrome.html2020-05-05T10:05:09+02:00 Roche gets FDA okay for COVID-19 antibody testhttps://european-biotechnology.com/up-to-date/latest-news/news/roche-gets-fda-okay-for-covid-19-antibody-test.html2020-05-05T06:48:00+02:00 Bone Therapeutics bags €11mhttps://european-biotechnology.com/up-to-date/latest-news/news/bone-therapeutics-bags-eur11m.html2020-04-30T06:45:00+02:00 Cevec launches ELEVECTA platformhttps://european-biotechnology.com/up-to-date/latest-news/news/cevec-launches-elevecta-platform.html2020-04-29T06:07:00+02:00 Artes enters COVID-19 vaccine racehttps://european-biotechnology.com/up-to-date/latest-news/news/artes-enters-covid-19-vaccine-race.html2020-04-28T06:38:00+02:00 Bayer, Novartis, and Trump convicted by Nature https://european-biotechnology.com/up-to-date/latest-news/news/bayer-novartis-and-trump-convicted-by-nature.html2020-04-24T12:09:46+02:00 Drug from worms dampens autoimmune responsehttps://european-biotechnology.com/up-to-date/latest-news/news/drug-from-worms-dampens-autoimmune-response.html2020-04-23T07:03:00+02:00 Swiss biotech sector with robust growthhttps://european-biotechnology.com/up-to-date/latest-news/news/swiss-biotech-sector-with-robust-growth.html2020-04-22T09:33:24+02:00 COVID-19: Novartis starts study on hyped malaria drughttps://european-biotechnology.com/up-to-date/latest-news/news/covid-19-novartis-starts-study-on-hyped-malaria-drug.html2020-04-20T20:10:28+02:00 COVID 19: Halix ready for vaccine productionhttps://european-biotechnology.com/up-to-date/latest-news/news/covid-19-halix-ready-for-vaccine-production.html2020-04-16T17:26:00+02:00 Carbios SAS publishes PET recycling technologyhttps://european-biotechnology.com/up-to-date/latest-news/news/carbios-sas-publishes-pet-recycling-technology.html2020-04-15T08:07:11+02:00 Mobidiag’s COVID-19 test okayed for emergency usehttps://european-biotechnology.com/up-to-date/latest-news/news/mobidiags-covid-19-test-okayed-for-emergency-use.html2020-04-14T09:29:51+02:00 Researchers reconstruct SARS-CoV-2 evolutionhttps://european-biotechnology.com/up-to-date/latest-news/news/researchers-reconstruct-sars-cov-2-evolution.html2020-04-09T10:02:46+02:00 COVID-19: Solnatide approved for compassionate usehttps://european-biotechnology.com/up-to-date/latest-news/news/covid-19-solnatide-approved-for-compassionate-use.html2020-04-08T09:20:56+02:00 GE renamed Cytiva upon take-over by Danaherhttps://european-biotechnology.com/up-to-date/latest-news/news/ge-renamed-cytiva-upon-take-over-by-danaher.html2020-04-02T12:50:17+02:00 Making opoids more effective pain killershttps://european-biotechnology.com/up-to-date/latest-news/news/making-opoids-more-effective-pain-killers.html2020-04-02T06:25:00+02:00 Apeptico gets EU grant for COVID-19 drughttps://european-biotechnology.com/up-to-date/latest-news/news/apeptico-gets-eu-grant-for-covid-19-drug.html2020-04-01T09:06:54+02:00 CHMP greenlights Novartis’ Zolgensmahttps://european-biotechnology.com/up-to-date/latest-news/news/chmp-greenlights-novartis-zolgensma.html2020-03-31T06:03:00+02:00 New resource models human metabolismhttps://european-biotechnology.com/up-to-date/latest-news/news/new-resource-models-human-metabolism.html2020-03-26T06:42:41+01:00 Novacyt inks contract on Covid-19 diagnosticshttps://european-biotechnology.com/up-to-date/latest-news/news/novacyt-inks-contract-on-covid-19-diagnostics.html2020-03-25T09:10:44+01:00 AC Immune SA gets Lilly milestone for Alzheimers’ candidatehttps://european-biotechnology.com/up-to-date/latest-news/news/ac-immune-sa-gets-lilly-milestone-for-alzheimers-candidate.html2020-03-24T06:39:00+01:00 Experts discuss link between sepsis and Covid-19https://european-biotechnology.com/up-to-date/latest-news/news/experts-discuss-link-between-sepsis-and-covid-19.html2020-03-19T08:39:51+01:00 Evonik Industries AG establishes production of recombinant collagenhttps://european-biotechnology.com/up-to-date/latest-news/news/evonik-industries-ag-establishes-production-of-recombinant-collagen.html2020-03-18T05:38:00+01:00 BioNTech SE’s COVID-19 vaccine attracts investmenthttps://european-biotechnology.com/up-to-date/latest-news/news/biontech-ses-covid-19-vaccine-attracts-investment.html2020-03-17T08:07:03+01:00 Commission relaunches circular economy action planhttps://european-biotechnology.com/up-to-date/latest-news/news/commission-relaunches-circular-economy-action-plan.html2020-03-16T05:50:00+01:00 Roche unravel biomarker for checkpoint blockadehttps://european-biotechnology.com/up-to-date/latest-news/news/roche-unravel-biomarker-for-checkpoint-blockade.html2020-03-12T09:01:00+01:00 Nutrition influences the course of MShttps://european-biotechnology.com/up-to-date/latest-news/news/nutrition-influences-the-course-of-ms.html2020-03-10T08:37:00+01:00 LSP launches US-$600m European life sciences fundhttps://european-biotechnology.com/up-to-date/latest-news/news/lsp-launches-us-600m-european-life-sciences-fund.html2020-03-09T09:00:00+01:00 Biotalys grabs €45m in Series C financinghttps://european-biotechnology.com/up-to-date/latest-news/news/biotalys-grabs-eur45m-in-series-c-financing.html2020-03-05T09:38:40+01:00 German and UK researchers cut time to sepsis diagnosishttps://european-biotechnology.com/up-to-date/latest-news/news/german-and-uk-researchers-cut-time-to-sepsis-diagnosis.html2020-03-05T07:45:00+01:00 IMI launches €45m call for coronavirus emergencyhttps://european-biotechnology.com/up-to-date/latest-news/news/imi-launches-eur45m-call-for-coronavirus-emergency.html2020-03-04T07:31:00+01:00 Immunocore Ltd raises US$130m in Series B roundhttps://european-biotechnology.com/up-to-date/latest-news/news/immunocore-ltd-raises-us130m-in-series-b-round.html2020-03-02T08:52:00+01:00 Vitamin C may boost checkpoint inhibitor efficacyhttps://european-biotechnology.com/up-to-date/latest-news/news/vitamin-c-may-boost-checkpoint-inhibitor-efficacy.html2020-02-26T20:18:20+01:00 Roche grabs Bicycle Therapeutics’ platformhttps://european-biotechnology.com/up-to-date/latest-news/news/roche-grabs-bicycle-therapeutics-platform.html2020-02-26T07:33:38+01:00 Microglia inhibitor stops neuronal cell death after TBI https://european-biotechnology.com/up-to-date/latest-news/news/microglia-inhibitor-stops-neuronal-cell-death-after-tbi.html2020-02-24T15:29:26+01:00 Post-Brexit budget drives cuts in Horizon Europehttps://european-biotechnology.com/up-to-date/latest-news/news/post-brexit-budget-drives-cuts-in-horizon-europe.html2020-02-24T06:29:00+01:00 Royal DSM acquires Glycom A/S for €765mhttps://european-biotechnology.com/up-to-date/latest-news/news/royal-dsm-acquires-glycom-as-for-eur765m.html2020-02-21T09:27:59+01:00 Immatics Biotechnologies lands €1.1bn deal with GSKhttps://european-biotechnology.com/up-to-date/latest-news/news/immatics-biotechnologies-lands-eur11bn-deal-with-gsk.html2020-02-20T11:00:00+01:00 KKR backs Belgian tech provider Univercells SAhttps://european-biotechnology.com/up-to-date/latest-news/news/kkr-backs-belgian-tech-provider-univercells-sa.html2020-02-19T07:11:42+01:00 EU diagnostic labs prepared for Sars-CoV-2https://european-biotechnology.com/up-to-date/latest-news/news/eu-diagnostic-labs-prepared-for-sars-cov-2.html2020-02-18T10:17:47+01:00 PharmaMar/Jazz Pharmaceuticals get NDA priority for lung cancer drughttps://european-biotechnology.com/up-to-date/latest-news/news/pharmamarjazz-pharmaceuticals-get-nda-priority-for-lung-cancer-drug.html2020-02-17T08:39:34+01:00 Diabetes combo improves regeneration of beta cellshttps://european-biotechnology.com/up-to-date/latest-news/news/diabetes-combo-improves-regeneration-of-beta-cells.html2020-02-14T07:18:49+01:00 JAKPot for treating bone losshttps://european-biotechnology.com/up-to-date/latest-news/news/jakpot-for-treating-bone-loss.html2020-02-13T10:26:22+01:00 Mereo BioPharma raise money to back Phase III trialshttps://european-biotechnology.com/up-to-date/latest-news/news/mereo-biopharma-raise-money-to-back-phase-iii-trials.html2020-02-12T08:00:00+01:00 Stilla raises €20m in series B financing roundhttps://european-biotechnology.com/up-to-date/latest-news/news/stilla-raises-eur20m-in-series-b-financing-round.html2020-02-11T08:00:00+01:00 BIH scientists optimise CRISPR gene scissorshttps://european-biotechnology.com/up-to-date/latest-news/news/bih-scientists-optimise-crispr-gene-scissors.html2020-02-09T19:47:22+01:00 Azafaros BV raises €25m in Series A roundhttps://european-biotechnology.com/up-to-date/latest-news/news/azafaros-bv-raises-eur25m-in-series-a-round.html2020-02-06T13:43:44+01:00 Researchers identify roots of childhood asthmahttps://european-biotechnology.com/up-to-date/latest-news/news/researchers-identify-roots-of-childhood-asthma.html2020-02-06T07:06:25+01:00 MaaT Pharma raise €18m to advance clinical pipeline https://european-biotechnology.com/up-to-date/latest-news/news/maat-pharma-raise-eur18m-to-advance-clinical-pipeline.html2020-02-05T12:27:23+01:00 Valneva raises US$85mhttps://european-biotechnology.com/up-to-date/latest-news/news/valneva-raises-us85m.html2020-02-04T06:18:27+01:00 EMA greenlights 15 new medshttps://european-biotechnology.com/up-to-date/latest-news/news/ema-greenlights-15-new-meds.html2020-02-03T05:50:00+01:00 Sleeping sickness target decipheredhttps://european-biotechnology.com/up-to-date/latest-news/news/sleeping-sickness-target-deciphered.html2020-01-31T07:37:02+01:00 UK researchers present dengue virus transmission map https://european-biotechnology.com/up-to-date/latest-news/news/uk-researchers-present-dengue-virus-transmission-map.html2020-01-30T07:39:46+01:00 AMR: IMI’s Enable project reaches endpointshttps://european-biotechnology.com/up-to-date/latest-news/news/amr-imis-enable-project-reaches-endpoints.html2020-01-28T10:16:33+01:00 MercachemSyncom, Bionetix, and ProQinase ink AML contracthttps://european-biotechnology.com/up-to-date/latest-news/news/mercachemsyncom-bionetix-and-proqinase-ink-aml-contract.html2020-01-28T09:13:00+01:00 iOnctura SA bags €15m in Series A roundhttps://european-biotechnology.com/up-to-date/latest-news/news/ionctura-sa-bags-eur15m-in-series-a-round.html2020-01-27T09:01:08+01:00 Agriculture ministers commit to global trade ruleshttps://european-biotechnology.com/up-to-date/latest-news/news/agriculture-ministers-commit-to-global-trade-rules.html2020-01-23T09:20:00+01:00 HepaRegeniX: €11m for liver disease treatmenthttps://european-biotechnology.com/up-to-date/latest-news/news/heparegenix-eur11m-for-liver-disease-treatment.html2020-01-21T09:20:00+01:00 Nestlé heavily invests in sustainable packaging https://european-biotechnology.com/up-to-date/latest-news/news/nestle-heavily-invests-in-sustainable-packaging.html2020-01-20T10:20:00+01:00 BioNTech acquires Neon at cheapest for $67mhttps://european-biotechnology.com/up-to-date/latest-news/news/biontech-acquires-neon-at-cheapest-for-67m.html2020-01-17T08:42:23+01:00 New stromal target overcomes cancer resistancehttps://european-biotechnology.com/up-to-date/latest-news/news/new-stromal-target-overcomes-cancer-resistance.html2020-01-16T05:52:12+01:00 Astellas and Adaptimmune team up in CAR-T developmenthttps://european-biotechnology.com/up-to-date/latest-news/news/astellas-and-adaptimmune-team-up-in-car-t-development.html2020-01-15T07:20:24+01:00 Illumina embraces Roche https://european-biotechnology.com/up-to-date/latest-news/news/illumina-embraces-roche.html2020-01-14T07:48:22+01:00 Incyte licenses Morphosys’ tafasitamab in US$2bn dealhttps://european-biotechnology.com/up-to-date/latest-news/news/incyte-licenses-morphosys-tafasitamab-in-us2bn-deal.html2020-01-13T07:42:13+01:00 Novadiscovery takes off with €5 Series A financing https://european-biotechnology.com/up-to-date/latest-news/news/novadiscovery-takes-off-with-eur5-series-a-financing.html2020-01-10T07:12:00+01:00 Alderaan Biotechnology raise €18.5m in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/alderaan-biotechnology-raise-eur185m-in-series-a-financing.html2020-01-09T08:00:00+01:00 North Sea Therapeutics raises US$40m in Series Bhttps://european-biotechnology.com/up-to-date/latest-news/news/north-sea-therapeutics-raises-us40m-in-series-b.html2020-01-08T10:25:14+01:00 Merck and 4SC collaborate in immunooncologyhttps://european-biotechnology.com/up-to-date/latest-news/news/merck-and-4sc-collaborate-in-immunooncology.html2020-01-08T09:15:05+01:00 Novo Holdings invest US$12m in AMR companieshttps://european-biotechnology.com/up-to-date/latest-news/news/novo-holdings-invest-us12m-in-amr-companies.html2020-01-06T17:45:13+01:00 Fighting sepsis mortalityhttps://european-biotechnology.com/up-to-date/latest-news/news/fighting-sepsis-mortality.html2020-01-06T06:23:00+01:00 Antabio SAS advances cystic fibrosis programmehttps://european-biotechnology.com/up-to-date/latest-news/news/antabio-sas-advances-cystic-fibrosis-programme.html2020-01-03T07:54:04+01:00 Hydrogel fights wound infection and inflammation https://european-biotechnology.com/up-to-date/latest-news/news/hydrogel-fights-wound-infection-and-inflammation.html2020-01-02T05:22:00+01:00 Merry Christmas and a Happy New Yearhttps://european-biotechnology.com/up-to-date/latest-news/news/merry-christmas-and-a-happy-new-year-1.html2019-12-24T11:33:00+01:00 British diagnostics play OBD lands contract with US pharmahttps://european-biotechnology.com/up-to-date/latest-news/news/british-diagnostics-play-obd-lands-contract-with-us-pharma.html2019-12-20T12:49:49+01:00 Truffle's BioMedTech fund filled with €250mhttps://european-biotechnology.com/up-to-date/latest-news/news/truffles-biomedtech-fund-filled-with-eur250m.html2019-12-19T11:20:34+01:00 Cellestia: €20m to get to Phase IIhttps://european-biotechnology.com/up-to-date/latest-news/news/cellestia-eur20m-to-get-to-phase-ii.html2019-12-18T08:06:00+01:00 Biomarker identifies residual congestion in heart failure patientshttps://european-biotechnology.com/up-to-date/latest-news/news/biomarker-identifies-residual-congestion-in-heart-failure-patients.html2019-12-17T05:06:52+01:00 Belgian start-up takes fight on neuropathieshttps://european-biotechnology.com/up-to-date/latest-news/news/belgian-start-up-takes-fight-on-neuropathies.html2019-12-16T13:24:19+01:00 Second clinical failure of Transgene in 2019https://european-biotechnology.com/up-to-date/latest-news/news/second-clinical-failure-of-transgene-in-2019.html2019-12-13T07:45:05+01:00 Microbiota contribute to skin damage in cancer therapyhttps://european-biotechnology.com/up-to-date/latest-news/news/microbiota-contribute-to-skin-damage-in-cancer-therapy.html2019-12-12T08:04:52+01:00 BIOncoTech Therapeutics and MSD combine cancer drugshttps://european-biotechnology.com/up-to-date/latest-news/news/bioncotech-therapeutics-and-msd-combine-cancer-drugs.html2019-12-11T09:44:35+01:00 Urokinase clears blot clots in stroke patientshttps://european-biotechnology.com/up-to-date/latest-news/news/urokinase-clears-blot-clots-in-stroke-patients.html2019-12-10T08:36:55+01:00 Sanofi buys Synthorx Inc for US$2.35bnhttps://european-biotechnology.com/up-to-date/latest-news/news/sanofi-buys-synthorx-inc-for-us235bn.html2019-12-09T07:41:04+01:00 Meatable NV raises US$10m in seed fundinghttps://european-biotechnology.com/up-to-date/latest-news/news/meatable-nv-raises-us10m-in-seed-funding.html2019-12-06T07:39:32+01:00 Big Pharma is cost driver of GAVIhttps://european-biotechnology.com/up-to-date/latest-news/news/big-pharma-is-cost-driver-of-gavi.html2019-12-05T05:39:00+01:00 ImCheck Therapeutics SAS raises €48m https://european-biotechnology.com/up-to-date/latest-news/news/imcheck-therapeutics-sas-raises-eur48m.html2019-12-04T07:59:07+01:00 Pierre Fabre amends license agreement with Puma Biotechnology https://european-biotechnology.com/up-to-date/latest-news/news/pierre-fabre-amends-license-agreement-with-puma-biotechnology.html2019-12-03T07:38:30+01:00 European circular bioeconomy fund near closinghttps://european-biotechnology.com/up-to-date/latest-news/news/european-circular-bioeconomy-fund-near-closing.html2019-12-02T09:02:07+01:00 Researchers find new indication for cancer drughttps://european-biotechnology.com/up-to-date/latest-news/news/researchers-find-new-indication-for-cancer-drug.html2019-11-29T19:41:00+01:00 Research team improves safety of LGMD2A gene therapyhttps://european-biotechnology.com/up-to-date/latest-news/news/research-team-improves-safety-of-lgmd2a-gene-therapy.html2019-11-28T06:27:01+01:00 €7.34m for cancer vaccine developerhttps://european-biotechnology.com/up-to-date/latest-news/news/eur734m-for-cancer-vaccine-developer.html2019-11-27T05:14:00+01:00 GeNeuro and Karolinska Institute collaborate in multiple sclerosis https://european-biotechnology.com/up-to-date/latest-news/news/geneuro-and-karolinska-institute-collaborate-in-multiple-sclerosis.html2019-11-26T05:14:00+01:00 Tecentriq-Avastin combo hits endpoint in liver cancerhttps://european-biotechnology.com/up-to-date/latest-news/news/tecentriq-avastin-combo-hits-endpoint-in-liver-cancer.html2019-11-25T06:09:00+01:00 Azeria Therapeutics bags €37.3m in Series B financing roundhttps://european-biotechnology.com/up-to-date/latest-news/news/azeria-therapeutics-bags-eur373m-in-series-b-financing-round.html2019-11-22T05:59:00+01:00 GHO capital launches EU's largest fund ever for life scienceshttps://european-biotechnology.com/up-to-date/latest-news/news/gho-capital-launches-eus-largest-fund-ever-for-life-sciences.html2019-11-21T05:20:00+01:00 Update: BIO-Europe growing furtherhttps://european-biotechnology.com/up-to-date/latest-news/news/update-bio-europe-growing-further.html2019-11-21T03:14:00+01:00 Zelluna Immunotherapy and Glycostem Therapeutics in licence dealhttps://european-biotechnology.com/up-to-date/latest-news/news/zelluna-immunotherapy-and-glycostem-therapeutics-in-licence-deal.html2019-11-20T18:58:00+01:00 Novo secures Dicerna’s RNAi liver assets https://european-biotechnology.com/up-to-date/latest-news/news/novo-secures-dicernas-rnai-liver-assets.html2019-11-19T05:43:01+01:00 EU with poor success in fighting superbugshttps://european-biotechnology.com/up-to-date/latest-news/news/eu-with-poor-success-in-fighting-superbugs.html2019-11-18T07:24:19+01:00 Cellectis presents way to safer CAR-Tshttps://european-biotechnology.com/up-to-date/latest-news/news/cellectis-presents-way-to-safer-car-ts.html2019-11-15T06:58:44+01:00 Magenta Therapeutics exercises ATAC licence optionhttps://european-biotechnology.com/up-to-date/latest-news/news/magenta-therapeutics-exercises-atac-licence-option.html2019-11-13T08:49:54+01:00 Vaximm goes East for cancer vaccine dealhttps://european-biotechnology.com/up-to-date/latest-news/news/vaximm-goes-east-for-cancer-vaccine-deal.html2019-11-12T08:19:00+01:00 Abcam buys Expedeon’s immunology businesshttps://european-biotechnology.com/up-to-date/latest-news/news/abcam-buys-expedeons-immunology-business.html2019-11-11T10:19:00+01:00 SciRhom targets autoimmunity switchhttps://european-biotechnology.com/up-to-date/latest-news/news/scirhom-targets-autoimmunity-switch.html2019-11-08T08:22:00+01:00 AMR: ENABLE selects Mutabilis candidatehttps://european-biotechnology.com/up-to-date/latest-news/news/amr-enable-selects-mutabilis-candidate.html2019-11-06T12:19:07+01:00 NSCLC: Bemcentinib + anti-PD1 triple PFShttps://european-biotechnology.com/up-to-date/latest-news/news/nsclc-bemcentinib-anti-pd1-triple-pfs.html2019-11-06T07:36:39+01:00 Transposase makes CAR-T production cheaperhttps://european-biotechnology.com/up-to-date/latest-news/news/transposase-makes-car-t-production-cheaper.html2019-11-05T07:13:31+01:00 Test detects breast cancer in earliest stagehttps://european-biotechnology.com/up-to-date/latest-news/news/test-detects-breast-cancer-in-earliest-stage.html2019-11-04T06:58:28+01:00 Sherlock Bioscience and Mologic enter partnershiphttps://european-biotechnology.com/up-to-date/latest-news/news/sherlock-bioscience-and-mologic-enter-partnership.html2019-11-01T08:49:44+01:00 Protein protects against liver fibrosishttps://european-biotechnology.com/up-to-date/latest-news/news/protein-protects-against-liver-fibrosis.html2019-10-31T07:51:08+01:00 bit bio restarts with new managementhttps://european-biotechnology.com/up-to-date/latest-news/news/bit-bio-restarts-with-new-management.html2019-10-30T06:46:00+01:00 BioVersys receives up to €8m from CARB-Xhttps://european-biotechnology.com/up-to-date/latest-news/news/bioversys-receives-up-to-eur8m-from-carb-x.html2019-10-29T06:00:00+01:00 Researchers identify viral inflammation switchhttps://european-biotechnology.com/up-to-date/latest-news/news/researchers-identify-viral-inflammation-switch.html2019-10-28T05:13:00+01:00 Rotavirus vaccines kill cancer cellshttps://european-biotechnology.com/up-to-date/latest-news/news/rotavirus-vaccines-kill-cancer-cells.html2019-10-24T14:42:53+02:00 Polyphor presents AMR breakerhttps://european-biotechnology.com/up-to-date/latest-news/news/polyphor-presents-amr-breaker.html2019-10-24T06:56:01+02:00 Zealand Pharma acquires Encyclehttps://european-biotechnology.com/up-to-date/latest-news/news/zealand-pharma-acquires-encycle.html2019-10-23T08:09:15+02:00 Researchers target ferroptosis resistance of cancer cellshttps://european-biotechnology.com/up-to-date/latest-news/news/researchers-target-ferroptosis-resistance-of-cancer-cells.html2019-10-22T05:37:13+02:00 CHMP selects drugs for EU market approvalhttps://european-biotechnology.com/up-to-date/latest-news/news/chmp-selects-drugs-for-eu-market-approval.html2019-10-21T06:00:00+02:00 New risk factor for autism and epilepsy identifiedhttps://european-biotechnology.com/up-to-date/latest-news/news/new-risk-factor-for-autism-and-epilepsy-identified.html2019-10-18T07:27:01+02:00 Healx Ltd raises $56m in Series B financinghttps://european-biotechnology.com/up-to-date/latest-news/news/healx-ltd-raises-56m-in-series-b-financing.html2019-10-17T09:05:00+02:00 4SC expands domatinostat combo testing https://european-biotechnology.com/up-to-date/latest-news/news/4sc-expands-domatinostat-combo-testing.html2019-10-16T08:09:35+02:00 Cell transdifferentiation specialist Mogrify Ltd raises US$16mhttps://european-biotechnology.com/up-to-date/latest-news/news/cell-transdifferentiation-specialist-mogrify-ltd-raises-us16m.html2019-10-15T07:29:45+02:00 Patient's organoids predict response to chemotherapy https://european-biotechnology.com/up-to-date/latest-news/news/patients-organoids-predict-response-to-chemotherapy.html2019-10-14T08:09:35+02:00 ADC Therapeutics enters licence option deal with Avacta Group https://european-biotechnology.com/up-to-date/latest-news/news/adc-therapeutics-enters-licence-option-deal-with-avacta-group.html2019-10-11T08:08:01+02:00 Novo Nordisk enters haemophilia gene therapy fieldhttps://european-biotechnology.com/up-to-date/latest-news/news/novo-nordisk-enters-haemophilia-gene-therapy-field.html2019-10-10T06:27:13+02:00 Evotec and Celmatix enter strategic partnershiphttps://european-biotechnology.com/up-to-date/latest-news/news/evotec-and-celmatix-enter-strategic-partnership.html2019-10-09T07:51:48+02:00 Qiagen/Illumina: Earthquake in NGS IVD markethttps://european-biotechnology.com/up-to-date/latest-news/news/qiagenillumina-earthquake-in-ngs-ivd-market.html2019-10-08T05:44:28+02:00 Researchers unravel how ADEP antibiotics workhttps://european-biotechnology.com/up-to-date/latest-news/news/researchers-unravel-how-adep-antibiotics-work.html2019-10-07T07:23:54+02:00 New method allows tracking of HIVhttps://european-biotechnology.com/up-to-date/latest-news/news/new-method-allows-tracking-of-hiv.html2019-10-04T10:49:13+02:00 Successful EFIB in Brusselshttps://european-biotechnology.com/up-to-date/latest-news/news/successful-efib-in-brussels.html2019-10-03T12:11:00+02:00 Rottapharm Biotech: POC in osteoarthritis painhttps://european-biotechnology.com/up-to-date/latest-news/news/rottapharm-biotech-poc-in-osteoarthritis-pain.html2019-10-02T08:34:34+02:00 Spanish sector attracting more and more investmenthttps://european-biotechnology.com/up-to-date/latest-news/news/spanish-sector-attracting-more-and-more-investment.html2019-10-01T08:15:00+02:00 Creoptix AG closes CHF8m financing roundhttps://european-biotechnology.com/up-to-date/latest-news/news/creoptix-ag-closes-chf8m-financing-round.html2019-10-01T07:56:26+02:00 AMR: GARDP and Entasis Therapeutics start pivotal studyhttps://european-biotechnology.com/up-to-date/latest-news/news/amr-gardp-and-entasis-therapeutics-start-pivotal-study.html2019-09-30T07:49:11+02:00 BASF broadens biotech business by Isobionics acquisitionhttps://european-biotechnology.com/up-to-date/latest-news/news/basf-broadens-biotech-business-by-isobionics-acquisition.html2019-09-27T09:08:12+02:00 2nd ECP Summer Summit at Henkel HQ, Düsseldorfhttps://european-biotechnology.com/up-to-date/latest-news/news/2nd-ecp-summer-summit-at-henkel-hq-duesseldorf.html2019-09-27T08:15:00+02:00 Gut bacterial enzyme keeps inflammation awayhttps://european-biotechnology.com/up-to-date/latest-news/news/gut-bacterial-enzyme-keeps-inflammation-away.html2019-09-26T05:50:00+02:00 Tacalyx GmbH raises €7m in seed fundinghttps://european-biotechnology.com/up-to-date/latest-news/news/tacalyx-gmbh-raises-eur7m-in-seed-funding.html2019-09-25T09:34:07+02:00 Evotec and Takeda enter drug discovery dealhttps://european-biotechnology.com/up-to-date/latest-news/news/evotec-and-takeda-enter-drug-discovery-deal.html2019-09-24T07:34:06+02:00 EMA greenlights new medicineshttps://european-biotechnology.com/up-to-date/latest-news/news/ema-greenlights-new-medicines.html2019-09-23T06:53:00+02:00 New malaria lead kills 99.9% of pathogenshttps://european-biotechnology.com/up-to-date/latest-news/news/new-malaria-lead-kills-999-of-pathogens.html2019-09-20T07:46:00+02:00 Versantis raises CHF16m in Series B financinghttps://european-biotechnology.com/up-to-date/latest-news/news/versantis-raises-chf16m-in-series-b-financing.html2019-09-19T08:16:11+02:00 Lundback swallows migraine drug maker Alderhttps://european-biotechnology.com/up-to-date/latest-news/news/lundback-swallows-migraine-drug-maker-alder.html2019-09-18T06:59:45+02:00 PFF Group NV acquires stake in Autolus Therapeuticshttps://european-biotechnology.com/up-to-date/latest-news/news/pff-group-nv-acquires-stake-in-autolus-therapeutics.html2019-09-17T07:17:01+02:00 Researchers identify CTLA-4 response marker https://european-biotechnology.com/up-to-date/latest-news/news/researchers-identify-ctla-4-response-marker.html2019-09-16T06:43:00+02:00 Inotrem SA raises €39m to provide POC for nangibotidehttps://european-biotechnology.com/up-to-date/latest-news/news/inotrem-sa-raises-eur39m-to-provide-poc-for-nangibotide.html2019-09-13T07:47:38+02:00 Ermium Therapeutics bags €6.3m in Series A roundhttps://european-biotechnology.com/up-to-date/latest-news/news/ermium-therapeutics-bags-eur63m-in-series-a-round.html2019-09-12T06:22:18+02:00 Pharvaris BV raises $66m to advance oral HAE drughttps://european-biotechnology.com/up-to-date/latest-news/news/pharvaris-bv-raises-66m-to-advance-oral-hae-drug.html2019-09-11T07:44:52+02:00 4BIO Ventures launches US$50m fundhttps://european-biotechnology.com/up-to-date/latest-news/news/4bio-ventures-launches-us50m-fund.html2019-09-10T06:38:41+02:00 ADC Therapeutics set to go publichttps://european-biotechnology.com/up-to-date/latest-news/news/adc-therapeutics-set-to-go-public.html2019-09-08T14:58:50+02:00 iStar Medical SA raises €40.1mhttps://european-biotechnology.com/up-to-date/latest-news/news/istar-medical-sa-raises-eur401m.html2019-09-06T07:34:15+02:00 UniQure looking to raise US$200m https://european-biotechnology.com/up-to-date/latest-news/news/uniqure-looking-to-raise-us200m.html2019-09-05T08:45:00+02:00 MS: Polpharma joins forces with Sandozhttps://european-biotechnology.com/up-to-date/latest-news/news/ms-polpharma-joins-forces-with-sandoz.html2019-09-04T08:45:00+02:00 Boehringer and Zealand to advance obesity drughttps://european-biotechnology.com/up-to-date/latest-news/news/boehringer-and-zealand-to-advance-obesity-drug.html2019-09-03T09:45:51+02:00 DPP3 triggers myocardial depressionhttps://european-biotechnology.com/up-to-date/latest-news/news/dpp3-triggers-myocardial-depression.html2019-09-01T12:16:58+02:00 Pro-apoptotic protein blocks autoimmunityhttps://european-biotechnology.com/up-to-date/latest-news/news/pro-apoptotic-protein-blocks-autoimmunity.html2019-08-31T06:00:00+02:00 Immatics and Celgene enter $1.5bn dealhttps://european-biotechnology.com/up-to-date/latest-news/news/immatics-and-celgene-enter-15bn-deal.html2019-08-28T13:23:19+02:00 Microbial feed company Unibio raises US$15mhttps://european-biotechnology.com/up-to-date/latest-news/news/microbial-feed-company-unibio-raises-us15m.html2019-08-28T07:26:52+02:00 ADC Therapeutics and Freenome enter biomarker collaboration https://european-biotechnology.com/up-to-date/latest-news/news/adc-therapeutics-and-freenome-enter-biomarker-collaboration.html2019-08-27T06:03:42+02:00 GSK reaches endpoint in pivotal blood cancer studyhttps://european-biotechnology.com/up-to-date/latest-news/news/gsk-reaches-endpoint-in-pivotal-blood-cancer-study.html2019-08-26T08:00:12+02:00 Swiss researchers report on metastasis switchhttps://european-biotechnology.com/up-to-date/latest-news/news/swiss-researchers-report-on-metastasis-switch.html2019-08-23T09:55:20+02:00 Preclinical antibody stops rheumatoid arthritis https://european-biotechnology.com/up-to-date/latest-news/news/preclinical-antibody-stops-rheumatoid-arthritis.html2019-08-22T08:56:36+02:00 Nabriva receives FDA approval for novel antibioticshttps://european-biotechnology.com/up-to-date/latest-news/news/nabriva-receives-fda-approval-for-novel-antibiotics.html2019-08-21T07:41:00+02:00 Araris Biotech AG kicks-off with CHF2.5m seed financinghttps://european-biotechnology.com/up-to-date/latest-news/news/araris-biotech-ag-kicks-off-with-chf25m-seed-financing.html2019-08-20T08:11:44+02:00 PharmaMar moves ahead with NDA for Zepsyrehttps://european-biotechnology.com/up-to-date/latest-news/news/pharmamar-moves-ahead-with-nda-for-zepsyre.html2019-08-19T09:35:00+02:00 Swedish researchers find new pain organhttps://european-biotechnology.com/up-to-date/latest-news/news/swedish-researchers-find-new-pain-organ.html2019-08-16T09:35:42+02:00 Researchers unravel potential cancer targethttps://european-biotechnology.com/up-to-date/latest-news/news/researchers-unravel-potential-cancer-target.html2019-08-15T06:12:21+02:00 Pharming licenses orphan drug from Novartishttps://european-biotechnology.com/up-to-date/latest-news/news/pharming-licenses-orphan-drug-from-novartis.html2019-08-13T09:56:01+02:00 New stem cell population may help repair teethhttps://european-biotechnology.com/up-to-date/latest-news/news/new-stem-cell-population-may-help-repair-teeth.html2019-08-12T07:42:46+02:00 Bayer bags iPSC specialist BlueRock Therapeuticshttps://european-biotechnology.com/up-to-date/latest-news/news/bayer-bags-ipsc-specialist-bluerock-therapeutics.html2019-08-09T07:51:33+02:00 Liquid biopsy identifies residual breast cancerhttps://european-biotechnology.com/up-to-date/latest-news/news/liquid-biopsy-identifies-residual-breast-cancer.html2019-08-08T06:15:42+02:00 Novo Holdings puts $72m in Lanzatechhttps://european-biotechnology.com/up-to-date/latest-news/news/novo-holdings-puts-72m-in-lanzatech.html2019-08-07T08:20:44+02:00 Google maps for tumours and organshttps://european-biotechnology.com/up-to-date/latest-news/news/google-maps-for-tumours-and-organs.html2019-08-06T07:12:00+02:00 Transgene’s licenced oncolytic virus fails in Phase IIIhttps://european-biotechnology.com/up-to-date/latest-news/news/transgenes-licenced-oncolytic-virus-fails-in-phase-iii.html2019-08-05T08:18:25+02:00 Wellington Partners launch €210m Life Sciences fundhttps://european-biotechnology.com/up-to-date/latest-news/news/wellington-partners-launch-eur210m-life-sciences-fund.html2019-08-02T07:23:55+02:00 Alizé Pharma 3 bags largest EU financing so farhttps://european-biotechnology.com/up-to-date/latest-news/news/alize-pharma-3-bags-largest-eu-financing-so-far.html2019-07-31T12:02:19+02:00 Better TNF∝ receptor blockers on the horizonhttps://european-biotechnology.com/up-to-date/latest-news/news/better-tnf-receptor-blockers-on-the-horizon.html2019-07-31T06:42:00+02:00 AgroSavfe raises €35m in Series C financinghttps://european-biotechnology.com/up-to-date/latest-news/news/agrosavfe-raises-eur35m-in-series-c-financing.html2019-07-30T08:58:15+02:00 European Commission approves ten GMOshttps://european-biotechnology.com/up-to-date/latest-news/news/european-commission-approves-ten-gmos.html2019-07-29T08:08:08+02:00 Zambon heading to US market with €500m acquisitionhttps://european-biotechnology.com/up-to-date/latest-news/news/zambon-heading-to-us-market-with-eur500m-acquisition.html2019-07-26T05:52:36+02:00 Gut microbiome boosts muscle strengthhttps://european-biotechnology.com/up-to-date/latest-news/news/gut-microbiome-boosts-muscle-strength.html2019-07-25T06:03:00+02:00 3P Pharma finds new major investorhttps://european-biotechnology.com/up-to-date/latest-news/news/3p-pharma-finds-new-major-investor.html2019-07-24T07:53:14+02:00 Curetis lower respiratory tract panel ready for FDA clearance https://european-biotechnology.com/up-to-date/latest-news/news/curetis-lower-respiratory-tract-panel-ready-for-fda-clearance.html2019-07-23T08:55:32+02:00 Merck and Broad Institute announce CRISPR license agreementhttps://european-biotechnology.com/up-to-date/latest-news/news/merck-and-broad-institute-announce-crispr-license-agreement.html2019-07-22T08:23:51+02:00 Billions for the circular economyhttps://european-biotechnology.com/up-to-date/latest-news/news/billions-for-the-circular-economy.html2019-07-19T05:58:00+02:00 Genmab launches US$502m IPOhttps://european-biotechnology.com/up-to-date/latest-news/news/genmab-launches-us502m-ipo.html2019-07-18T09:58:00+02:00 AM-Pharma raises €116m for Phase IIIhttps://european-biotechnology.com/up-to-date/latest-news/news/am-pharma-raises-eur116m-for-phase-iii.html2019-07-17T09:58:00+02:00 US$5bn deal for Galapagos https://european-biotechnology.com/up-to-date/latest-news/news/us5bn-deal-for-galapagos.html2019-07-16T10:58:00+02:00 Boehringer snaps up cancer vaccine developerhttps://european-biotechnology.com/up-to-date/latest-news/news/boehringer-snaps-up-cancer-vaccine-developer.html2019-07-15T10:58:00+02:00 €28.5m for microalgae expert Microphythttps://european-biotechnology.com/up-to-date/latest-news/news/eur285m-for-microalgae-expert-microphyt.html2019-07-14T10:58:00+02:00 €8m for universal flu vaccinehttps://european-biotechnology.com/up-to-date/latest-news/news/eur8m-for-universal-flu-vaccine.html2019-07-11T12:58:00+02:00 BioNTech pulls in massive €290m financinghttps://european-biotechnology.com/up-to-date/latest-news/news/biontech-pulls-in-massive-eur290m-financing.html2019-07-09T12:58:00+02:00 Biophytis launches €9m Nasdaq IPOhttps://european-biotechnology.com/up-to-date/latest-news/news/biophytis-launches-eur9m-nasdaq-ipo.html2019-07-09T06:58:00+02:00 €30m for Evotec cancer spin-outhttps://european-biotechnology.com/up-to-date/latest-news/news/eur30m-for-evotec-cancer-spin-out.html2019-07-08T06:58:00+02:00 Partnership in pursuit of new antibiotics classhttps://european-biotechnology.com/up-to-date/latest-news/news/partnership-in-pursuit-of-new-antibiotics-class.html2019-07-05T06:58:00+02:00 Drug puts CAR T activity on holdhttps://european-biotechnology.com/up-to-date/latest-news/news/drug-puts-car-t-activity-on-hold.html2019-07-04T06:58:00+02:00 License deal in oncolytic virotherapieshttps://european-biotechnology.com/up-to-date/latest-news/news/license-deal-in-oncolytic-virotherapies.html2019-07-03T06:58:00+02:00 Boehringer Ingelheim and Yuhan Corp. in US$870m NASH dealhttps://european-biotechnology.com/up-to-date/latest-news/news/boehringer-ingelheim-and-yuhan-corp-in-us870m-nash-deal.html2019-07-01T13:58:11+02:00 Smart bra set to detect breast cancerhttps://european-biotechnology.com/up-to-date/latest-news/news/smart-bra-set-to-detect-breast-cancer.html2019-06-28T08:43:23+02:00 GARDP wants five AMR breakers by 2025 https://european-biotechnology.com/up-to-date/latest-news/news/gardp-wants-five-amr-breakers-by-2025.html2019-06-27T08:39:19+02:00 Sanifit raise €72.2m to push SNF472 development https://european-biotechnology.com/up-to-date/latest-news/news/sanifit-raise-eur722m-to-push-snf472-development.html2019-06-26T08:36:04+02:00 Genfit in $228m deal with Terns Pharmaceuticalshttps://european-biotechnology.com/up-to-date/latest-news/news/genfit-in-228m-deal-with-terns-pharmaceuticals.html2019-06-26T07:02:00+02:00 Vesalius Biocapital III Fund closes at €120 millionhttps://european-biotechnology.com/up-to-date/latest-news/news/vesalius-biocapital-iii-fund-closes-at-eur120-million.html2019-06-25T11:48:21+02:00 Erytech Pharma SA bags US$57m from SQZ Biotechnologieshttps://european-biotechnology.com/up-to-date/latest-news/news/erytech-pharma-sa-bags-us57m-from-sqz-biotechnologies.html2019-06-25T07:28:34+02:00 Sanofi/Regeneron's IL-33 blocker meets endpoint in POC studyhttps://european-biotechnology.com/up-to-date/latest-news/news/sanofiregenerons-il-33-blocker-meets-endpoint-in-poc-study.html2019-06-24T08:02:19+02:00 Karo Pharma acquires Trimb AB https://european-biotechnology.com/up-to-date/latest-news/news/karo-pharma-acquires-trimb-ab.html2019-06-21T10:30:23+02:00 UK biotech to make proteins from carbon dioxide emissionshttps://european-biotechnology.com/up-to-date/latest-news/news/uk-biotech-to-make-proteins-from-carbon-dioxide-emissions.html2019-06-19T12:45:38+02:00 GM proponents grill German government https://european-biotechnology.com/up-to-date/latest-news/news/gm-proponents-grill-german-government.html2019-06-18T12:06:53+02:00 Human cell chip predicts chemotherapy effectshttps://european-biotechnology.com/up-to-date/latest-news/news/human-cell-chip-predicts-chemotherapy-effects.html2019-06-18T10:17:17+02:00 IL-10R-deficient macrophages trigger IBDhttps://european-biotechnology.com/up-to-date/latest-news/news/il-10r-deficient-macrophages-trigger-ibd.html2019-06-17T10:49:24+02:00 Breakthrough in liquid biopsyhttps://european-biotechnology.com/up-to-date/latest-news/news/breakthrough-in-liquid-biopsy.html2019-06-14T07:39:00+02:00 ADC Therapeutics raise $76m in Series E expansionhttps://european-biotechnology.com/up-to-date/latest-news/news/adc-therapeutics-raise-76m-in-series-e-expansion.html2019-06-12T12:13:06+02:00 Janssen and Genmab in licence option dealhttps://european-biotechnology.com/up-to-date/latest-news/news/janssen-and-genmab-in-licence-option-deal.html2019-06-12T06:27:47+02:00 Evotec bags US$23.8m to fight tuberculosishttps://european-biotechnology.com/up-to-date/latest-news/news/evotec-bags-us238m-to-fight-tuberculosis.html2019-06-11T07:12:45+02:00 How lungs trigger innate lymphoid cell dynamicshttps://european-biotechnology.com/up-to-date/latest-news/news/how-lungs-trigger-innate-lymphoid-cell-dynamics.html2019-06-07T07:10:00+02:00 Researchers find clue to Parkinson's gene therapyhttps://european-biotechnology.com/up-to-date/latest-news/news/researchers-find-clue-to-parkinsons-gene-therapy.html2019-06-06T06:49:49+02:00 Chikungunya vaccine developer Themis bags $21m https://european-biotechnology.com/up-to-date/latest-news/news/chikungunya-vaccine-developer-themis-bags-21m.html2019-06-05T07:57:08+02:00 Genetically modified fungus stops malaria mosquitoeshttps://european-biotechnology.com/up-to-date/latest-news/news/genetically-modified-fungus-stops-malaria-mosquitoes.html2019-06-04T09:28:25+02:00 Abacus Medicine postpones IPOhttps://european-biotechnology.com/up-to-date/latest-news/news/abacus-medicine-postpones-ipo.html2019-06-02T05:04:00+02:00 Make leukaemia therapy saferhttps://european-biotechnology.com/up-to-date/latest-news/news/make-leukaemia-therapy-safer.html2019-05-31T06:57:00+02:00 Nanobiotix spins out Curadigmhttps://european-biotechnology.com/up-to-date/latest-news/news/nanobiotix-spins-out-curadigm.html2019-05-29T08:57:20+02:00 Double win for Novartishttps://european-biotechnology.com/up-to-date/latest-news/news/double-win-for-novartis.html2019-05-28T08:13:00+02:00 Most expensive gene therapy globally approvedhttps://european-biotechnology.com/up-to-date/latest-news/news/most-expensive-gene-therapy-globally-approved.html2019-05-27T08:13:59+02:00 Healthy figures from Spainhttps://european-biotechnology.com/up-to-date/latest-news/news/healthy-figures-from-spain.html2019-05-24T06:48:00+02:00 Chiesi acquires ex-US Raxone marketing rightshttps://european-biotechnology.com/up-to-date/latest-news/news/chiesi-acquires-ex-us-raxone-marketing-rights.html2019-05-23T07:17:28+02:00 EU ministers set to exclude CRISPR crops from GMO legislationhttps://european-biotechnology.com/up-to-date/latest-news/news/eu-ministers-set-to-exclude-crispr-crops-from-gmo-legislation.html2019-05-22T10:25:39+02:00 Evotec acquires CDMO Just Biotherapeutics in US$90m dealhttps://european-biotechnology.com/up-to-date/latest-news/news/evotec-acquires-cdmo-just-biotherapeutics-in-us90m-deal.html2019-05-21T07:04:50+02:00 AI improves protein manufacturehttps://european-biotechnology.com/up-to-date/latest-news/news/ai-improves-protein-manufacture.html2019-05-20T06:54:03+02:00 DNA Script raises US$38.5m in Series B roundhttps://european-biotechnology.com/up-to-date/latest-news/news/dna-script-raises-us385m-in-series-b-round.html2019-05-17T06:22:00+02:00 Hedging successhttps://european-biotechnology.com/up-to-date/latest-news/news/hedging-success.html2019-05-16T16:21:10+02:00 Dutch-Italian team improves retinal gene therapyhttps://european-biotechnology.com/up-to-date/latest-news/news/dutch-italian-team-improves-retinal-gene-therapy.html2019-05-16T07:36:09+02:00 Mobidiag secures €25m loan from EIBhttps://european-biotechnology.com/up-to-date/latest-news/news/mobidiag-secures-eur25m-loan-from-eib.html2019-05-15T07:30:30+02:00 Philogen SpA raises €62m to push registration https://european-biotechnology.com/up-to-date/latest-news/news/philogen-spa-raises-eur62m-to-push-registration.html2019-05-14T07:03:51+02:00 Halt of Polyphor trial shrinks company valuationhttps://european-biotechnology.com/up-to-date/latest-news/news/halt-of-polyphor-trial-shrinks-company-valuation.html2019-05-13T06:19:00+02:00 Ethics Council calls for moratorium of clinical germline manipulationhttps://european-biotechnology.com/up-to-date/latest-news/news/ethics-council-calls-for-moratorium-of-clinical-germline-manipulation.html2019-05-10T06:46:51+02:00 BioNtech aquires antibody assets from MabVax Therapeuticshttps://european-biotechnology.com/up-to-date/latest-news/news/biontech-aquires-antibody-assets-from-mabvax-therapeutics.html2019-05-09T07:38:42+02:00 MS linked to epigenetic changes in immune cells https://european-biotechnology.com/up-to-date/latest-news/news/ms-linked-to-epigenetic-changes-in-immune-cells.html2019-05-08T08:10:55+02:00 Confo Therapeutics raise €30m in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/confo-therapeutics-raise-eur30m-in-series-a-financing.html2019-05-07T10:45:38+02:00 Researchers report how body fat affects imune cellshttps://european-biotechnology.com/up-to-date/latest-news/news/researchers-report-how-body-fat-affects-imune-cells.html2019-05-06T09:51:41+02:00 European Lead Factory gets €36.5m support from IMIhttps://european-biotechnology.com/up-to-date/latest-news/news/european-lead-factory-gets-eur365m-support-from-imi.html2019-05-02T14:46:02+02:00 AstraZeneca set to licence 5 programmes from Transgène SA https://european-biotechnology.com/up-to-date/latest-news/news/astrazeneca-set-to-licence-5-programmes-from-transgene-sa.html2019-05-02T08:27:22+02:00 Alentis Therapeutics debuts with CHF12.5mhttps://european-biotechnology.com/up-to-date/latest-news/news/alentis-therapeutics-debuts-with-chf125m.html2019-04-30T07:16:06+02:00 EMA recommends nine drugs for market approvalhttps://european-biotechnology.com/up-to-date/latest-news/news/ema-recommends-nine-drugs-for-market-approval.html2019-04-29T07:41:34+02:00 A novel strategy against rheumatoid arthritishttps://european-biotechnology.com/up-to-date/latest-news/news/a-novel-strategy-against-rheumatoid-arthritis.html2019-04-24T14:44:23+02:00 US patent office grants Charpentier CRISPR patenthttps://european-biotechnology.com/up-to-date/latest-news/news/us-patent-office-grants-charpentier-crispr-patent.html2019-04-24T04:54:29+02:00 European Parliament greenlights Horizon Europe prioritieshttps://european-biotechnology.com/up-to-date/latest-news/news/european-parliament-greenlights-horizon-europe-priorities.html2019-04-23T06:57:59+02:00 Biotechpharma UAB expanding productionhttps://european-biotechnology.com/up-to-date/latest-news/news/biotechpharma-uab-expanding-production.html2019-04-18T06:19:00+02:00 Kiadis Pharma NV to acquire CytoSen Therapeutics, Inc.https://european-biotechnology.com/up-to-date/latest-news/news/kiadis-pharma-nv-to-acquire-cytosen-therapeutics-inc.html2019-04-17T10:36:48+02:00 Treating diabetes by mimicking gut bacteria effectshttps://european-biotechnology.com/up-to-date/latest-news/news/treating-diabetes-by-mimicking-gut-bacteria-effects.html2019-04-16T09:10:28+02:00 Immunic lists at Nasdaqhttps://european-biotechnology.com/up-to-date/latest-news/news/immunic-lists-at-nasdaq.html2019-04-15T06:48:00+02:00 Preventing virus infections in newbornshttps://european-biotechnology.com/up-to-date/latest-news/news/preventing-virus-infections-in-newborns.html2019-04-12T07:03:18+02:00 Evotec and Indivumed join forces in CRChttps://european-biotechnology.com/up-to-date/latest-news/news/evotec-and-indivumed-join-forces-in-crc.html2019-04-11T08:12:32+02:00 Theranexus colloborates with AI expert Dylisshttps://european-biotechnology.com/up-to-date/latest-news/news/theranexus-colloborates-with-ai-expert-dyliss.html2019-04-10T08:47:51+02:00 uniQure Receives FDA Fast Track Designation for AMT-130https://european-biotechnology.com/up-to-date/latest-news/news/uniqure-receives-fda-fast-track-designation-for-amt-130.html2019-04-09T08:38:24+02:00 Sanofi ends option phase of rare disease partnership with Alnylamhttps://european-biotechnology.com/up-to-date/latest-news/news/sanofi-ends-option-phase-of-rare-disease-partnership-with-alnylam.html2019-04-08T06:59:15+02:00 Medigene AG in potential €1bn licence and R&D dealhttps://european-biotechnology.com/up-to-date/latest-news/news/medigene-ag-in-potential-eur1bn-licence-and-rd-deal.html2019-04-05T07:42:48+02:00 AMR diagnostic specialist Gradientech raise $4.6m https://european-biotechnology.com/up-to-date/latest-news/news/amr-diagnostic-specialist-gradientech-raise-46m.html2019-04-04T08:58:04+02:00 AgomAb Therapeutics bags €21m Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/agomab-therapeutics-bags-eur21m-series-a-financing.html2019-04-03T09:12:03+02:00 Novartis acquires inflammasome blocker company IFM Trehttps://european-biotechnology.com/up-to-date/latest-news/news/novartis-acquires-inflammasome-blocker-company-ifm-tre.html2019-04-02T06:22:47+02:00 EMA recommends bluebird's β-thalassemia gene therapyhttps://european-biotechnology.com/up-to-date/latest-news/news/ema-recommends-bluebirds-b-thalassemia-gene-therapy.html2019-04-01T08:33:30+02:00 Selvita to spin out cancer businesshttps://european-biotechnology.com/up-to-date/latest-news/news/selvita-to-spin-out-cancer-business.html2019-03-29T06:31:00+01:00 Polyneuron Pharma raise CHF22.5m in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/polyneuron-pharma-raise-chf225m-in-series-a-financing.html2019-03-28T09:18:25+01:00 Genfit prices IPO at $135mhttps://european-biotechnology.com/up-to-date/latest-news/news/genfit-prices-ipo-at-135m.html2019-03-27T08:25:25+01:00 Evotec partners with Mark Foundation for Cancer Researchhttps://european-biotechnology.com/up-to-date/latest-news/news/evotec-partners-with-mark-foundation-for-cancer-research.html2019-03-26T08:10:54+01:00 Hookipa Pharma files for US-$86m IPOhttps://european-biotechnology.com/up-to-date/latest-news/news/hookipa-pharma-files-for-us-86m-ipo.html2019-03-25T08:51:00+01:00 New approach to treat eye cancerhttps://european-biotechnology.com/up-to-date/latest-news/news/new-approach-to-treat-eye-cancer.html2019-03-22T06:38:31+01:00 Pfizer buys stake in liver gene therapy player Vivet https://european-biotechnology.com/up-to-date/latest-news/news/pfizer-buys-stake-in-liver-gene-therapy-player-vivet.html2019-03-21T07:42:20+01:00 Sotio on track for 2nd Phase III trialhttps://european-biotechnology.com/up-to-date/latest-news/news/sotio-on-track-for-2nd-phase-iii-trial.html2019-03-20T07:44:16+01:00 AMR Conference in Berlin: Call for better incentiveshttps://european-biotechnology.com/up-to-date/latest-news/news/amr-conference-in-berlin-call-for-better-incentives.html2019-03-19T07:55:00+01:00 Biomarker can exclude acute kidney injuryhttps://european-biotechnology.com/up-to-date/latest-news/news/biomarker-can-exclude-acute-kidney-injury.html2019-03-18T06:47:00+01:00 Researchers target neuroblastoma with ALK-ADChttps://european-biotechnology.com/up-to-date/latest-news/news/researchers-target-neuroblastoma-with-alk-adc.html2019-03-14T13:16:05+01:00 AMR: Germany set to invest €39m into CARB-Xhttps://european-biotechnology.com/up-to-date/latest-news/news/amr-germany-set-to-invest-eur39m-into-carb-x.html2019-03-14T06:27:00+01:00 AstraZeneca partners with Seres Therapeuticshttps://european-biotechnology.com/up-to-date/latest-news/news/astrazeneca-partners-with-seres-therapeutics.html2019-03-13T09:01:01+01:00 AMR: Snipr Biome Aps raises €43m to programme pathogens for deathhttps://european-biotechnology.com/up-to-date/latest-news/news/amr-snipr-biome-aps-raises-eur43m-to-programme-pathogens-for-death.html2019-03-12T07:34:59+01:00 Small-molecule acts as broad-band influenza entry blockerhttps://european-biotechnology.com/up-to-date/latest-news/news/small-molecule-acts-as-broad-band-influenza-entry-blocker.html2019-03-11T09:02:51+01:00 Seventure starts second microbiome-focussed fund https://european-biotechnology.com/up-to-date/latest-news/news/seventure-starts-second-microbiome-focussed-fund.html2019-03-07T08:26:38+01:00 Numab AG bags CHF70m in licencing dealhttps://european-biotechnology.com/up-to-date/latest-news/news/numab-ag-bags-chf70m-in-licencing-deal.html2019-03-06T08:55:46+01:00 Biogen bags UK company Nightstar for US$877mhttps://european-biotechnology.com/up-to-date/latest-news/news/biogen-bags-uk-company-nightstar-for-us877m.html2019-03-05T07:16:10+01:00 EMA approves eight meds for markethttps://european-biotechnology.com/up-to-date/latest-news/news/ema-approves-eight-meds-for-market.html2019-03-04T07:11:04+01:00 Genfit set to raise $100m in Nasdaq IPO https://european-biotechnology.com/up-to-date/latest-news/news/genfit-set-to-raise-100m-in-nasdaq-ipo.html2019-03-01T07:38:54+01:00 Targeting NFkappaB protects tendons from injury https://european-biotechnology.com/up-to-date/latest-news/news/targeting-nfkappab-protects-tendons-from-injury.html2019-02-27T10:38:49+01:00 Anaveon bags CHF35m series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/anaveon-bags-chf35m-series-a-financing.html2019-02-27T07:55:24+01:00 AMR network CARB-X expands reach https://european-biotechnology.com/up-to-date/latest-news/news/amr-network-carb-x-expands-reach.html2019-02-26T08:07:08+01:00 Roche swallows Spark Therapeutics in $4.3bn dealhttps://european-biotechnology.com/up-to-date/latest-news/news/roche-swallows-spark-therapeutics-in-43bn-deal.html2019-02-25T08:05:13+01:00 How salt triggers allergyhttps://european-biotechnology.com/up-to-date/latest-news/news/how-salt-triggers-allergy.html2019-02-21T22:16:26+01:00 Calypso Biotech cash in €20M Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/calypso-biotech-cash-in-eur20m-series-a-financing.html2019-02-20T14:32:56+01:00 Evotec and HZI join forces in antibiotics discoveryhttps://european-biotechnology.com/up-to-date/latest-news/news/evotec-and-hzi-join-forces-in-antibiotics-discovery.html2019-02-20T08:31:47+01:00 First immunotolerant allogenic cell transplants revealedhttps://european-biotechnology.com/up-to-date/latest-news/news/first-immunotolerant-allogenic-cell-transplants-revealed.html2019-02-19T07:42:41+01:00 Arvelle Therapeutics raises $180m in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/arvelle-therapeutics-raises-180m-in-series-a-financing.html2019-02-18T07:27:53+01:00 Bio-plastics production grows to 7.5 million tonneshttps://european-biotechnology.com/up-to-date/latest-news/news/bio-plastics-production-grows-to-75-million-tonnes.html2019-02-15T07:37:02+01:00 Reprogrammed pancreatic cells cure type I diabeteshttps://european-biotechnology.com/up-to-date/latest-news/news/reprogrammed-pancreatic-cells-cure-type-i-diabetes.html2019-02-14T08:40:17+01:00 Afyren raises €21m to launch production planthttps://european-biotechnology.com/up-to-date/latest-news/news/afyren-raises-eur21m-to-launch-production-plant.html2019-02-12T20:38:31+01:00 Industrial biotech hub validates start-up ideashttps://european-biotechnology.com/up-to-date/latest-news/news/industrial-biotech-hub-validates-start-up-ideas.html2019-02-12T07:41:11+01:00 uniqure delivers POC for hemophilia B gene therapyhttps://european-biotechnology.com/up-to-date/latest-news/news/uniqure-delivers-poc-for-hemophilia-b-gene-therapy.html2019-02-11T07:14:30+01:00 Ose Pharma gets clinical milestone for IL7R antagonisthttps://european-biotechnology.com/up-to-date/latest-news/news/ose-pharma-gets-clinical-milestone-for-il7r-antagonist.html2019-02-08T07:45:57+01:00 How stroma cells trigger tumour angiogenesishttps://european-biotechnology.com/up-to-date/latest-news/news/how-stroma-cells-trigger-tumour-angiogenesis.html2019-02-07T07:44:54+01:00 Jennewein Biotechnologie expands into Chinese markethttps://european-biotechnology.com/up-to-date/latest-news/news/jennewein-biotechnologie-expands-into-chinese-market.html2019-02-06T07:47:07+01:00 Medicxi put €40m into two Sosei spin off companieshttps://european-biotechnology.com/up-to-date/latest-news/news/medicxi-put-eur40m-into-two-sosei-spin-off-companies.html2019-02-05T08:16:17+01:00 EMA greenlights two orphan drugs and two biosimilarshttps://european-biotechnology.com/up-to-date/latest-news/news/ema-greenlights-two-orphan-drugs-and-two-biosimilars.html2019-02-03T16:49:57+01:00 Hitachi expands European reach in cell and gene therapyhttps://european-biotechnology.com/up-to-date/latest-news/news/hitachi-expands-european-reach-in-cell-and-gene-therapy.html2019-02-01T09:18:18+01:00 Dewpoint Therapeutics kicks off with $60m financinghttps://european-biotechnology.com/up-to-date/latest-news/news/dewpoint-therapeutics-kicks-off-with-60m-financing.html2019-01-31T07:11:23+01:00 IPO: Marinomed sets offer pricehttps://european-biotechnology.com/up-to-date/latest-news/news/ipo-marinomed-sets-offer-price.html2019-01-30T07:15:30+01:00 Novozymes partners with Carbios subsidiary Carbiolicehttps://european-biotechnology.com/up-to-date/latest-news/news/novozymes-partners-with-carbios-subsidiary-carbiolice.html2019-01-29T07:17:10+01:00 Biomarker predicts response to TNF blockershttps://european-biotechnology.com/up-to-date/latest-news/news/biomarker-predicts-response-to-tnf-blockers.html2019-01-28T10:11:00+01:00 UK launches new payment model for antimicrobialshttps://european-biotechnology.com/up-to-date/latest-news/news/uk-launches-new-payment-model-for-antimicrobials.html2019-01-25T07:27:26+01:00 BioNtech swallows MAB Discovery antibody unithttps://european-biotechnology.com/up-to-date/latest-news/news/biontech-swallows-mab-discovery-antibody-unit.html2019-01-24T07:32:19+01:00 Clariant inks cellulosic biodiesel pact with ExxonMobil/REGhttps://european-biotechnology.com/up-to-date/latest-news/news/clariant-inks-cellulosic-biodiesel-pact-with-exxonmobilreg.html2019-01-23T08:09:00+01:00 IMI launches €80m callhttps://european-biotechnology.com/up-to-date/latest-news/news/imi-launches-eur80m-call.html2019-01-22T10:02:21+01:00 AMR: Novo Holdings funds companies with €18mhttps://european-biotechnology.com/up-to-date/latest-news/news/amr-novo-holdings-funds-companies-with-eur18m.html2019-01-21T09:05:28+01:00 Boehringer expands neurology activitieshttps://european-biotechnology.com/up-to-date/latest-news/news/boehringer-expands-neurology-activities.html2019-01-18T07:50:25+01:00 New target for lung fibrosis discoveredhttps://european-biotechnology.com/up-to-date/latest-news/news/new-target-for-lung-fibrosis-discovered.html2019-01-17T07:18:28+01:00 Valneva inks $59m JE vaccine supply contracthttps://european-biotechnology.com/up-to-date/latest-news/news/valneva-inks-59m-je-vaccine-supply-contract.html2019-01-16T08:07:40+01:00 VTT turn waste into biofuels and chemicalshttps://european-biotechnology.com/up-to-date/latest-news/news/vtt-turn-waste-into-biofuels-and-chemicals.html2019-01-15T08:08:18+01:00 Tissue specific tumour transition needs few cellshttps://european-biotechnology.com/up-to-date/latest-news/news/tissue-specific-tumour-transition-needs-few-cells.html2019-01-14T07:56:58+01:00 Drug dissociates metastasis precursors in bloodhttps://european-biotechnology.com/up-to-date/latest-news/news/drug-dissociates-metastasis-precursors-in-blood.html2019-01-11T07:29:37+01:00 Policymakers take no action after ECJ mutagenesis rulinghttps://european-biotechnology.com/up-to-date/latest-news/news/policymakers-take-no-action-after-ecj-mutagenesis-ruling.html2019-01-10T08:06:59+01:00 Sandoz’ antiinfectives partner Ares Genetics gets fund https://european-biotechnology.com/up-to-date/latest-news/news/sandoz-antiinfectives-partner-ares-genetics-gets-fund.html2019-01-08T14:17:23+01:00 AI provides face read-out of genetic diseaseshttps://european-biotechnology.com/up-to-date/latest-news/news/ai-provides-face-read-out-of-genetic-diseases.html2019-01-08T05:32:00+01:00 Sanofi ends immuno-oncology discovery with Regeneronhttps://european-biotechnology.com/up-to-date/latest-news/news/sanofi-ends-immuno-oncology-discovery-with-regeneron.html2019-01-07T08:58:27+01:00 Merry Christmas and a Happy New Yearhttps://european-biotechnology.com/up-to-date/latest-news/news/merry-christmas-and-a-happy-new-year.html2018-12-25T19:02:34+01:00 Diverse cells make up the endotheliumhttps://european-biotechnology.com/up-to-date/latest-news/news/diverse-cells-make-up-the-endothelium.html2018-12-22T05:43:00+01:00 Microbiome defines gut conditionshttps://european-biotechnology.com/up-to-date/latest-news/news/microbiome-defines-gut-conditions.html2018-12-21T08:10:54+01:00 Cellestia Biotech AG attracts Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/cellestia-biotech-ag-attracts-series-a-financing.html2018-12-19T12:40:24+01:00 Staten Biotechnology in $430m deal with Novo Nordiskhttps://european-biotechnology.com/up-to-date/latest-news/news/staten-biotechnology-in-430m-deal-with-novo-nordisk.html2018-12-18T06:00:00+01:00 Kurma Partners announce closing of Biofund III https://european-biotechnology.com/up-to-date/latest-news/news/kurma-partners-announce-closing-of-biofund-iii.html2018-12-17T07:40:00+01:00 MEPs back €120bn budget for Horizon Europehttps://european-biotechnology.com/up-to-date/latest-news/news/meps-back-eur120bn-budget-for-horizon-europe.html2018-12-14T08:53:39+01:00 New cheap CRS-blockers at the horizonhttps://european-biotechnology.com/up-to-date/latest-news/news/new-cheap-crs-blockers-at-the-horizon.html2018-12-13T08:03:26+01:00 Oxford BioTherapeutics in $450 deal with Wuxi Biologicshttps://european-biotechnology.com/up-to-date/latest-news/news/oxford-biotherapeutics-in-450-deal-with-wuxi-biologics.html2018-12-12T06:39:24+01:00 Diabetes doubles risk for heart failurehttps://european-biotechnology.com/up-to-date/latest-news/news/diabetes-doubles-risk-for-heart-failure.html2018-12-11T07:31:55+01:00 AZ checkpoint blocker combo fails in head and neck cancerhttps://european-biotechnology.com/up-to-date/latest-news/news/az-checkpoint-blocker-combo-fails-in-head-and-neck-cancer.html2018-12-10T08:01:46+01:00 XyloCor Therapeutics bags US$17m in Series A financinghttps://european-biotechnology.com/up-to-date/latest-news/news/xylocor-therapeutics-bags-us17m-in-series-a-financing.html2018-12-06T08:38:00+01:00 BioFIT: innovation and investorshttps://european-biotechnology.com/up-to-date/latest-news/news/biofit-innovation-and-investors.html2018-12-06T07:07:00+01:00 Uncommon mutations affect breast cancer prognosishttps://european-biotechnology.com/up-to-date/latest-news/news/uncommon-mutations-affect-breast-cancer-prognosis.html2018-12-05T08:07:48+01:00 GSK swallows Tesaro in US$5.1bn dealhttps://european-biotechnology.com/up-to-date/latest-news/news/gsk-swallows-tesaro-in-us51bn-deal.html2018-12-04T07:38:26+01:00 Argenx in US$1.6bn deal with J&J affiliate Janssenhttps://european-biotechnology.com/up-to-date/latest-news/news/argenx-in-us16bn-deal-with-jj-affiliate-janssen.html2018-12-03T08:28:38+01:00 Driver of GVHD after blood stem cell transplantation identifiedhttps://european-biotechnology.com/up-to-date/latest-news/news/driver-of-gvhd-after-blood-stem-cell-transplantation-identified.html2018-11-30T09:04:29+01:00 Investors pool €27m for new Proteomics tech https://european-biotechnology.com/up-to-date/latest-news/news/investors-pool-eur27m-for-new-proteomics-tech.html2018-11-29T10:12:39+01:00 Carbios set to build closed-loop PET planthttps://european-biotechnology.com/up-to-date/latest-news/news/carbios-set-to-build-closed-loop-pet-plant.html2018-11-28T07:02:47+01:00 Adrenomed bags €24m in growth financinghttps://european-biotechnology.com/up-to-date/latest-news/news/adrenomed-bags-eur24m-in-growth-financing.html2018-11-26T14:07:22+01:00 Roche targets asthma with inhalable JAK1 blockerhttps://european-biotechnology.com/up-to-date/latest-news/news/roche-targets-asthma-with-inhalable-jak1-blocker.html2018-11-26T07:46:15+01:00 British F2G Biotech bags €24mhttps://european-biotechnology.com/up-to-date/latest-news/news/british-f2g-biotech-bags-eur24m.html2018-11-22T14:08:55+01:00 Sugar replacement slows cancer growthhttps://european-biotechnology.com/up-to-date/latest-news/news/sugar-replacement-slows-cancer-growth.html2018-11-22T06:36:00+01:00 Epigenetic drugs can increase tumour malignancyhttps://european-biotechnology.com/up-to-date/latest-news/news/epigenetic-drugs-can-increase-tumour-malignancy.html2018-11-21T06:57:17+01:00 Forbion leads €40m financing in Inflazome Ltdhttps://european-biotechnology.com/up-to-date/latest-news/news/forbion-leads-eur40m-financing-in-inflazome-ltd.html2018-11-19T09:35:03+01:00 EC advisors call for update of GM legislationhttps://european-biotechnology.com/up-to-date/latest-news/news/ec-advisors-call-for-update-of-gm-legislation.html2018-11-19T07:30:34+01:00 Boehringer and Epizyme enter US$300m dealhttps://european-biotechnology.com/up-to-date/latest-news/news/boehringer-and-epizyme-enter-us300m-deal.html2018-11-15T14:54:30+01:00 Breakthrough in restless legs syndromehttps://european-biotechnology.com/up-to-date/latest-news/news/breakthrough-in-restless-legs-syndrome.html2018-11-15T05:28:00+01:00 SOBI and AstraZeneca in US$2bn+ deal on RSV antibodieshttps://european-biotechnology.com/up-to-date/latest-news/news/sobi-and-astrazeneca-in-us2bn-deal-on-rsv-antibodies.html2018-11-14T07:01:00+01:00 Amal bags €21.2m financinghttps://european-biotechnology.com/up-to-date/latest-news/news/amal-bags-eur212m-financing.html2018-11-13T07:36:45+01:00 Antibiotic resistance spreading across Europehttps://european-biotechnology.com/up-to-date/latest-news/news/antibiotic-resistance-spreading-across-europe.html2018-11-12T07:05:23+01:00 Liquid biopsy: size mattershttps://european-biotechnology.com/up-to-date/latest-news/news/liquid-biopsy-size-matters.html2018-11-09T09:41:00+01:00 Themis postpones IPOhttps://european-biotechnology.com/up-to-date/latest-news/news/themis-postpones-ipo.html2018-11-09T07:26:00+01:00 New checkpoint inhibitor on the blockhttps://european-biotechnology.com/up-to-date/latest-news/news/new-checkpoint-inhibitor-on-the-block.html2018-11-07T10:56:00+01:00 BIO-Europe: advanced therapies in focushttps://european-biotechnology.com/up-to-date/latest-news/news/bio-europe-advanced-therapies-in-focus.html2018-11-06T16:12:51+01:00 Dry AMD: Oxurion licences heparanase blockers from Beta Therapeuticshttps://european-biotechnology.com/up-to-date/latest-news/news/dry-amd-oxurion-licences-heparanase-blockers-from-beta-therapeutics.html2018-11-05T18:22:35+01:00 Nanobots heading to eye deliveryhttps://european-biotechnology.com/up-to-date/latest-news/news/nanobots-heading-to-eye-delivery.html2018-11-04T18:12:58+01:00 Argenx antibody kills AMLhttps://european-biotechnology.com/up-to-date/latest-news/news/argenx-antibody-kills-aml.html2018-11-02T08:23:43+01:00 Sanofi and Denali Therapeutics ink €1.125bn deal in neurology/inflammationhttps://european-biotechnology.com/up-to-date/latest-news/news/sanofi-and-denali-therapeutics-ink-eur1125bn-deal-in-neurologyinflammation.html2018-11-01T07:29:13+01:00 ProQR in licence deal with Ionis Pharmaceuticalshttps://european-biotechnology.com/up-to-date/latest-news/news/proqr-in-licence-deal-with-ionis-pharmaceuticals.html2018-10-31T07:23:03+01:00 Newron bags €40m EIB loanhttps://european-biotechnology.com/up-to-date/latest-news/news/newron-bags-eur40m-eib-loan.html2018-10-30T07:53:41+01:00 TES Pharma presents new treatment approach towards AKI and NALFD https://european-biotechnology.com/up-to-date/latest-news/news/tes-pharma-presents-new-treatment-approach-towards-aki-and-nalfd.html2018-10-26T07:39:36+02:00 MEPs vote for ban of single-use plasticshttps://european-biotechnology.com/up-to-date/latest-news/news/meps-vote-for-ban-of-single-use-plastics.html2018-10-25T07:26:40+02:00 AstraZeneca and Innate Pharma in US$5bn oncology dealhttps://european-biotechnology.com/up-to-date/latest-news/news/astrazeneca-and-innate-pharma-in-us5bn-oncology-deal.html2018-10-24T05:21:03+02:00 Takeda strikes US$640m deal with Enteromehttps://european-biotechnology.com/up-to-date/latest-news/news/takeda-strikes-us640m-deal-with-enterome.html2018-10-23T08:15:03+02:00 EMA recommends four biologicals for markethttps://european-biotechnology.com/up-to-date/latest-news/news/ema-recommends-four-biologicals-for-market.html2018-10-21T14:18:16+02:00 Companies at EFIB set to drive the bioeconomyhttps://european-biotechnology.com/up-to-date/latest-news/news/companies-at-efib-set-to-drive-the-bioeconomy.html2018-10-19T09:55:21+02:00 Oxford Nanopore wins over Amgenhttps://european-biotechnology.com/up-to-date/latest-news/news/oxford-nanopore-wins-over-amgen.html2018-10-19T06:51:00+02:00 French Acticor Biotech raises €15.3m https://european-biotechnology.com/up-to-date/latest-news/news/french-acticor-biotech-raises-eur153m.html2018-10-18T09:51:00+02:00 HiFiBiO bags immuno-oncology specialist H-Immune https://european-biotechnology.com/up-to-date/latest-news/news/hifibio-bags-immuno-oncology-specialist-h-immune.html2018-10-16T16:51:00+02:00 Phase III success for Roche breast cancer drughttps://european-biotechnology.com/up-to-date/latest-news/news/phase-iii-success-for-roche-breast-cancer-drug.html2018-10-16T07:51:00+02:00 Targovax reports promising disease-free survival (DFS) datahttps://european-biotechnology.com/up-to-date/latest-news/news/targovax-reports-promising-disease-free-survival-dfs-data.html2018-10-15T07:51:31+02:00 EU set to speed up switch to bioeconomy by new action planhttps://european-biotechnology.com/up-to-date/latest-news/news/eu-set-to-speed-up-switch-to-bioeconomy-by-new-action-plan.html2018-10-12T05:38:00+02:00 Bacterial antigen mimicry drives MShttps://european-biotechnology.com/up-to-date/latest-news/news/bacterial-antigen-mimicry-drives-ms.html2018-10-10T14:52:29+02:00 Affimed halts trial after patient death and SAEshttps://european-biotechnology.com/up-to-date/latest-news/news/affimed-halts-trial-after-patient-death-and-saes.html2018-10-10T08:11:23+02:00 Sitryx Therapeutics bags $30m in Series A Financinghttps://european-biotechnology.com/up-to-date/latest-news/news/sitryx-therapeutics-bags-30m-in-series-a-financing.html2018-10-09T05:29:18+02:00 Orchard plans to raise US$172m in ADShttps://european-biotechnology.com/up-to-date/latest-news/news/orchard-plans-to-raise-us172m-in-ads.html2018-10-08T05:48:27+02:00 Sphingotec raises €20m in growth equity financinghttps://european-biotechnology.com/up-to-date/latest-news/news/sphingotec-raises-eur20m-in-growth-equity-financing.html2018-10-07T08:50:00+02:00 Sanofi and Evotec launch drug discovery PPPhttps://european-biotechnology.com/up-to-date/latest-news/news/sanofi-and-evotec-launch-drug-discovery-ppp.html2018-10-05T07:24:34+02:00 Roche providing improved anti-Her2 bispecific antibody https://european-biotechnology.com/up-to-date/latest-news/news/roche-providing-improved-anti-her2-bispecific-antibody.html2018-10-03T06:45:52+02:00 Forbion closes Life Sciences VC Fund at €360mhttps://european-biotechnology.com/up-to-date/latest-news/news/forbion-closes-life-sciences-vc-fund-at-eur360m.html2018-10-01T10:43:04+02:00 BIOSPAIN expanding https://european-biotechnology.com/up-to-date/latest-news/news/biospain-expanding.html2018-10-01T07:17:20+02:00 Minoryx bags €21.3m Series B financinghttps://european-biotechnology.com/up-to-date/latest-news/news/minoryx-bags-eur213m-series-b-financing.html2018-09-27T06:04:00+02:00 PD-1+ T cells trigger pulmonary fibrosishttps://european-biotechnology.com/up-to-date/latest-news/news/pd-1-t-cells-trigger-pulmonary-fibrosis.html2018-09-26T14:25:23+02:00 Roche’s Tecentriq prolongs OS in SCLC https://european-biotechnology.com/up-to-date/latest-news/news/roches-tecentriq-prolongs-os-in-sclc.html2018-09-26T08:02:31+02:00 CRISPR-gene drive safely kills mosquitoshttps://european-biotechnology.com/up-to-date/latest-news/news/crispr-gene-drive-safely-kills-mosquitos.html2018-09-25T06:02:15+02:00 CHMP with new Chair – 13 meds recommendedhttps://european-biotechnology.com/up-to-date/latest-news/news/chmp-with-new-chair-13-meds-recommended.html2018-09-24T08:55:17+02:00 European biotech companies enter IPO prep coursehttps://european-biotechnology.com/up-to-date/latest-news/news/european-biotech-companies-enter-ipo-prep-course.html2018-09-21T09:57:06+02:00 Novo Nordisk reveals details about its R&D transformationhttps://european-biotechnology.com/up-to-date/latest-news/news/novo-nordisk-reveals-details-about-its-rd-transformation.html2018-09-20T11:35:34+02:00 Pharming receives complete response letter from FDAhttps://european-biotechnology.com/up-to-date/latest-news/news/pharming-receives-complete-response-letter-from-fda.html2018-09-19T07:06:14+02:00 CRISPR Therapeutics and Viacyte launch diabetes partnershiphttps://european-biotechnology.com/up-to-date/latest-news/news/crispr-therapeutics-and-viacyte-launch-diabetes-partnership.html2018-09-18T07:12:00+02:00 Sanofi preparing label extension for dupilumabhttps://european-biotechnology.com/up-to-date/latest-news/news/sanofi-preparing-label-extension-for-dupilumab.html2018-09-17T07:23:04+02:00 Calcium does not contribute to heart failurehttps://european-biotechnology.com/up-to-date/latest-news/news/calcium-does-not-contribute-to-heart-failure.html2018-09-13T14:05:17+02:00 Boehringer Ingelheim bags ViraT in €210m dealhttps://european-biotechnology.com/up-to-date/latest-news/news/boehringer-ingelheim-bags-virat-in-eur210m-deal.html2018-09-13T09:11:49+02:00 EU approves Shire's van Willebrand factorhttps://european-biotechnology.com/up-to-date/latest-news/news/eu-approves-shires-van-willebrand-factor.html2018-09-12T08:50:50+02:00 PD1/PD-L1blockers trigger metastaseshttps://european-biotechnology.com/up-to-date/latest-news/news/pd1pd-l1blockers-trigger-metastases.html2018-09-11T05:23:08+02:00 EIB incentivises bioeconomy investments https://european-biotechnology.com/up-to-date/latest-news/news/eib-incentivises-bioeconomy-investments.html2018-09-10T09:17:21+02:00 New antibiotics on the blockhttps://european-biotechnology.com/up-to-date/latest-news/news/new-antibiotics-on-the-block.html2018-09-07T09:53:50+02:00 Adaptimmune raises US$100mhttps://european-biotechnology.com/up-to-date/latest-news/news/adaptimmune-raises-us100m.html2018-09-06T07:33:54+02:00 CAR-Ts: Novartis wins UK https://european-biotechnology.com/up-to-date/latest-news/news/car-ts-novartis-wins-uk.html2018-09-05T08:03:12+02:00 Evox raises €37m in Series B roundhttps://european-biotechnology.com/up-to-date/latest-news/news/evox-raises-eur37m-in-series-b-round.html2018-09-04T07:21:07+02:00 Sanofi gets the EU’s ok for caplacizumabhttps://european-biotechnology.com/up-to-date/latest-news/news/sanofi-gets-the-eus-ok-for-caplacizumab.html2018-09-03T07:12:03+02:00 Cancer drug cures orphan disease skin damage https://european-biotechnology.com/up-to-date/latest-news/news/cancer-drug-cures-orphan-disease-skin-damage.html2018-08-31T09:39:47+02:00 Germany to pump €1bn into breakthrough innovationhttps://european-biotechnology.com/up-to-date/latest-news/news/germany-to-pump-eur1bn-into-breakthrough-innovation.html2018-08-30T08:14:15+02:00 Urovant Sciences licenses OAB gene therapy https://european-biotechnology.com/up-to-date/latest-news/news/urovant-sciences-licenses-oab-gene-therapy.html2018-08-29T07:07:21+02:00 Roche and Affimed in US$5bn cancer dealhttps://european-biotechnology.com/up-to-date/latest-news/news/roche-and-affimed-in-us5bn-cancer-deal.html2018-08-28T07:36:45+02:00 Foundation launches £30m awardhttps://european-biotechnology.com/up-to-date/latest-news/news/foundation-launches-pound30m-award.html2018-08-27T07:15:31+02:00 FDA greenlights Shire’s HAE mAB Takhzyrohttps://european-biotechnology.com/up-to-date/latest-news/news/fda-greenlights-shires-hae-mab-takhzyro.html2018-08-24T08:21:31+02:00 Matrikines give hint to new asthma medshttps://european-biotechnology.com/up-to-date/latest-news/news/matrikines-give-hint-to-new-asthma-meds.html2018-08-23T09:28:22+02:00 Novo Nordisk joins Evotec as drug discovery partnerhttps://european-biotechnology.com/up-to-date/latest-news/news/novo-nordisk-joins-evotec-as-drug-discovery-partner.html2018-08-22T07:53:15+02:00 Genkyotex cashes in €7.5mhttps://european-biotechnology.com/up-to-date/latest-news/news/genkyotex-cashes-in-eur75m.html2018-08-21T07:16:06+02:00 Roche's Alecensa approved in Chinahttps://european-biotechnology.com/up-to-date/latest-news/news/roches-alecensa-approved-in-china.html2018-08-20T07:09:54+02:00 Pfizer partners with Biontech in US$425m dealhttps://european-biotechnology.com/up-to-date/latest-news/news/pfizer-partners-with-biontech-in-us425m-deal.html2018-08-17T07:30:33+02:00 New lupus target unraveledhttps://european-biotechnology.com/up-to-date/latest-news/news/new-lupus-target-unraveled.html2018-08-16T06:43:08+02:00 Small molecule restores liver regenerationhttps://european-biotechnology.com/up-to-date/latest-news/news/small-molecule-restores-liver-regeneration.html2018-08-14T13:40:29+02:00 Orchard Therapeutics raise US-$150m https://european-biotechnology.com/up-to-date/latest-news/news/orchard-therapeutics-raise-us-150m.html2018-08-14T07:30:31+02:00 Artios Pharma raise €85m in Series B roundhttps://european-biotechnology.com/up-to-date/latest-news/news/artios-pharma-raise-eur85m-in-series-b-round.html2018-08-13T07:01:46+02:00 Researchers remyelinate neurons https://european-biotechnology.com/up-to-date/latest-news/news/researchers-remyelinate-neurons.html2018-08-10T07:42:08+02:00 Switch for osteoporosis and obesityhttps://european-biotechnology.com/up-to-date/latest-news/news/switch-for-osteoporosis-and-obesity.html2018-08-09T07:04:28+02:00 Roche presents biomarker test to identify NSCLC responders to Tecentriqhttps://european-biotechnology.com/up-to-date/latest-news/news/roche-presents-biomarker-test-to-identify-nsclc-responders-to-tecentriq.html2018-08-08T07:53:16+02:00 Boehringer Ingelheim starts gene therapy collaboration for cystic fibrosishttps://european-biotechnology.com/up-to-date/latest-news/news/boehringer-ingelheim-starts-gene-therapy-collaboration-for-cystic-fibrosis.html2018-08-07T08:23:40+02:00 Arix Bioscience acquires 11% stake in Phamaxis Ltd.https://european-biotechnology.com/up-to-date/latest-news/news/arix-bioscience-acquires-11-stake-in-phamaxis-ltd.html2018-08-06T11:30:14+02:00 Getting ready for Brexithttps://european-biotechnology.com/up-to-date/latest-news/news/getting-ready-for-brexit.html2018-08-02T13:29:00+02:00 ReViral raises US$55m https://european-biotechnology.com/up-to-date/latest-news/news/reviral-raises-us55m.html2018-08-01T10:29:00+02:00 EU’s single-use plastic rules boost bioplasticshttps://european-biotechnology.com/up-to-date/latest-news/news/eus-single-use-plastic-rules-boost-bioplastics.html2018-08-01T09:29:00+02:00 First migraine prevention drug hits EU markethttps://european-biotechnology.com/up-to-date/latest-news/news/first-migraine-prevention-drug-hits-eu-market.html2018-07-31T09:29:00+02:00 Nanobiotix signs €40m deal with EIBhttps://european-biotechnology.com/up-to-date/latest-news/news/nanobiotix-signs-eur40m-deal-with-eib.html2018-07-28T15:29:00+02:00 CRISPR & Co are GMOs, says EU courthttps://european-biotechnology.com/up-to-date/latest-news/news/crispr-co-are-gmos-says-eu-court.html2018-07-25T15:29:00+02:00 Nabriva nabs market-ready antibiotichttps://european-biotechnology.com/up-to-date/latest-news/news/nabriva-nabs-market-ready-antibiotic.html2018-07-25T08:29:00+02:00 TxCell snapped up by Sangamohttps://european-biotechnology.com/up-to-date/latest-news/news/txcell-snapped-up-by-sangamo.html2018-07-24T08:29:00+02:00 Sobi in €387m orphan drug deal with Novimmunehttps://european-biotechnology.com/up-to-date/latest-news/news/sobi-in-eur387m-orphan-drug-deal-with-novimmune.html2018-07-23T08:29:00+02:00 Novartis pays €945m for eczema programmehttps://european-biotechnology.com/up-to-date/latest-news/news/novartis-pays-eur945m-for-eczema-programme.html2018-07-19T14:29:00+02:00 IMI to spur on antibiotics research amidst big pharma pullback https://european-biotechnology.com/up-to-date/latest-news/news/imi-to-spur-on-antibiotics-research-amidst-big-pharma-pullback.html2018-07-18T15:29:00+02:00 Roche granted breakthrough status for liver cancer combohttps://european-biotechnology.com/up-to-date/latest-news/news/roche-granted-breakthrough-status-for-liver-cancer-combo.html2018-07-18T09:29:00+02:00 Epigenetic biomarkers predict immunotherapy successhttps://european-biotechnology.com/up-to-date/latest-news/news/epigenetic-biomarkers-predict-immunotherapy-success.html2018-07-17T12:29:00+02:00 Urovant launches US$150m IPOhttps://european-biotechnology.com/up-to-date/latest-news/news/urovant-launches-us150m-ipo.html2018-07-16T08:29:00+02:00 Immunooncology: Genmab teams up with Immaticshttps://european-biotechnology.com/up-to-date/latest-news/news/immunooncology-genmab-teams-up-with-immatics.html2018-07-12T08:29:00+02:00 Big Data: Tracking cancer risk geneshttps://european-biotechnology.com/up-to-date/latest-news/news/big-data-tracking-cancer-risk-genes.html2018-07-11T08:29:00+02:00 Lifecare floats on Oslo stock exchangehttps://european-biotechnology.com/up-to-date/latest-news/news/lifecare-floats-on-oslo-stock-exchange.html2018-07-10T16:29:00+02:00 Abingworth closes new biotech fund at €268m https://european-biotechnology.com/up-to-date/latest-news/news/abingworth-closes-new-biotech-fund-at-eur268m.html2018-07-10T08:29:00+02:00 €47m for rare disease biotechhttps://european-biotechnology.com/up-to-date/latest-news/news/eur47m-for-rare-disease-biotech.html2018-07-09T07:29:00+02:00 €7m for French microbiome start-uphttps://european-biotechnology.com/up-to-date/latest-news/news/eur7m-for-french-microbiome-start-up.html2018-07-06T07:29:00+02:00 Highs and lows for Fresenius Medical Carehttps://european-biotechnology.com/up-to-date/latest-news/news/highs-and-lows-for-fresenius-medical-care.html2018-07-05T07:29:00+02:00 Chemspec Europe 2018 in Cologne closes with a record in visitor numbershttps://european-biotechnology.com/up-to-date/latest-news/news/chemspec-europe-2018-in-cologne-closes-with-a-record-in-visitor-numbers.html2018-07-04T11:25:00+02:00 Piglet vaccination to reduce antibiotics usehttps://european-biotechnology.com/up-to-date/latest-news/news/piglet-vaccination-to-reduce-antibiotics-use.html2018-07-04T05:29:00+02:00 VarmX raises €12.5m https://european-biotechnology.com/up-to-date/latest-news/news/varmx-raises-eur125m.html2018-07-03T05:30:00+02:00 CHMP greenlights first two CAR-T cell therapies in the EUhttps://european-biotechnology.com/up-to-date/latest-news/news/chmp-greenlights-first-two-car-t-cell-therapies-in-the-eu.html2018-07-01T18:48:21+02:00 Improving models of chronic hepatitishttps://european-biotechnology.com/up-to-date/latest-news/news/improving-models-of-chronic-hepatitis.html2018-06-29T06:39:00+02:00 GMO acreage growing globallyhttps://european-biotechnology.com/up-to-date/latest-news/news/gmo-acreage-growing-globally.html2018-06-28T08:46:24+02:00 Chugai ends licence for PharmaMar’s lurbinectedinhttps://european-biotechnology.com/up-to-date/latest-news/news/chugai-ends-licence-for-pharmamars-lurbinectedin.html2018-06-27T07:32:36+02:00 Inflammasome specialist NodThera Ltd raises €31.8mhttps://european-biotechnology.com/up-to-date/latest-news/news/inflammasome-specialist-nodthera-ltd-raises-eur318m.html2018-06-26T07:11:13+02:00 Researchers identify T cell guardians of the intestinehttps://european-biotechnology.com/up-to-date/latest-news/news/researchers-identify-t-cell-guardians-of-the-intestine.html2018-06-25T07:00:00+02:00 Afatinib push back K-RAS-positive lung cancerhttps://european-biotechnology.com/up-to-date/latest-news/news/afatinib-push-back-k-ras-positive-lung-cancer.html2018-06-22T07:56:42+02:00 Novimmune enters US$195m option deal with TG Therapeutics Inc.https://european-biotechnology.com/up-to-date/latest-news/news/novimmune-enters-us195m-option-deal-with-tg-therapeutics-inc.html2018-06-20T13:40:53+02:00 Chemspec Europe 2018 startinghttps://european-biotechnology.com/up-to-date/latest-news/news/chemspec-europe-2018-starting.html2018-06-20T04:56:00+02:00 Roche pays US$2.4bn for FMI take-overhttps://european-biotechnology.com/up-to-date/latest-news/news/roche-pays-us24bn-for-fmi-take-over.html2018-06-19T08:27:22+02:00 Deinobiotics reports novel antibiotics class https://european-biotechnology.com/up-to-date/latest-news/news/deinobiotics-reports-novel-antibiotics-class.html2018-06-19T08:03:52+02:00 EPO under pressure not to lower quality standardshttps://european-biotechnology.com/up-to-date/latest-news/news/epo-under-pressure-not-to-lower-quality-standards.html2018-06-18T07:08:24+02:00 Adrenomed reveals MOA of sepsis antibodyhttps://european-biotechnology.com/up-to-date/latest-news/news/adrenomed-reveals-moa-of-sepsis-antibody.html2018-06-15T08:25:16+02:00 AMR: FDA provides financing model for novel antibioticshttps://european-biotechnology.com/up-to-date/latest-news/news/amr-fda-provides-financing-model-for-novel-antibiotics.html2018-06-13T09:21:53+02:00 Targovax refocussing clinical pipeline post-ASCOhttps://european-biotechnology.com/up-to-date/latest-news/news/targovax-refocussing-clinical-pipeline-post-asco.html2018-06-12T07:43:47+02:00 Autolus Therapeutics aiming for NASDAQ IPOhttps://european-biotechnology.com/up-to-date/latest-news/news/autolus-therapeutics-aiming-for-nasdaq-ipo.html2018-06-11T07:09:56+02:00 EC earmarks €100bn for Horizon Europehttps://european-biotechnology.com/up-to-date/latest-news/news/ec-earmarks-eur100bn-for-horizon-europe.html2018-06-08T08:08:52+02:00 MS: Alkermes bags US$50m milestone from Biogen https://european-biotechnology.com/up-to-date/latest-news/news/ms-alkermes-bags-us50m-milestone-from-biogen.html2018-06-07T07:06:55+02:00 Hookipa and Gilead ink US$400m dealhttps://european-biotechnology.com/up-to-date/latest-news/news/hookipa-and-gilead-ink-us400m-deal.html2018-06-06T05:27:36+02:00 Roche set to extend Hemlibra labelhttps://european-biotechnology.com/up-to-date/latest-news/news/roche-set-to-extend-hemlibra-label.html2018-06-05T08:04:25+02:00 EMA recommends nine drugs for approvalhttps://european-biotechnology.com/up-to-date/latest-news/news/ema-recommends-nine-drugs-for-approval.html2018-06-04T05:57:12+02:00 New epilepsy target discoveredhttps://european-biotechnology.com/up-to-date/latest-news/news/new-epilepsy-target-discovered.html2018-06-01T07:06:13+02:00 Denali bags F-Star Gammahttps://european-biotechnology.com/up-to-date/latest-news/news/denali-bags-f-star-gamma.html2018-05-31T06:52:05+02:00 Roche mets endpoints in first-line NSCLC studyhttps://european-biotechnology.com/up-to-date/latest-news/news/roche-mets-endpoints-in-first-line-nsclc-study.html2018-05-30T08:29:18+02:00 New way to safer CAR-T cell therapieshttps://european-biotechnology.com/up-to-date/latest-news/news/new-way-to-safer-car-t-cell-therapies.html2018-05-29T07:08:57+02:00 Janssen ends combo with daratumumabhttps://european-biotechnology.com/up-to-date/latest-news/news/janssen-ends-combo-with-daratumumab.html2018-05-28T07:47:16+02:00 Targovax drug boosts 2-year OS in pancreatic cancer https://european-biotechnology.com/up-to-date/latest-news/news/targovax-drug-boosts-2-year-os-in-pancreatic-cancer.html2018-05-24T13:52:53+02:00 Researchers target metastases https://european-biotechnology.com/up-to-date/latest-news/news/researchers-target-metastases.html2018-05-24T07:34:09+02:00 Vifor Pharma in €70m pruritus drug dealhttps://european-biotechnology.com/up-to-date/latest-news/news/vifor-pharma-in-eur70m-pruritus-drug-deal.html2018-05-23T07:09:39+02:00 Evotec signs US$65m deal with Celgenehttps://european-biotechnology.com/up-to-date/latest-news/news/evotec-signs-us65m-deal-with-celgene.html2018-05-22T07:02:13+02:00 Biomaterials growth and crash side by sidehttps://european-biotechnology.com/up-to-date/latest-news/news/biomaterials-growth-and-crash-side-by-side.html2018-05-17T09:45:37+02:00 Cell type switch helps colon cancer evade treatmenthttps://european-biotechnology.com/up-to-date/latest-news/news/cell-type-switch-helps-colon-cancer-evade-treatment.html2018-05-17T07:18:39+02:00 Kite expands cell therapy manufacturing in Europehttps://european-biotechnology.com/up-to-date/latest-news/news/kite-expands-cell-therapy-manufacturing-in-europe.html2018-05-16T07:12:44+02:00 bluebird bio expands US$1bn deal with MediGene https://european-biotechnology.com/up-to-date/latest-news/news/bluebird-bio-expands-us1bn-deal-with-medigene.html2018-05-15T06:53:51+02:00 AZ COPD drug fails in Phase III study https://european-biotechnology.com/up-to-date/latest-news/news/az-copd-drug-fails-in-phase-iii-study.html2018-05-13T16:58:36+02:00 3-D printed device delivers drugs in humanshttps://european-biotechnology.com/up-to-date/latest-news/news/3-d-printed-device-delivers-drugs-in-humans.html2018-05-09T14:07:05+02:00 Shire accepts €52.4bn takeover bid by Takeda https://european-biotechnology.com/up-to-date/latest-news/news/shire-accepts-eur524bn-takeover-bid-by-takeda.html2018-05-09T08:33:55+02:00 Narasimhan embraces Swiss biotech industryhttps://european-biotechnology.com/up-to-date/latest-news/news/narasimhan-embraces-swiss-biotech-industry.html2018-05-07T15:37:10+02:00 Partnership drives connectivity in injectible medshttps://european-biotechnology.com/up-to-date/latest-news/news/partnership-drives-connectivity-in-injectible-meds.html2018-05-07T07:37:05+02:00 Go Jelly, gohttps://european-biotechnology.com/up-to-date/latest-news/news/go-jelly-go.html2018-05-04T07:46:00+02:00 Irish Iterum files for IPO on Nasdaqhttps://european-biotechnology.com/up-to-date/latest-news/news/irish-iterum-files-for-ipo-on-nasdaq.html2018-05-02T17:24:01+02:00 Near-term capital for Neurimmune https://european-biotechnology.com/up-to-date/latest-news/news/near-term-capital-for-neurimmune.html2018-05-02T11:39:45+02:00 Diabetes drug reverses PAHhttps://european-biotechnology.com/up-to-date/latest-news/news/diabetes-drug-reverses-pah.html2018-04-26T11:51:23+02:00 Targovax gives pipeline updatehttps://european-biotechnology.com/up-to-date/latest-news/news/targovax-gives-pipeline-update.html2018-04-26T05:27:08+02:00 AZ’s Durvalumab/Tremelimumab combo flops in NSCLChttps://european-biotechnology.com/up-to-date/latest-news/news/azs-durvalumabtremelimumab-combo-flops-in-nsclc.html2018-04-25T05:43:41+02:00 Palbociclib companion biomarker unraveledhttps://european-biotechnology.com/up-to-date/latest-news/news/palbociclib-companion-biomarker-unraveled.html2018-04-24T06:25:55+02:00 GBS 2018: Bioeconomy leaders foster shift to sustainable industry productionhttps://european-biotechnology.com/up-to-date/latest-news/news/gbs-2018-bioeconomy-leaders-foster-shift-to-sustainable-industry-production.html2018-04-23T07:36:49+02:00 A bioengineered tattoo monitors blood calcium levelshttps://european-biotechnology.com/up-to-date/latest-news/news/a-bioengineered-tattoo-monitors-blood-calcium-levels.html2018-04-18T15:45:00+02:00 German biotech sector growinghttps://european-biotechnology.com/up-to-date/latest-news/news/german-biotech-sector-growing.html2018-04-18T15:23:06+02:00 Servier to bag Shire's cancer businesshttps://european-biotechnology.com/up-to-date/latest-news/news/servier-to-bag-shires-cancer-business.html2018-04-18T07:48:49+02:00 Germany to boost the bioeconomyhttps://european-biotechnology.com/up-to-date/latest-news/news/germany-to-boost-the-bioeconomy.html2018-04-17T09:20:48+02:00 Canopy acquires Czech Annabis Medical srohttps://european-biotechnology.com/up-to-date/latest-news/news/canopy-acquires-czech-annabis-medical-sro.html2018-04-16T08:55:36+02:00 New Pierre Guerin site in Hildesheim, Germanyhttps://european-biotechnology.com/up-to-date/latest-news/news/new-pierre-guerin-site-in-hildesheim-germany.html2018-04-16T00:00:00+02:00 GSK pass orphan gene therapy assets to Orchard Therapeuticshttps://european-biotechnology.com/up-to-date/latest-news/news/gsk-pass-orphan-gene-therapy-assets-to-orchard-therapeutics.html2018-04-12T10:27:44+02:00 Alexion in €639m bid for Wilson Therapeutics ABhttps://european-biotechnology.com/up-to-date/latest-news/news/alexion-in-eur639m-bid-for-wilson-therapeutics-ab.html2018-04-11T08:44:06+02:00 Novartis enters SMA race acquiring AveXis for US$8.7bnhttps://european-biotechnology.com/up-to-date/latest-news/news/novartis-enters-sma-race-acquiring-avexis-for-us87bn.html2018-04-10T11:18:20+02:00 Blood test predincting Alzheimer's paves way to earlier therapyhttps://european-biotechnology.com/up-to-date/latest-news/news/blood-test-predincting-alzheimers-paves-way-to-earlier-therapy.html2018-04-09T08:01:34+02:00 Poor investigator brochures: Resarchers call for standardisationhttps://european-biotechnology.com/up-to-date/latest-news/news/poor-investigator-brochures-resarchers-call-for-standardisation.html2018-04-06T07:19:04+02:00 Ose and Boehringer ink €1.1bn deal in immunoncologyhttps://european-biotechnology.com/up-to-date/latest-news/news/ose-and-boehringer-ink-eur11bn-deal-in-immunoncology.html2018-04-05T07:39:07+02:00 Cellectis in offering of US$175m ADS following asset swaphttps://european-biotechnology.com/up-to-date/latest-news/news/cellectis-in-offering-of-us175m-ads-following-asset-swap.html2018-04-03T18:44:15+02:00 Motif Bio to submit NDA for iclaprimhttps://european-biotechnology.com/up-to-date/latest-news/news/motif-bio-to-submit-nda-for-iclaprim.html2018-04-03T08:26:33+02:00 Takeda announced bid for Shirehttps://european-biotechnology.com/up-to-date/latest-news/news/takeda-announced-bid-for-shire.html2018-03-29T08:58:48+02:00 Roche reports 5 deaths after dosing of Hemlibra https://european-biotechnology.com/up-to-date/latest-news/news/roche-reports-5-deaths-after-dosing-of-hemlibra.html2018-03-28T08:01:19+02:00 From biorefineries to consumer goodshttps://european-biotechnology.com/up-to-date/latest-news/news/from-biorefineries-to-consumer-goods.html2018-03-27T09:14:37+02:00 Ablynx’ SLE antibody vobarilizumab miss endpointhttps://european-biotechnology.com/up-to-date/latest-news/news/ablynx-sle-antibody-vobarilizumab-miss-endpoint.html2018-03-26T08:16:43+02:00 MorphoSys files registration for ADS offeringhttps://european-biotechnology.com/up-to-date/latest-news/news/morphosys-files-registration-for-ads-offering.html2018-03-23T10:43:48+01:00 Deinove to licence antibiotic leads form RedX Pharmahttps://european-biotechnology.com/up-to-date/latest-news/news/deinove-to-licence-antibiotic-leads-form-redx-pharma.html2018-03-22T10:21:21+01:00 Bioeconomy: Germany to lose pole positionhttps://european-biotechnology.com/up-to-date/latest-news/news/bioeconomy-germany-to-lose-pole-position.html2018-03-21T08:28:21+01:00 Eylea met Phase III endpoint in diabetic retinopathyhttps://european-biotechnology.com/up-to-date/latest-news/news/eylea-met-phase-iii-endpoint-in-diabetic-retinopathy.html2018-03-20T11:21:34+01:00 Lundbeck acquiring Prexton in €905m deal https://european-biotechnology.com/up-to-date/latest-news/news/lundbeck-acquiring-prexton-in-eur905m-deal.html2018-03-19T05:47:30+01:00 Stroke alarmin spurs further embolieshttps://european-biotechnology.com/up-to-date/latest-news/news/stroke-alarmin-spurs-further-embolies.html2018-03-16T06:06:43+01:00 Algorithm tracks cancer type down to methylation patternhttps://european-biotechnology.com/up-to-date/latest-news/news/algorithm-tracks-cancer-type-down-to-methylation-pattern.html2018-03-15T07:26:43+01:00 Business as usual in Amsterdamhttps://european-biotechnology.com/up-to-date/latest-news/news/business-as-usual-in-amsterdam.html2018-03-14T08:39:27+01:00 MYR Pharma completes chronic hepatitis delta POC trial https://european-biotechnology.com/up-to-date/latest-news/news/myr-pharma-completes-chronic-hepatitis-delta-poc-trial.html2018-03-13T07:35:17+01:00 Sanofi’s alirocumab improves cardiovascular event rate over statins https://european-biotechnology.com/up-to-date/latest-news/news/sanofis-alirocumab-improves-cardiovascular-event-rate-over-statins.html2018-03-12T05:55:02+01:00 Medimmune finds target against systemic sclerosishttps://european-biotechnology.com/up-to-date/latest-news/news/medimmune-finds-target-against-systemic-sclerosis.html2018-03-09T07:49:10+01:00 Bioprocessing challenges in the focushttps://european-biotechnology.com/up-to-date/latest-news/news/bioprocessing-challenges-in-the-focus.html2018-03-09T06:57:00+01:00 Sanofi to outsource antiinfectives R&D to Evotechttps://european-biotechnology.com/up-to-date/latest-news/news/sanofi-to-outsource-antiinfectives-rd-to-evotec.html2018-03-08T08:55:07+01:00 Heidelberg Pharma inks US$334m R&D contract with Magenta Therapeutics https://european-biotechnology.com/up-to-date/latest-news/news/heidelberg-pharma-inks-us334m-rd-contract-with-magenta-therapeutics.html2018-03-07T08:16:39+01:00 Investors keen to put money into AMR SMEs https://european-biotechnology.com/up-to-date/latest-news/news/investors-keen-to-put-money-into-amr-smes.html2018-03-05T17:39:55+01:00 Santhera’s idebenone not efficient in PPMS patientshttps://european-biotechnology.com/up-to-date/latest-news/news/santheras-idebenone-not-efficient-in-ppms-patients.html2018-03-05T08:34:10+01:00 Inhaled IL-4 halts neuron destruction in MS modelshttps://european-biotechnology.com/up-to-date/latest-news/news/inhaled-il-4-halts-neuron-destruction-in-ms-models.html2018-03-01T16:22:03+01:00 Convert Pharmaceuticals SA closes €13.6m Series A roundhttps://european-biotechnology.com/up-to-date/latest-news/news/convert-pharmaceuticals-sa-closes-eur136m-series-a-round.html2018-03-01T09:26:03+01:00 Novo Holdings launches €135m fund to combat antimicrobial resistancehttps://european-biotechnology.com/up-to-date/latest-news/news/novo-holdings-launches-eur135m-fund-to-combat-antimicrobial-resistance.html2018-02-28T07:33:08+01:00 Bavarian Nordic and AZ combine cancer jab with durvalumab https://european-biotechnology.com/up-to-date/latest-news/news/bavarian-nordic-and-az-combine-cancer-jab-with-durvalumab.html2018-02-27T07:58:55+01:00 EMA recommends two orphan drugs for approvalhttps://european-biotechnology.com/up-to-date/latest-news/news/ema-recommends-two-orphan-drugs-for-approval.html2018-02-26T07:46:06+01:00 Bioeconomy: Bringing in the public https://european-biotechnology.com/up-to-date/latest-news/news/bioeconomy-bringing-in-the-public.html2018-02-23T09:03:43+01:00 New Screening method for Antibiotic Discovery Pipeline https://european-biotechnology.com/up-to-date/latest-news/news/new-screening-method-for-antibiotic-discovery-pipeline.html2018-02-22T05:55:22+01:00 Cullinan Oncology partners with MAB Discoveryhttps://european-biotechnology.com/up-to-date/latest-news/news/cullinan-oncology-partners-with-mab-discovery.html2018-02-21T06:14:33+01:00 Locking malaria parasites into red blood cellshttps://european-biotechnology.com/up-to-date/latest-news/news/locking-malaria-parasites-into-red-blood-cells.html2018-02-20T11:21:29+01:00 PharmaMar in licence deal with Seattle Geneticshttps://european-biotechnology.com/up-to-date/latest-news/news/pharmamar-in-licence-deal-with-seattle-genetics.html2018-02-19T09:06:22+01:00 Roche to pay US$1.9bn for Flatiron Healthhttps://european-biotechnology.com/up-to-date/latest-news/news/roche-to-pay-us19bn-for-flatiron-health.html2018-02-16T11:58:32+01:00 Santhera licenses CF drug from Polyphor https://european-biotechnology.com/up-to-date/latest-news/news/santhera-licenses-cf-drug-from-polyphor.html2018-02-15T08:52:46+01:00 AML: Sorafenib boosts graft-versus-leukemia activityhttps://european-biotechnology.com/up-to-date/latest-news/news/aml-sorafenib-boosts-graft-versus-leukemia-activity.html2018-02-14T08:38:14+01:00 Poxel in €506m diabetes deal with Roivant Scienceshttps://european-biotechnology.com/up-to-date/latest-news/news/poxel-in-eur506m-diabetes-deal-with-roivant-sciences.html2018-02-13T08:03:12+01:00 Pieris inks US$1.2bn immuno-oncology deal with Seattle Geneticshttps://european-biotechnology.com/up-to-date/latest-news/news/pieris-inks-us12bn-immuno-oncology-deal-with-seattle-genetics.html2018-02-12T08:09:40+01:00 DMD drug aids heart failure patientshttps://european-biotechnology.com/up-to-date/latest-news/news/dmd-drug-aids-heart-failure-patients.html2018-02-09T08:02:21+01:00 New target could minimise transplant riskshttps://european-biotechnology.com/up-to-date/latest-news/news/new-target-could-minimise-transplant-risks.html2018-02-08T09:47:15+01:00 EU General Court rejects industry’s confidentiality claimshttps://european-biotechnology.com/up-to-date/latest-news/news/eu-general-court-rejects-industrys-confidentiality-claims.html2018-02-07T10:07:45+01:00 FIND funding diagnostics to fight AMRhttps://european-biotechnology.com/up-to-date/latest-news/news/find-funding-diagnostics-to-fight-amr.html2018-02-06T10:26:07+01:00 Cancer is a gate-opener to data sharinghttps://european-biotechnology.com/up-to-date/latest-news/news/cancer-is-a-gate-opener-to-data-sharing.html2018-02-05T11:08:30+01:00 Bacterial duo triggers colorectal cancerhttps://european-biotechnology.com/up-to-date/latest-news/news/bacterial-duo-triggers-colorectal-cancer.html2018-02-02T07:55:55+01:00 CRISPR corrects clustered DMD mutationshttps://european-biotechnology.com/up-to-date/latest-news/news/crispr-corrects-clustered-dmd-mutations.html2018-02-01T05:30:00+01:00 EPO bows to pressure from industry https://european-biotechnology.com/up-to-date/latest-news/news/epo-bows-to-pressure-from-industry.html2018-01-31T09:46:32+01:00 Sanofi acquiring Ablynxhttps://european-biotechnology.com/up-to-date/latest-news/news/sanofi-acquiring-ablynx.html2018-01-29T08:46:22+01:00 EMA recommends seven new drugs for markethttps://european-biotechnology.com/up-to-date/latest-news/news/ema-recommends-seven-new-drugs-for-market.html2018-01-26T13:57:03+01:00 Bacterium blocks dengue and Zika virus transmission https://european-biotechnology.com/up-to-date/latest-news/news/bacterium-blocks-dengue-and-zika-virus-transmission.html2018-01-25T10:52:10+01:00 Novartis in US$170m licence deal with Spark Therapeuticshttps://european-biotechnology.com/up-to-date/latest-news/news/novartis-in-us170m-licence-deal-with-spark-therapeutics.html2018-01-25T10:32:39+01:00 Protein keeps breast cancer metastases at bayhttps://european-biotechnology.com/up-to-date/latest-news/news/protein-keeps-breast-cancer-metastases-at-bay.html2018-01-23T15:00:57+01:00 Seventure Partners joins US$35m round into Zipongohttps://european-biotechnology.com/up-to-date/latest-news/news/seventure-partners-joins-us35m-round-into-zipongo.html2018-01-23T08:26:51+01:00 Sanofi takes over Bioverativ in US$11.8bn dealhttps://european-biotechnology.com/up-to-date/latest-news/news/sanofi-takes-over-bioverativ-in-us118bn-deal.html2018-01-22T07:47:22+01:00 Novel blood test detects eight cancershttps://european-biotechnology.com/up-to-date/latest-news/news/novel-blood-test-detects-eight-cancers.html2018-01-19T07:43:15+01:00 Government funds TxCell’s CAR-Treg therapyhttps://european-biotechnology.com/up-to-date/latest-news/news/government-funds-txcells-car-treg-therapy.html2018-01-18T09:24:30+01:00 Da Volterra’s DAV132 helps fighting AMR crisishttps://european-biotechnology.com/up-to-date/latest-news/news/da-volterras-dav132-helps-fighting-amr-crisis.html2018-01-17T10:33:08+01:00 Avacta Group plc partners with Glythera https://european-biotechnology.com/up-to-date/latest-news/news/avacta-group-plc-partners-with-glythera.html2018-01-16T08:03:11+01:00 European biotech stocks: 2017 with strong resultshttps://european-biotechnology.com/up-to-date/latest-news/news/european-biotech-stocks-2017-with-strong-results.html2018-01-15T20:23:00+01:00 Western diet triggers inflammatory diseaseshttps://european-biotechnology.com/up-to-date/latest-news/news/western-diet-triggers-inflammatory-diseases.html2018-01-12T10:11:56+01:00 Scientists crack down immune cells that promote fibrosishttps://european-biotechnology.com/up-to-date/latest-news/news/scientists-crack-down-immune-cells-that-promote-fibrosis.html2018-01-11T08:24:16+01:00 Truffle Capital closes new BioMedTech venture fund at €85mhttps://european-biotechnology.com/up-to-date/latest-news/news/truffle-capital-closes-new-biomedtech-venture-fund-at-eur85m.html2018-01-10T15:45:15+01:00 Ablynx rejects Novo's €2.3bn bidhttps://european-biotechnology.com/up-to-date/latest-news/news/ablynx-rejects-novos-eur23bn-bid.html2018-01-10T07:25:53+01:00 Roche further expands in digital medicinehttps://european-biotechnology.com/up-to-date/latest-news/news/roche-further-expands-in-digital-medicine.html2018-01-09T06:00:00+01:00 New method identifies harmful medicines metaboliteshttps://european-biotechnology.com/up-to-date/latest-news/news/new-method-identifies-harmful-medicines-metabolites.html2018-01-07T16:33:41+01:00 Takeda bids €520m for TiGenix https://european-biotechnology.com/up-to-date/latest-news/news/takeda-bids-eur520m-for-tigenix.html2018-01-05T09:00:02+01:00 Boehringer Ingelheim expands Venture Funds to €250m https://european-biotechnology.com/up-to-date/latest-news/news/boehringer-ingelheim-expands-venture-funds-to-eur250m.html2018-01-04T06:58:25+01:00 Addex inks US$339m deal with Indiviorhttps://european-biotechnology.com/up-to-date/latest-news/news/addex-inks-us339m-deal-with-indivior.html2018-01-03T09:03:11+01:00 Diabetes drug halts Alzheimer’shttps://european-biotechnology.com/up-to-date/latest-news/news/diabetes-drug-halts-alzheimers.html2018-01-02T08:52:41+01:00 What’s up in 2018?https://european-biotechnology.com/up-to-date/latest-news/news/whats-up-in-2018.html2017-12-27T17:03:04+01:00 Cancer senescence: licence to killhttps://european-biotechnology.com/up-to-date/latest-news/news/cancer-senescence-licence-to-kill.html2017-12-21T15:15:01+01:00 Sheets of eye cells improve retina repairhttps://european-biotechnology.com/up-to-date/latest-news/news/sheets-of-eye-cells-improve-retina-repair.html2017-12-21T06:36:00+01:00 Roche does not have to pay US$685m fine https://european-biotechnology.com/up-to-date/latest-news/news/roche-does-not-have-to-pay-us685m-fine.html2017-12-20T06:00:00+01:00 A new fund from the northhttps://european-biotechnology.com/up-to-date/latest-news/news/a-new-fund-from-the-north.html2017-12-18T18:25:35+01:00 CHMP recommends EU approval of seven medicines https://european-biotechnology.com/up-to-date/latest-news/news/chmp-recommends-eu-approval-of-seven-medicines.html2017-12-18T08:42:33+01:00 reMYND in €350m diabetes deal with Novohttps://european-biotechnology.com/up-to-date/latest-news/news/remynd-in-eur350m-diabetes-deal-with-novo.html2017-12-15T09:27:55+01:00 TB urine test outperforms standard of carehttps://european-biotechnology.com/up-to-date/latest-news/news/tb-urine-test-outperforms-standard-of-care.html2017-12-14T07:36:41+01:00 LSP raises €280m for late-stage med-tech companieshttps://european-biotechnology.com/up-to-date/latest-news/news/lsp-raises-eur280m-for-late-stage-med-tech-companies.html2017-12-12T12:31:45+01:00 Aelin Therapeutics NV bags €27m in Series A financing https://european-biotechnology.com/up-to-date/latest-news/news/aelin-therapeutics-nv-bags-eur27m-in-series-a-financing.html2017-12-11T14:40:25+01:00 ArgenX reports hints to efficacy of ARGX-113 in generalised myasthenia gravishttps://european-biotechnology.com/up-to-date/latest-news/news/argenx-reports-hints-to-efficacy-of-argx-113-in-generalised-myasthenia-gravis.html2017-12-11T07:51:20+01:00 Ortho markets predictive heart failure re-hospitalisation testhttps://european-biotechnology.com/up-to-date/latest-news/news/ortho-markets-predictive-heart-failure-re-hospitalisation-test.html2017-12-08T10:00:15+01:00 Advicenne raised a €27m IPO on Euronext Parishttps://european-biotechnology.com/up-to-date/latest-news/news/advicenne-raised-a-eur27m-ipo-on-euronext-paris.html2017-12-07T10:59:08+01:00 Researchers create druggable "love hormone" https://european-biotechnology.com/up-to-date/latest-news/news/researchers-create-druggable-love-hormone.html2017-12-06T08:45:54+01:00 FDA approves pan-tumour genomic profiling assayhttps://european-biotechnology.com/up-to-date/latest-news/news/fda-approves-pan-tumour-genomic-profiling-assay.html2017-12-05T09:15:55+01:00 Sanofi Pasteur ends Clostridium difficile vaccine programmehttps://european-biotechnology.com/up-to-date/latest-news/news/sanofi-pasteur-ends-clostridium-difficile-vaccine-programme.html2017-12-04T08:21:47+01:00 Shire expands orphan drug portfoliohttps://european-biotechnology.com/up-to-date/latest-news/news/shire-expands-orphan-drug-portfolio.html2017-12-01T08:33:53+01:00 Speeding up digital transformation in the life science industryhttps://european-biotechnology.com/up-to-date/latest-news/news/speeding-up-digital-transformation-in-the-life-science-industry.html2017-11-30T10:25:45+01:00 Biocartis raises €80mhttps://european-biotechnology.com/up-to-date/latest-news/news/biocartis-raises-eur80m.html2017-11-29T09:50:23+01:00 Global Bioenergies delivers first batch of cosmetics ingredienthttps://european-biotechnology.com/up-to-date/latest-news/news/global-bioenergies-delivers-first-batch-of-cosmetics-ingredient.html2017-11-28T08:14:34+01:00 EuropaBio names top EU biotech SMEshttps://european-biotechnology.com/up-to-date/latest-news/news/europabio-names-top-eu-biotech-smes.html2017-11-27T09:00:39+01:00 Tumour-associated bacteria co-migrate to metastatic siteshttps://european-biotechnology.com/up-to-date/latest-news/news/tumour-associated-bacteria-co-migrate-to-metastatic-sites.html2017-11-23T16:46:54+01:00 Philips leads €6.3m EU liquid biopsy consortiumhttps://european-biotechnology.com/up-to-date/latest-news/news/philips-leads-eur63m-eu-liquid-biopsy-consortium.html2017-11-23T09:54:12+01:00 Heidelberg Pharma AG raises €34.4m https://european-biotechnology.com/up-to-date/latest-news/news/heidelberg-pharma-ag-raises-eur344m.html2017-11-22T08:45:52+01:00 Amsterdam applauded as new EMA headquartershttps://european-biotechnology.com/up-to-date/latest-news/news/amsterdam-applauded-as-new-ema-headquarters.html2017-11-21T05:28:16+01:00 Roche chemo-immunotherapy combo meet NSCLC Phase III endpointhttps://european-biotechnology.com/up-to-date/latest-news/news/roche-chemo-immunotherapy-combo-meet-nsclc-phase-iii-endpoint.html2017-11-20T07:10:47+01:00 Orphazyme raises €80m in oversubscribed IPOhttps://european-biotechnology.com/up-to-date/latest-news/news/orphazyme-raises-eur80m-in-oversubscribed-ipo.html2017-11-16T16:40:03+01:00 Antibiotic Resistance: EU SME alliance calls for specific support to thrive AMR R&Dhttps://european-biotechnology.com/up-to-date/latest-news/news/antibiotic-resistance-eu-sme-alliance-calls-for-specific-support-to-thrive-amr-rd.html2017-11-16T09:19:07+01:00 Bayer inks US$1.55bn cancer deal with Loxo Oncologyhttps://european-biotechnology.com/up-to-date/latest-news/news/bayer-inks-us155bn-cancer-deal-with-loxo-oncology.html2017-11-15T08:19:23+01:00 Bill Gates invests into Alzheimer's R&Dhttps://european-biotechnology.com/up-to-date/latest-news/news/bill-gates-invests-into-alzheimers-rd.html2017-11-14T08:12:31+01:00 CHMP recommends EU marketing approval of ten drugs https://european-biotechnology.com/up-to-date/latest-news/news/chmp-recommends-eu-marketing-approval-of-ten-drugs.html2017-11-12T13:44:34+01:00 BIO-Europe more popular than everhttps://european-biotechnology.com/up-to-date/latest-news/news/bio-europe-more-popular-than-ever.html2017-11-10T14:37:04+01:00 Spain pushes circular bioeconomyhttps://european-biotechnology.com/up-to-date/latest-news/news/spain-pushes-circular-bioeconomy.html2017-11-10T10:56:59+01:00 Stem cells cure deadly human skin diseasehttps://european-biotechnology.com/up-to-date/latest-news/news/stem-cells-cure-deadly-human-skin-disease.html2017-11-09T08:43:38+01:00 InflaRx Announces Pricing of Initial Public Offeringhttps://european-biotechnology.com/up-to-date/latest-news/news/inflarx-announces-pricing-of-initial-public-offering.html2017-11-08T09:20:34+01:00 FDA lifts clinical hold on Cellectis Phase I trials https://european-biotechnology.com/up-to-date/latest-news/news/fda-lifts-clinical-hold-on-cellectis-phase-i-trials.html2017-11-07T07:54:55+01:00 MAB Discovery expands 2013 partnership with BioNTech AGhttps://european-biotechnology.com/up-to-date/latest-news/news/mab-discovery-expands-2013-partnership-with-biontech-ag.html2017-11-07T06:10:00+01:00 European biotech stocks: New wave of optimism https://european-biotechnology.com/up-to-date/latest-news/news/european-biotech-stocks-new-wave-of-optimism.html2017-11-06T20:23:00+01:00 NousCom raises €42m https://european-biotechnology.com/up-to-date/latest-news/news/nouscom-raises-eur42m.html2017-11-06T07:58:39+01:00 Blocking antibody recycling vs autoimmune diseaseshttps://european-biotechnology.com/up-to-date/latest-news/news/blocking-antibody-recycling-vs-autoimmune-diseases.html2017-11-02T16:44:14+01:00 Another death related to allogenic CAR-T cell therapyhttps://european-biotechnology.com/up-to-date/latest-news/news/another-death-related-to-allogenic-car-t-cell-therapy.html2017-11-02T08:38:22+01:00 BioGeneration Ventures Fund III closed at €82mhttps://european-biotechnology.com/up-to-date/latest-news/news/biogeneration-ventures-fund-iii-closed-at-eur82m.html2017-11-01T06:00:00+01:00 Ablynx raises US$230m https://european-biotechnology.com/up-to-date/latest-news/news/ablynx-raises-us230m.html2017-10-30T06:54:00+01:00 CPHI Worldwide expands outreachhttps://european-biotechnology.com/up-to-date/latest-news/news/cphi-worldwide-expands-outreach.html2017-10-27T09:42:53+02:00 300 jobs more: US company expands its Irish campushttps://european-biotechnology.com/up-to-date/latest-news/news/300-jobs-more-us-company-expands-its-irish-campus.html2017-10-26T11:18:55+02:00 Immunethep receives grant from Gates Foundationhttps://european-biotechnology.com/up-to-date/latest-news/news/immunethep-receives-grant-from-gates-foundation.html2017-10-25T12:04:01+02:00 EU researchers unveil how T cell dysfunction triggers MShttps://european-biotechnology.com/up-to-date/latest-news/news/eu-researchers-unveil-how-t-cell-dysfunction-triggers-ms.html2017-10-24T18:01:00+02:00 Uniqure readies share stock offeringhttps://european-biotechnology.com/up-to-date/latest-news/news/uniqure-readies-share-stock-offering.html2017-10-24T11:44:06+02:00 Biofuels: study challenges EU’s “tank or table” paradigmhttps://european-biotechnology.com/up-to-date/latest-news/news/biofuels-study-challenges-eus-tank-or-table-paradigm.html2017-10-23T11:49:00+02:00 ADC Therapeutics raises US$200m in private financing https://european-biotechnology.com/up-to-date/latest-news/news/adc-therapeutics-raises-us200m-in-private-financing.html2017-10-23T08:12:06+02:00 Valuating biotech’s benefitshttps://european-biotechnology.com/up-to-date/latest-news/news/valuating-biotechs-benefits.html2017-10-22T14:00:00+02:00 CureVac inks $1.7bn deal on mRNA cancer vaccineshttps://european-biotechnology.com/up-to-date/latest-news/news/curevac-inks-17bn-deal-on-mrna-cancer-vaccines.html2017-10-18T14:31:20+02:00 Ablynx prices global offering https://european-biotechnology.com/up-to-date/latest-news/news/ablynx-prices-global-offering.html2017-10-17T14:32:20+02:00 HPV vaccines: Cochrane Centre’s complaint vs safety review failedhttps://european-biotechnology.com/up-to-date/latest-news/news/hpv-vaccines-cochrane-centres-complaint-vs-safety-review-failed.html2017-10-17T11:52:10+02:00 CHMP upgrades Roche’s lung cancer drug Alecensa https://european-biotechnology.com/up-to-date/latest-news/news/chmp-upgrades-roches-lung-cancer-drug-alecensa.html2017-10-16T09:33:01+02:00 InflaRX raises US$55m in Series D roundhttps://european-biotechnology.com/up-to-date/latest-news/news/inflarx-raises-us55m-in-series-d-round.html2017-10-13T18:19:00+02:00 Targovax reports 100% one-year survival in pancreatic cancer trialhttps://european-biotechnology.com/up-to-date/latest-news/news/targovax-reports-100-one-year-survival-in-pancreatic-cancer-trial.html2017-10-12T08:42:48+02:00 Sanofi invests €170m to expand flu jab facilityhttps://european-biotechnology.com/up-to-date/latest-news/news/sanofi-invests-eur170m-to-expand-flu-jab-facility.html2017-10-12T08:15:00+02:00 Researchers describe alternative psoriasis targethttps://european-biotechnology.com/up-to-date/latest-news/news/researchers-describe-alternative-psoriasis-target.html2017-10-12T06:24:10+02:00 Neurim tables Phase III data of insomnia drughttps://european-biotechnology.com/up-to-date/latest-news/news/neurim-tables-phase-iii-data-of-insomnia-drug.html2017-10-11T09:07:41+02:00 Erytech Pharma set to raise US$100m in IPO and private placementhttps://european-biotechnology.com/up-to-date/latest-news/news/erytech-pharma-set-to-raise-us100m-in-ipo-and-private-placement.html2017-10-10T06:18:38+02:00 uniQure’s AMT-130 receives FDA Orphan Drug Designation in Huntington’s diseasehttps://european-biotechnology.com/up-to-date/latest-news/news/uniqures-amt-130-receives-fda-orphan-drug-designation-in-huntingtons-disease.html2017-10-09T06:06:32+02:00 Promethera Biosciences partners with Shibuya Corphttps://european-biotechnology.com/up-to-date/latest-news/news/promethera-biosciences-partners-with-shibuya-corp.html2017-10-06T06:13:21+02:00 Immatics raises $58mhttps://european-biotechnology.com/up-to-date/latest-news/news/immatics-raises-58m.html2017-10-05T08:27:00+02:00 NuCana raises US$114m in IPO of ADSs https://european-biotechnology.com/up-to-date/latest-news/news/nucana-raises-us114m-in-ipo-of-adss.html2017-10-04T08:01:33+02:00 Researchers unravel patterns of cancer heterogeneityhttps://european-biotechnology.com/up-to-date/latest-news/news/researchers-unravel-patterns-of-cancer-heterogeneity.html2017-10-02T20:43:15+02:00 Ablynx takes Phase III hurdle in acquired TTPhttps://european-biotechnology.com/up-to-date/latest-news/news/ablynx-takes-phase-iii-hurdle-in-acquired-ttp.html2017-10-02T07:52:32+02:00 Dipstick test detects Zika https://european-biotechnology.com/up-to-date/latest-news/news/dipstick-test-detects-zika.html2017-09-29T09:54:09+02:00 Why to watch out Spainhttps://european-biotechnology.com/up-to-date/latest-news/news/why-to-watch-out-spain.html2017-09-28T10:22:00+02:00 Evotec acquires stake in Exscientiahttps://european-biotechnology.com/up-to-date/latest-news/news/evotec-acquires-stake-in-exscientia.html2017-09-28T08:56:24+02:00 Genmab bags €25m milestone upon market approval of daratumumabhttps://european-biotechnology.com/up-to-date/latest-news/news/genmab-bags-eur25m-milestone-upon-market-approval-of-daratumumab.html2017-09-27T10:22:52+02:00 Newron raises CHF27m https://european-biotechnology.com/up-to-date/latest-news/news/newron-raises-chf27m.html2017-09-26T08:22:36+02:00 EU approves Roche’s atezolizumab for bladder cancer https://european-biotechnology.com/up-to-date/latest-news/news/eu-approves-roches-atezolizumab-for-bladder-cancer.html2017-09-25T10:38:16+02:00 Da Volterra bags €20m EIB investmenthttps://european-biotechnology.com/up-to-date/latest-news/news/da-volterra-bags-eur20m-eib-investment.html2017-09-22T10:09:54+02:00 microRNA blocks life-threatening ARDShttps://european-biotechnology.com/up-to-date/latest-news/news/microrna-blocks-life-threatening-ards.html2017-09-20T21:15:08+02:00 Vesalius Biocapital and IFD launch life sciences fundhttps://european-biotechnology.com/up-to-date/latest-news/news/vesalius-biocapital-and-ifd-launch-life-sciences-fund.html2017-09-19T16:08:09+02:00 Immunocore nabs US$40m from Gates Foundationhttps://european-biotechnology.com/up-to-date/latest-news/news/immunocore-nabs-us40m-from-gates-foundation.html2017-09-18T09:19:11+02:00 CHMP candidate checkhttps://european-biotechnology.com/up-to-date/latest-news/news/chmp-candidate-check.html2017-09-17T10:30:00+02:00 EMA rejects Santhera’s DMD drughttps://european-biotechnology.com/up-to-date/latest-news/news/ema-rejects-santheras-dmd-drug.html2017-09-15T08:44:13+02:00 Sophia Genetics raises US$30m https://european-biotechnology.com/up-to-date/latest-news/news/sophia-genetics-raises-us30m.html2017-09-14T08:32:38+02:00 MS: Gut microbobes drive inflammationhttps://european-biotechnology.com/up-to-date/latest-news/news/ms-gut-microbobes-drive-inflammation.html2017-09-13T08:19:28+02:00 Life Sciences majors expand digital cancer analyticshttps://european-biotechnology.com/up-to-date/latest-news/news/life-sciences-majors-expand-digital-cancer-analytics.html2017-09-12T08:01:08+02:00 Nova challenges EU’s „tank or table“ paradigmhttps://european-biotechnology.com/up-to-date/latest-news/news/nova-challenges-eus-tank-or-table-paradigm.html2017-09-11T09:45:29+02:00 Immunooncology: Roche presents blood biomarker testhttps://european-biotechnology.com/up-to-date/latest-news/news/immunooncology-roche-presents-blood-biomarker-test.html2017-09-08T09:27:51+02:00 'Adrenaline' of the immune system discoveredhttps://european-biotechnology.com/up-to-date/latest-news/news/adrenaline-of-the-immune-system-discovered.html2017-09-06T13:19:02+02:00 AMAL Therapeutics raises €8mhttps://european-biotechnology.com/up-to-date/latest-news/news/amal-therapeutics-raises-eur8m.html2017-09-06T08:54:25+02:00 EU states fuel antimicrobial R&D with €56.5mhttps://european-biotechnology.com/up-to-date/latest-news/news/eu-states-fuel-antimicrobial-rd-with-eur565m.html2017-09-05T08:14:16+02:00 Smartwatch for patient monitoringhttps://european-biotechnology.com/up-to-date/latest-news/news/smartwatch-for-patient-monitoring.html2017-09-03T09:22:00+02:00 EFSA okays GM bacteria as feed supplementhttps://european-biotechnology.com/up-to-date/latest-news/news/efsa-okays-gm-bacteria-as-feed-supplement.html2017-09-01T08:08:36+02:00 CAR-T: Novartis prices CTL019 at US$475,000https://european-biotechnology.com/up-to-date/latest-news/news/car-t-novartis-prices-ctl019-at-us475000.html2017-08-31T08:40:36+02:00 FDA approves Boehringer’s biosimilar adalimumabhttps://european-biotechnology.com/up-to-date/latest-news/news/fda-approves-boehringers-biosimilar-adalimumab.html2017-08-30T08:33:32+02:00 Apeiron bags €25m from EIB https://european-biotechnology.com/up-to-date/latest-news/news/apeiron-bags-eur25m-from-eib.html2017-08-29T08:36:20+02:00 Implementation of EU Unitary Patent Court delayinghttps://european-biotechnology.com/up-to-date/latest-news/news/implementation-of-eu-unitary-patent-court-delaying.html2017-08-25T14:58:05+02:00 Daratumumab meets endpoint as first-line multiple myeloma therapyhttps://european-biotechnology.com/up-to-date/latest-news/news/daratumumab-meets-endpoint-as-first-line-multiple-myeloma-therapy.html2017-08-25T09:27:50+02:00 Macrophage Pharma backed by Merck Ventureshttps://european-biotechnology.com/up-to-date/latest-news/news/macrophage-pharma-backed-by-merck-ventures.html2017-08-23T11:24:00+02:00 Parkinson's: factor protects from neuron decayhttps://european-biotechnology.com/up-to-date/latest-news/news/parkinsons-factor-protects-from-neuron-decay.html2017-08-23T08:35:34+02:00 Topas Therapeutics lands option deal with Eli Lillyhttps://european-biotechnology.com/up-to-date/latest-news/news/topas-therapeutics-lands-option-deal-with-eli-lilly.html2017-08-22T08:09:58+02:00 Medivir licenses HCV drug MIV-802 to Chinese Ascletishttps://european-biotechnology.com/up-to-date/latest-news/news/medivir-licenses-hcv-drug-miv-802-to-chinese-ascletis.html2017-08-21T08:29:43+02:00 Swedish reasearchers link up cancer survival to protein levelshttps://european-biotechnology.com/up-to-date/latest-news/news/swedish-reasearchers-link-up-cancer-survival-to-protein-levels.html2017-08-18T08:39:18+02:00 Metsä Group started up its bioproduct millhttps://european-biotechnology.com/up-to-date/latest-news/news/metsae-group-started-up-its-bioproduct-mill.html2017-08-17T08:29:02+02:00 Oxford Immunotec value drops after public offeringhttps://european-biotechnology.com/up-to-date/latest-news/news/oxford-immunotec-value-drops-after-public-offering.html2017-08-16T08:30:16+02:00 Mundipharma pays US$250 for CAP7.1https://european-biotechnology.com/up-to-date/latest-news/news/mundipharma-pays-us250-for-cap71.html2017-08-15T12:28:26+02:00 Sepsis: Adrenomed receives approval for POC study in patients with early septic shockhttps://european-biotechnology.com/up-to-date/latest-news/news/sepsis-adrenomed-receives-approval-for-poc-study-in-patients-with-early-septic-shock.html2017-08-14T07:05:00+02:00 CDPQ acquires stake in Sebiahttps://european-biotechnology.com/up-to-date/latest-news/news/cdpq-acquires-stake-in-sebia.html2017-08-11T08:26:14+02:00 Swiss Roivant bags US$1.1bn financinghttps://european-biotechnology.com/up-to-date/latest-news/news/swiss-roivant-bags-us11bn-financing.html2017-08-10T09:11:41+02:00 Voluntary health agency jump-starts Selvita’s SEL120 programmehttps://european-biotechnology.com/up-to-date/latest-news/news/voluntary-health-agency-jump-starts-selvitas-sel120-programme.html2017-08-09T11:50:15+02:00 LEO orders Hitgen to discover new leadshttps://european-biotechnology.com/up-to-date/latest-news/news/leo-orders-hitgen-to-discover-new-leads.html2017-08-08T10:35:39+02:00 Vernalis receives next veto by FDAhttps://european-biotechnology.com/up-to-date/latest-news/news/vernalis-receives-next-veto-by-fda.html2017-08-07T12:16:59+02:00 Hansa’s immunomodulatory enzyme does the jobhttps://european-biotechnology.com/up-to-date/latest-news/news/hansas-immunomodulatory-enzyme-does-the-job.html2017-08-04T12:37:55+02:00 TC Biopharm gets €4m Horizon2020 granthttps://european-biotechnology.com/up-to-date/latest-news/news/tc-biopharm-gets-eur4m-horizon2020-grant.html2017-08-03T10:27:32+02:00 Zealand taps US markethttps://european-biotechnology.com/up-to-date/latest-news/news/zealand-taps-us-market.html2017-08-02T12:17:49+02:00 Uniqure from now on alonehttps://european-biotechnology.com/up-to-date/latest-news/news/uniqure-from-now-on-alone.html2017-08-01T13:40:38+02:00 Neovacs raises €6m through private placementhttps://european-biotechnology.com/up-to-date/latest-news/news/neovacs-raises-eur6m-through-private-placement.html2017-07-31T11:52:23+02:00 J&J intensifies vaccine endeavour with Bavarian Nordichttps://european-biotechnology.com/up-to-date/latest-news/news/jj-intensifies-vaccine-endeavour-with-bavarian-nordic.html2017-07-28T12:16:38+02:00 GSK cancels 30 preclinical and clinical programmeshttps://european-biotechnology.com/up-to-date/latest-news/news/gsk-cancels-30-preclinical-and-clinical-programmes.html2017-07-27T11:51:18+02:00 Lesaffre invests €15.5m in phage start-uphttps://european-biotechnology.com/up-to-date/latest-news/news/lesaffre-invests-eur155m-in-phage-start-up.html2017-07-26T11:55:11+02:00 €7.6m by CARB-X dangling for Antabiohttps://european-biotechnology.com/up-to-date/latest-news/news/eur76m-by-carb-x-dangling-for-antabio.html2017-07-25T10:45:31+02:00 Borreliosis vaccine receives FDA Fast Track Statushttps://european-biotechnology.com/up-to-date/latest-news/news/borreliosis-vaccine-receives-fda-fast-track-status.html2017-07-24T10:30:56+02:00 Roche exits epigenetic drug dealhttps://european-biotechnology.com/up-to-date/latest-news/news/roche-exits-epigenetic-drug-deal.html2017-07-21T11:14:17+02:00 Ablynx adds Sanofi to its list of pharma partnershttps://european-biotechnology.com/up-to-date/latest-news/news/ablynx-adds-sanofi-to-its-list-of-pharma-partners.html2017-07-20T10:24:59+02:00 Shire licensed bispecific antibody from Novimmunehttps://european-biotechnology.com/up-to-date/latest-news/news/shire-licensed-bispecific-antibody-from-novimmune.html2017-07-19T11:00:53+02:00 UK invests £86m in healthcare SMEshttps://european-biotechnology.com/up-to-date/latest-news/news/uk-invests-pound86m-in-healthcare-smes.html2017-07-18T06:43:18+02:00 German PEI limits use of daclizumabhttps://european-biotechnology.com/up-to-date/latest-news/news/german-pei-limits-use-of-daclizumab.html2017-07-17T10:07:29+02:00 Microbiome shows COPD subtypeshttps://european-biotechnology.com/up-to-date/latest-news/news/microbiome-shows-copd-subtypes.html2017-07-17T09:29:51+02:00 Psoriasis: FDA approves guselkumabhttps://european-biotechnology.com/up-to-date/latest-news/news/psoriasis-fda-approves-guselkumab.html2017-07-14T09:03:56+02:00 ODAC greenlights Novartis’ CAR-T cell therapy CTL019 https://european-biotechnology.com/up-to-date/latest-news/news/odac-greenlights-novartis-car-t-cell-therapy-ctl019.html2017-07-13T09:38:09+02:00 Enterome and Nestlé form JVhttps://european-biotechnology.com/up-to-date/latest-news/news/enterome-and-nestle-form-jv.html2017-07-12T08:16:06+02:00 Bavaria and Germany push digital medicinehttps://european-biotechnology.com/up-to-date/latest-news/news/bavaria-and-germany-push-digital-medicine.html2017-07-11T09:15:02+02:00 FMI to launch digital oncology service at Roche sitehttps://european-biotechnology.com/up-to-date/latest-news/news/fmi-to-launch-digital-oncology-service-at-roche-site.html2017-07-10T09:30:00+02:00 Biocartis inks breast cancer R&D dealhttps://european-biotechnology.com/up-to-date/latest-news/news/biocartis-inks-breast-cancer-rd-deal.html2017-07-10T08:01:18+02:00 4SC AG raises €41mhttps://european-biotechnology.com/up-to-date/latest-news/news/4sc-ag-raises-eur41m.html2017-07-07T05:45:29+02:00 Success for individualised cancer vaccinehttps://european-biotechnology.com/up-to-date/latest-news/news/success-for-individualised-cancer-vaccine.html2017-07-06T10:52:56+02:00 Seventure debuts in Japan with microbiome investmenthttps://european-biotechnology.com/up-to-date/latest-news/news/seventure-debuts-in-japan-with-microbiome-investment.html2017-07-05T11:40:39+02:00 Noxxon/MSD start testing of immunoncologic combohttps://european-biotechnology.com/up-to-date/latest-news/news/noxxonmsd-start-testing-of-immunoncologic-combo.html2017-07-04T09:41:12+02:00 Exscientia inks €37m contract with GSKhttps://european-biotechnology.com/up-to-date/latest-news/news/exscientia-inks-eur37m-contract-with-gsk.html2017-07-03T08:19:57+02:00 Breaking therapy resistance of follicular lymphomahttps://european-biotechnology.com/up-to-date/latest-news/news/breaking-therapy-resistance-of-follicular-lymphoma.html2017-06-30T09:29:18+02:00 AML: Cellectis testing allogenic CAR-T cell therapyhttps://european-biotechnology.com/up-to-date/latest-news/news/aml-cellectis-testing-allogenic-car-t-cell-therapy.html2017-06-29T09:53:03+02:00 Diabetes: J&J and Seventure Partners launch investmenthttps://european-biotechnology.com/up-to-date/latest-news/news/diabetes-jj-and-seventure-partners-launch-investment.html2017-06-28T08:59:34+02:00 €66m Life Sciences Fund focused on Germany and Beneluxhttps://european-biotechnology.com/up-to-date/latest-news/news/eur66m-life-sciences-fund-focused-on-germany-and-benelux.html2017-06-27T10:03:46+02:00 CHMP recommends several biologicshttps://european-biotechnology.com/up-to-date/latest-news/news/chmp-recommends-several-biologics.html2017-06-26T08:25:50+02:00 Roche’s lampalizumab halts geographic atrophyhttps://european-biotechnology.com/up-to-date/latest-news/news/roches-lampalizumab-halts-geographic-atrophy.html2017-06-23T10:43:56+02:00 Epigenetic drugs set to boost immunoncologyhttps://european-biotechnology.com/up-to-date/latest-news/news/epigenetic-drugs-set-to-boost-immunoncology.html2017-06-22T08:39:22+02:00 AMD: Novartis challenges Regeneronhttps://european-biotechnology.com/up-to-date/latest-news/news/amd-novartis-challenges-regeneron.html2017-06-21T11:29:57+02:00 Evotec invests in Facio Therapieshttps://european-biotechnology.com/up-to-date/latest-news/news/evotec-invests-in-facio-therapies.html2017-06-20T08:33:21+02:00 Delay in MAA for Asit Biotech’s BTT009https://european-biotechnology.com/up-to-date/latest-news/news/delay-in-maa-for-asit-biotechs-btt009.html2017-06-19T08:38:32+02:00 J&J completes acquisition of Actelionhttps://european-biotechnology.com/up-to-date/latest-news/news/jj-completes-acquisition-of-actelion.html2017-06-16T07:31:52+02:00 Boehringer Ingelheim’s Humira biosimilar meets endpointhttps://european-biotechnology.com/up-to-date/latest-news/news/boehringer-ingelheims-humira-biosimilar-meets-endpoint.html2017-06-15T09:26:00+02:00 Medicxi launches €267m fundhttps://european-biotechnology.com/up-to-date/latest-news/news/medicxi-launches-eur267m-fund.html2017-06-15T08:57:26+02:00 Germany is blocking EU Unitary Patent Courthttps://european-biotechnology.com/up-to-date/latest-news/news/germany-is-blocking-eu-unitary-patent-court.html2017-06-15T08:10:03+02:00 Abivax Ebola antiviral gets financinghttps://european-biotechnology.com/up-to-date/latest-news/news/abivax-ebola-antiviral-gets-financing.html2017-06-14T08:37:21+02:00 Centogene raises a €25m in Series A financing https://european-biotechnology.com/up-to-date/latest-news/news/centogene-raises-a-eur25m-in-series-a-financing.html2017-06-13T10:09:11+02:00 Bonesupport is planning €60m IPOhttps://european-biotechnology.com/up-to-date/latest-news/news/bonesupport-is-planning-eur60m-ipo.html2017-06-12T08:46:16+02:00 Targovax raises €21m in private placementhttps://european-biotechnology.com/up-to-date/latest-news/news/targovax-raises-eur21m-in-private-placement.html2017-06-09T08:30:41+02:00 Grünenthal in US$300m deal with AstraZeneca https://european-biotechnology.com/up-to-date/latest-news/news/gruenenthal-in-us300m-deal-with-astrazeneca.html2017-06-08T06:54:00+02:00 Biocartis launches partnership in liquid biopsyhttps://european-biotechnology.com/up-to-date/latest-news/news/biocartis-launches-partnership-in-liquid-biopsy.html2017-06-07T07:55:57+02:00 Merck KGaA and F-star in €1bn dealhttps://european-biotechnology.com/up-to-date/latest-news/news/merck-kgaa-and-f-star-in-eur1bn-deal.html2017-06-06T07:19:50+02:00 Bicycle raises £40mhttps://european-biotechnology.com/up-to-date/latest-news/news/bicycle-raises-pound40m.html2017-06-02T05:43:06+02:00 EC and EMA provide Brexit guidancehttps://european-biotechnology.com/up-to-date/latest-news/news/ec-and-ema-provide-brexit-guidance.html2017-06-01T09:01:10+02:00 Addex further improves liquidityhttps://european-biotechnology.com/up-to-date/latest-news/news/addex-further-improves-liquidity.html2017-05-31T08:27:33+02:00 AMO Pharma receives FDA Fast Track Statushttps://european-biotechnology.com/up-to-date/latest-news/news/amo-pharma-receives-fda-fast-track-status.html2017-05-30T10:10:19+02:00 Biocorp partners with Virbachttps://european-biotechnology.com/up-to-date/latest-news/news/biocorp-partners-with-virbac.html2017-05-29T08:31:02+02:00 Janssen speeds up guselkumab approval processhttps://european-biotechnology.com/up-to-date/latest-news/news/janssen-speeds-up-guselkumab-approval-process.html2017-05-25T07:37:09+02:00 Abzena’s partner True North Therapeutics subject of US$825m take-overhttps://european-biotechnology.com/up-to-date/latest-news/news/abzenas-partner-true-north-therapeutics-subject-of-us825m-take-over.html2017-05-24T09:04:14+02:00 RA: Sanofi/Regeneron IL-6R blocker FDA-approved https://european-biotechnology.com/up-to-date/latest-news/news/ra-sanofiregeneron-il-6r-blocker-fda-approved.html2017-05-23T09:25:36+02:00 Safety event delays US market approval of romosozumab https://european-biotechnology.com/up-to-date/latest-news/news/safety-event-delays-us-market-approval-of-romosozumab.html2017-05-22T09:24:54+02:00 Vesalius Biocapital fund raises €65m https://european-biotechnology.com/up-to-date/latest-news/news/vesalius-biocapital-fund-raises-eur65m.html2017-05-19T07:56:53+02:00 Merck presents new CRISPR genome editing methodhttps://european-biotechnology.com/up-to-date/latest-news/news/merck-presents-new-crispr-genome-editing-method.html2017-05-18T07:36:58+02:00 Astellas completes Ogeda takeoverhttps://european-biotechnology.com/up-to-date/latest-news/news/astellas-completes-ogeda-takeover.html2017-05-17T05:51:22+02:00 Vifor Pharma acquires US$50m share in Akebiahttps://european-biotechnology.com/up-to-date/latest-news/news/vifor-pharma-acquires-us50m-share-in-akebia.html2017-05-16T09:13:30+02:00 NSCLC: AstraZeneca’s durvalumab meets PFS endpoint https://european-biotechnology.com/up-to-date/latest-news/news/nsclc-astrazenecas-durvalumab-meets-pfs-endpoint.html2017-05-15T05:56:18+02:00 Norgine to acquire Merus https://european-biotechnology.com/up-to-date/latest-news/news/norgine-to-acquire-merus.html2017-05-12T07:18:34+02:00 Cheap Avastin as effective as Eylea in CRVOhttps://european-biotechnology.com/up-to-date/latest-news/news/cheap-avastin-as-effective-as-eylea-in-crvo.html2017-05-11T10:23:01+02:00 Roche’s anti-PD-L1 fails in bladder cancerhttps://european-biotechnology.com/up-to-date/latest-news/news/roches-anti-pd-l1-fails-in-bladder-cancer.html2017-05-10T08:01:07+02:00 Dermtreat bags €16.2m financinghttps://european-biotechnology.com/up-to-date/latest-news/news/dermtreat-bags-eur162m-financing.html2017-05-09T08:22:24+02:00 GMO acreage growinghttps://european-biotechnology.com/up-to-date/latest-news/news/gmo-acreage-growing.html2017-05-08T07:34:07+02:00 Another great year for Swiss biotechhttps://european-biotechnology.com/up-to-date/latest-news/news/another-great-year-for-swiss-biotech.html2017-05-05T14:27:16+02:00 German biotech on the risehttps://european-biotechnology.com/up-to-date/latest-news/news/german-biotech-on-the-rise.html2017-05-04T14:32:32+02:00 €37.5 million for Vivet Therapeuticshttps://european-biotechnology.com/up-to-date/latest-news/news/eur375-million-for-vivet-therapeutics.html2017-05-04T13:57:34+02:00 Boehringer leads Series A of French Imcheckhttps://european-biotechnology.com/up-to-date/latest-news/news/boehringer-leads-series-a-of-french-imcheck.html2017-05-03T14:11:35+02:00 Abivax’ shares jump on new Phase IIa HIV datahttps://european-biotechnology.com/up-to-date/latest-news/news/abivax-shares-jump-on-new-phase-iia-hiv-data.html2017-05-02T15:23:50+02:00 Verona Pharma raised US-$77.8m at NASDAQhttps://european-biotechnology.com/up-to-date/latest-news/news/verona-pharma-raised-us-778m-at-nasdaq.html2017-04-28T10:45:40+02:00 Epigenomics in €171m take-over https://european-biotechnology.com/up-to-date/latest-news/news/epigenomics-in-eur171m-take-over.html2017-04-27T09:28:22+02:00 Euronext-listed Argenx plans €68.6m IPO in the UShttps://european-biotechnology.com/up-to-date/latest-news/news/euronext-listed-argenx-plans-eur686m-ipo-in-the-us.html2017-04-24T15:22:55+02:00 EMA backs authorisation of biologicshttps://european-biotechnology.com/up-to-date/latest-news/news/ema-backs-authorisation-of-biologics.html2017-04-24T08:09:59+02:00 Uniqure withdraws €1m drug Glybera from markethttps://european-biotechnology.com/up-to-date/latest-news/news/uniqure-withdraws-eur1m-drug-glybera-from-market.html2017-04-21T08:46:17+02:00 GE partner Synpromics completes financing roundhttps://european-biotechnology.com/up-to-date/latest-news/news/ge-partner-synpromics-completes-financing-round.html2017-04-20T08:27:03+02:00 Galapagos raises US$338m https://european-biotechnology.com/up-to-date/latest-news/news/galapagos-raises-us338m.html2017-04-19T08:44:57+02:00 Allergan and Novartis combine NASH candidateshttps://european-biotechnology.com/up-to-date/latest-news/news/allergan-and-novartis-combine-nash-candidates.html2017-04-18T08:46:50+02:00 bestbion dx to market sphingotec’s predictive biomarkers https://european-biotechnology.com/up-to-date/latest-news/news/bestbion-dx-to-market-sphingotecs-predictive-biomarkers.html2017-04-13T08:14:05+02:00 Galenica exercises over-allotment optionhttps://european-biotechnology.com/up-to-date/latest-news/news/galenica-exercises-over-allotment-option.html2017-04-12T09:17:21+02:00 Spain establishes world-class disease modeling facilityhttps://european-biotechnology.com/up-to-date/latest-news/news/spain-establishes-world-class-disease-modeling-facility.html2017-04-11T08:42:34+02:00 Roche’s alectinib superior to crizotinib https://european-biotechnology.com/up-to-date/latest-news/news/roches-alectinib-superior-to-crizotinib.html2017-04-10T08:26:11+02:00 Nanobiotix completes €25m private placementhttps://european-biotechnology.com/up-to-date/latest-news/news/nanobiotix-completes-eur25m-private-placement.html2017-04-07T09:36:48+02:00 Adaptimmune raises US$42m https://european-biotechnology.com/up-to-date/latest-news/news/adaptimmune-raises-us42m.html2017-04-06T06:12:01+02:00 Menarini expands into CTC liquid biopsyhttps://european-biotechnology.com/up-to-date/latest-news/news/menarini-expands-into-ctc-liquid-biopsy.html2017-04-04T06:28:21+02:00 Astellas to acquire Ogeda SA https://european-biotechnology.com/up-to-date/latest-news/news/astellas-to-acquire-ogeda-sa.html2017-04-03T06:41:39+02:00 Janssen terminates daratumab development in NHLhttps://european-biotechnology.com/up-to-date/latest-news/news/janssen-terminates-daratumab-development-in-nhl.html2017-03-30T20:43:42+02:00 Biostep Forum: Bioeconomy strategy update uncertainhttps://european-biotechnology.com/up-to-date/latest-news/news/biostep-forum-bioeconomy-strategy-update-uncertain.html2017-03-30T07:39:18+02:00 Selvita to cash in €90m in Menarini dealhttps://european-biotechnology.com/up-to-date/latest-news/news/selvita-to-cash-in-eur90m-in-menarini-deal.html2017-03-29T07:28:20+02:00 EU nations go on blocking GM cropshttps://european-biotechnology.com/up-to-date/latest-news/news/eu-nations-go-on-blocking-gm-crops.html2017-03-28T08:53:19+02:00 EMA backs three orphan drugs https://european-biotechnology.com/up-to-date/latest-news/news/ema-backs-three-orphan-drugs.html2017-03-27T10:08:15+02:00 FDA approves Merck’s avelumab in MCChttps://european-biotechnology.com/up-to-date/latest-news/news/fda-approves-mercks-avelumab-in-mcc.html2017-03-24T08:14:25+01:00 BIO-Europe Spring: Southern growth ambitionshttps://european-biotechnology.com/up-to-date/latest-news/news/bio-europe-spring-southern-growth-ambitions.html2017-03-22T09:03:35+01:00 Toxoplasmosis: novel target to prevent transmissionhttps://european-biotechnology.com/up-to-date/latest-news/news/toxoplasmosis-novel-target-to-prevent-transmission.html2017-03-21T09:37:08+01:00 Pulmocide raises £25m in Series B round https://european-biotechnology.com/up-to-date/latest-news/news/pulmocide-raises-pound25m-in-series-b-round.html2017-03-20T10:18:59+01:00 Investors purchase Imegen https://european-biotechnology.com/up-to-date/latest-news/news/investors-purchase-imegen.html2017-03-17T09:45:26+01:00 Cell Medica bags €68,8 in Series Chttps://european-biotechnology.com/up-to-date/latest-news/news/cell-medica-bags-eur688-in-series-c.html2017-03-16T09:28:01+01:00 Avantium raised €103m in oversubscribed IPOhttps://european-biotechnology.com/up-to-date/latest-news/news/avantium-raised-eur103m-in-oversubscribed-ipo.html2017-03-15T09:56:06+01:00 NSCLC: Transgene launches cancer combo testshttps://european-biotechnology.com/up-to-date/latest-news/news/nsclc-transgene-launches-cancer-combo-tests.html2017-03-14T09:16:21+01:00 Allogenic stem cell transplant safe in heart infarction patientshttps://european-biotechnology.com/up-to-date/latest-news/news/allogenic-stem-cell-transplant-safe-in-heart-infarction-patients.html2017-03-13T08:40:14+01:00 Pharnext partners with Galapagoshttps://european-biotechnology.com/up-to-date/latest-news/news/pharnext-partners-with-galapagos.html2017-03-10T08:27:02+01:00 BerGenBio plans IPO and partners with MSDhttps://european-biotechnology.com/up-to-date/latest-news/news/bergenbio-plans-ipo-and-partners-with-msd.html2017-03-09T09:30:54+01:00 Breath Therapeutics cashes in €43,5mhttps://european-biotechnology.com/up-to-date/latest-news/news/breath-therapeutics-cashes-in-eur435m.html2017-03-08T08:15:59+01:00 PwC reports high productivity of UK Life Scienceshttps://european-biotechnology.com/up-to-date/latest-news/news/pwc-reports-high-productivity-of-uk-life-sciences.html2017-03-07T09:26:35+01:00 Roche restarts pivotal Gantenerumab testshttps://european-biotechnology.com/up-to-date/latest-news/news/roche-restarts-pivotal-gantenerumab-tests.html2017-03-06T08:08:00+01:00 Sanofi and AZ ink €600m deal for RSV jabhttps://european-biotechnology.com/up-to-date/latest-news/news/sanofi-and-az-ink-eur600m-deal-for-rsv-jab.html2017-03-03T09:40:08+01:00 Nestle researchers link IBS to anxiety https://european-biotechnology.com/up-to-date/latest-news/news/nestle-researchers-link-ibs-to-anxiety.html2017-03-02T10:01:12+01:00 FDA grants Priority Review to avelumabhttps://european-biotechnology.com/up-to-date/latest-news/news/fda-grants-priority-review-to-avelumab.html2017-03-01T09:03:09+01:00 Big Pharma pushing up orphan drug priceshttps://european-biotechnology.com/up-to-date/latest-news/news/big-pharma-pushing-up-orphan-drug-prices.html2017-02-28T08:03:19+01:00 European dynamics in AMR https://european-biotechnology.com/up-to-date/latest-news/news/european-dynamics-in-amr.html2017-02-27T15:47:44+01:00 Oncopeptides raises €68m in IPOhttps://european-biotechnology.com/up-to-date/latest-news/news/oncopeptides-raises-eur68m-in-ipo.html2017-02-27T08:29:35+01:00 Funding: ENABLE goes pre-clinicalhttps://european-biotechnology.com/up-to-date/latest-news/news/funding-enable-goes-pre-clinical.html2017-02-24T09:00:00+01:00 Kick off for BaseLaunch acceleratorhttps://european-biotechnology.com/up-to-date/latest-news/news/kick-off-for-baselaunch-accelerator.html2017-02-23T05:26:22+01:00 Roche extends antibiotics collaborationhttps://european-biotechnology.com/up-to-date/latest-news/news/roche-extends-antibiotics-collaboration.html2017-02-22T08:00:32+01:00 Bioplastics market growth dropshttps://european-biotechnology.com/up-to-date/latest-news/news/bioplastics-market-growth-drops.html2017-02-21T08:01:51+01:00 Roche combo doubles RCC survival vs sunitinibhttps://european-biotechnology.com/up-to-date/latest-news/news/roche-combo-doubles-rcc-survival-vs-sunitinib.html2017-02-20T07:43:21+01:00 BioMedPartners raise CHF75m fundhttps://european-biotechnology.com/up-to-date/latest-news/news/biomedpartners-raise-chf75m-fund.html2017-02-17T11:03:19+01:00 Germany to allow GMOs without labellinghttps://european-biotechnology.com/up-to-date/latest-news/news/germany-to-allow-gmos-without-labelling.html2017-02-16T09:43:26+01:00 Inventiva raises €48m in Euronext IPOhttps://european-biotechnology.com/up-to-date/latest-news/news/inventiva-raises-eur48m-in-euronext-ipo.html2017-02-15T10:08:44+01:00 Vifor Pharma expands ChemoCentryx partnership https://european-biotechnology.com/up-to-date/latest-news/news/vifor-pharma-expands-chemocentryx-partnership.html2017-02-14T11:08:01+01:00 Novimmune partners with LegoChem Bioscienceshttps://european-biotechnology.com/up-to-date/latest-news/news/novimmune-partners-with-legochem-biosciences.html2017-02-13T09:20:31+01:00 Oncoinvent closes US$25m private placement https://european-biotechnology.com/up-to-date/latest-news/news/oncoinvent-closes-us25m-private-placement.html2017-02-09T19:17:57+01:00 AMR: EU Commission awards €45,000 https://european-biotechnology.com/up-to-date/latest-news/news/amr-eu-commission-awards-eur45000.html2017-02-09T05:48:35+01:00 Prexton Therapeutics gets €29m cash injectionhttps://european-biotechnology.com/up-to-date/latest-news/news/prexton-therapeutics-gets-eur29m-cash-injection.html2017-02-08T08:24:51+01:00 Biotechs concerned over EPO ruleshttps://european-biotechnology.com/up-to-date/latest-news/news/biotechs-concerned-over-epo-rules.html2017-02-07T03:55:23+01:00 Biotech investor plans IPO in Londonhttps://european-biotechnology.com/up-to-date/latest-news/news/biotech-investor-plans-ipo-in-london.html2017-02-06T15:04:46+01:00 Prize awarded to innovative products https://european-biotechnology.com/up-to-date/latest-news/news/prize-awarded-to-innovative-products.html2017-02-02T14:46:00+01:00 Molecule prevents oedemahttps://european-biotechnology.com/up-to-date/latest-news/news/molecule-prevents-oedema.html2017-02-02T07:47:18+01:00 Fighting AMR efficientlyhttps://european-biotechnology.com/up-to-date/latest-news/news/fighting-amr-efficiently.html2017-01-31T14:46:13+01:00 uniQure gets FDA breakthrough status for AMT-060https://european-biotechnology.com/up-to-date/latest-news/news/uniqure-gets-fda-breakthrough-status-for-amt-060.html2017-01-31T07:57:50+01:00 IBAM completes US$690m dealhttps://european-biotechnology.com/up-to-date/latest-news/news/ibam-completes-us690m-deal.html2017-01-30T11:11:19+01:00 €500m to push gene therapyhttps://european-biotechnology.com/up-to-date/latest-news/news/eur500m-to-push-gene-therapy.html2017-01-27T08:37:27+01:00 Johnson & Johnson to buy Actelion for US$30bn https://european-biotechnology.com/up-to-date/latest-news/news/johnson-johnson-to-buy-actelion-for-us30bn.html2017-01-26T09:26:11+01:00 HCC: resminostat boosts overall survivalhttps://european-biotechnology.com/up-to-date/latest-news/news/hcc-resminostat-boosts-overall-survival.html2017-01-25T10:29:08+01:00 GM mosquitoes to be released in Indiahttps://european-biotechnology.com/up-to-date/latest-news/news/gm-mosquitoes-to-be-released-in-india.html2017-01-24T09:23:29+01:00 Biotech CEOs advise EU on breakthrough innovationshttps://european-biotechnology.com/up-to-date/latest-news/news/biotech-ceos-advise-eu-on-breakthrough-innovations.html2017-01-23T09:03:08+01:00 Affimed is seeking fundshttps://european-biotechnology.com/up-to-date/latest-news/news/affimed-is-seeking-funds.html2017-01-20T09:28:24+01:00 Octimet bags €11m for development of cancer drugshttps://european-biotechnology.com/up-to-date/latest-news/news/octimet-bags-eur11m-for-development-of-cancer-drugs.html2017-01-19T10:33:43+01:00 Joint-venture Fibrocor tackles fibrosishttps://european-biotechnology.com/up-to-date/latest-news/news/joint-venture-fibrocor-tackles-fibrosis.html2017-01-17T10:28:02+01:00 New technology speeds up mapping of DNA-protein interactionhttps://european-biotechnology.com/up-to-date/latest-news/news/new-technology-speeds-up-mapping-of-dna-protein-interaction.html2017-01-16T13:44:56+01:00 Telix licenses Wilex’ girentuximab programmehttps://european-biotechnology.com/up-to-date/latest-news/news/telix-licenses-wilex-girentuximab-programme.html2017-01-16T09:51:04+01:00 EU neonicotinoid ban causes environmental damage https://european-biotechnology.com/up-to-date/latest-news/news/eu-neonicotinoid-ban-causes-environmental-damage.html2017-01-13T10:38:52+01:00 Curevac reports another failed cancer vaccinehttps://european-biotechnology.com/up-to-date/latest-news/news/curevac-reports-another-failed-cancer-vaccine.html2017-01-12T09:15:00+01:00 Researchers overcome chemotherapy resistance in AMLhttps://european-biotechnology.com/up-to-date/latest-news/news/researchers-overcome-chemotherapy-resistance-in-aml.html2017-01-10T09:00:00+01:00 Caution returns to European biotech stockshttps://european-biotechnology.com/up-to-date/latest-news/news/caution-returns-to-european-biotech-stocks.html2017-01-09T17:55:00+01:00 Roche gets FDA priority review for atezolizumab https://european-biotechnology.com/up-to-date/latest-news/news/roche-gets-fda-priority-review-for-atezolizumab.html2017-01-09T08:55:48+01:00 UK researchers find metastasis switch in breast cancer cellshttps://european-biotechnology.com/up-to-date/latest-news/news/uk-researchers-find-metastasis-switch-in-breast-cancer-cells.html2017-01-06T09:47:17+01:00 NeRRe Therapeutics pushes leads by €26m Series B financinghttps://european-biotechnology.com/up-to-date/latest-news/news/nerre-therapeutics-pushes-leads-by-eur26m-series-b-financing.html2017-01-05T10:30:15+01:00 Bayer antibiotics spin-out Aicuris bags IMI granthttps://european-biotechnology.com/up-to-date/latest-news/news/bayer-antibiotics-spin-out-aicuris-bags-imi-grant.html2017-01-04T11:19:48+01:00 Tiziana joins rheumatoid arthritis racehttps://european-biotechnology.com/up-to-date/latest-news/news/tiziana-joins-rheumatoid-arthritis-race.html2017-01-03T10:32:48+01:00 Sanofi and Boehringer Ingelheim close 
business swaphttps://european-biotechnology.com/up-to-date/latest-news/news/sanofi-and-boehringer-ingelheim-close-business-swap.html2017-01-02T08:11:25+01:00 Best of 2016: Our most wanted newshttps://european-biotechnology.com/up-to-date/latest-news/news/best-of-2016-our-most-wanted-news.html2016-12-23T09:48:00+01:00 Blood test on the scent of prionshttps://european-biotechnology.com/up-to-date/latest-news/news/blood-test-on-the-scent-of-prions.html2016-12-22T06:41:00+01:00 IMI launches €348m callhttps://european-biotechnology.com/up-to-date/latest-news/news/imi-launches-eur348m-call.html2016-12-21T12:30:33+01:00 Belgian spin-off Indigo challenges diabetes giantshttps://european-biotechnology.com/up-to-date/latest-news/news/belgian-spin-off-indigo-challenges-diabetes-giants.html2016-12-20T09:50:21+01:00 EMA recommends market approval of four biologicshttps://european-biotechnology.com/up-to-date/latest-news/news/ema-recommends-market-approval-of-four-biologics.html2016-12-19T08:32:33+01:00 Evotec bags US$45m upfront in Celgene dealhttps://european-biotechnology.com/up-to-date/latest-news/news/evotec-bags-us45m-upfront-in-celgene-deal.html2016-12-16T08:47:15+01:00 Grifols confirms €1.75bn acquisition in transplantation safety https://european-biotechnology.com/up-to-date/latest-news/news/grifols-confirms-eur175bn-acquisition-in-transplantation-safety.html2016-12-15T09:41:57+01:00 Oncology: Orion teams up with Wi2https://european-biotechnology.com/up-to-date/latest-news/news/oncology-orion-teams-up-with-wi2.html2016-12-14T09:36:33+01:00 Curetis bags EIB debt financing and expandshttps://european-biotechnology.com/up-to-date/latest-news/news/curetis-bags-eib-debt-financing-and-expands.html2016-12-13T10:14:57+01:00 Crenezumab data support Amyloid-beta targetinghttps://european-biotechnology.com/up-to-date/latest-news/news/crenezumab-data-support-amyloid-beta-targeting.html2016-12-12T09:09:01+01:00 TxCell gains Treg rightshttps://european-biotechnology.com/up-to-date/latest-news/news/txcell-gains-treg-rights.html2016-12-09T15:24:46+01:00 Researchers report ubiquitous cancer targethttps://european-biotechnology.com/up-to-date/latest-news/news/researchers-report-ubiquitous-cancer-target.html2016-12-08T19:02:00+01:00 Merck expands portfolio of liquid biopsy testshttps://european-biotechnology.com/up-to-date/latest-news/news/merck-expands-portfolio-of-liquid-biopsy-tests.html2016-12-07T09:40:33+01:00 TiGenix launches IPO in the UShttps://european-biotechnology.com/up-to-date/latest-news/news/tigenix-launches-ipo-in-the-us.html2016-12-06T10:00:51+01:00 Roche licenses Novimmune’s anti-TLR4 antibodyhttps://european-biotechnology.com/up-to-date/latest-news/news/roche-licenses-novimmunes-anti-tlr4-antibody.html2016-12-05T08:52:41+01:00 Mediolanum licences Apeptico’s TNF peptide Solnatidehttps://european-biotechnology.com/up-to-date/latest-news/news/mediolanum-licences-apepticos-tnf-peptide-solnatide.html2016-12-02T14:01:44+01:00 A fresh take on biotech?https://european-biotechnology.com/up-to-date/latest-news/news/a-fresh-take-on-biotech.html2016-12-02T02:21:00+01:00 Bioplastics industry grapples with ignorant consumers https://european-biotechnology.com/up-to-date/latest-news/news/bioplastics-industry-grapples-with-ignorant-consumers.html2016-12-01T11:24:05+01:00 Carbios tackles marine litteringhttps://european-biotechnology.com/up-to-date/latest-news/news/carbios-tackles-marine-littering.html2016-11-29T11:30:15+01:00 Neovacs teams up with 3Phttps://european-biotechnology.com/up-to-date/latest-news/news/neovacs-teams-up-with-3p.html2016-11-25T07:53:00+01:00 Kymab raises €94m for mAb pipelinehttps://european-biotechnology.com/up-to-date/latest-news/news/kymab-raises-eur94m-for-mab-pipeline.html2016-11-24T12:40:15+01:00 Proteros inks US$167m oncology pact with MSD https://european-biotechnology.com/up-to-date/latest-news/news/proteros-inks-us167m-oncology-pact-with-msd.html2016-11-22T08:37:14+01:00 Running made by biotechhttps://european-biotechnology.com/up-to-date/latest-news/news/running-made-by-biotech.html2016-11-18T13:01:13+01:00 Medigene offers neoantigen-specific TCRshttps://european-biotechnology.com/up-to-date/latest-news/news/medigene-offers-neoantigen-specific-tcrs.html2016-11-16T09:09:04+01:00 Roche ramps up immunotherapy R&Dhttps://european-biotechnology.com/up-to-date/latest-news/news/roche-ramps-up-immunotherapy-rd.html2016-11-15T09:17:25+01:00 Adaptimmune downgrades trial design after FDA clinical holdhttps://european-biotechnology.com/up-to-date/latest-news/news/adaptimmune-downgrades-trial-design-after-fda-clinical-hold.html2016-11-11T12:24:44+01:00 Multiple sclerosis diagnosis in early stage https://european-biotechnology.com/up-to-date/latest-news/news/multiple-sclerosis-diagnosis-in-early-stage.html2016-11-10T13:12:18+01:00 BIO Europe with new record numbers https://european-biotechnology.com/up-to-date/latest-news/news/bio-europe-with-new-record-numbers.html2016-11-08T08:33:34+01:00 AZ withdraws lung cancer drug from EU lead markethttps://european-biotechnology.com/up-to-date/latest-news/news/az-withdraws-lung-cancer-drug-from-eu-lead-market.html2016-11-04T09:36:10+01:00 Bioregions deliver action plan blueprinthttps://european-biotechnology.com/up-to-date/latest-news/news/bioregions-deliver-action-plan-blueprint.html2016-11-03T07:57:09+01:00 Germany lagging behind in stem cell researchhttps://european-biotechnology.com/up-to-date/latest-news/news/germany-lagging-behind-in-stem-cell-research.html2016-10-31T13:58:58+01:00 Belgian Fund+ raises €125m for biotechshttps://european-biotechnology.com/up-to-date/latest-news/news/belgian-fund-raises-eur125m-for-biotechs.html2016-10-28T11:23:07+02:00 ETH builds cyborg bacteriahttps://european-biotechnology.com/up-to-date/latest-news/news/eth-builds-cyborg-bacteria.html2016-10-27T11:41:07+02:00 Nordic Nanovector in blood cancer pacthttps://european-biotechnology.com/up-to-date/latest-news/news/nordic-nanovector-in-blood-cancer-pact.html2016-10-26T09:47:36+02:00 EMA unveils trial datahttps://european-biotechnology.com/up-to-date/latest-news/news/ema-unveils-trial-data.html2016-10-24T11:02:26+02:00 Dilaforette: Going public with a new namehttps://european-biotechnology.com/up-to-date/latest-news/news/dilaforette-going-public-with-a-new-name.html2016-10-20T11:21:04+02:00 Ysios closes €126m BioFundhttps://european-biotechnology.com/up-to-date/latest-news/news/ysios-closes-eur126m-biofund.html2016-10-19T10:57:05+02:00 Merck drops MS collaboration with Apitopehttps://european-biotechnology.com/up-to-date/latest-news/news/merck-drops-ms-collaboration-with-apitope.html2016-10-17T10:23:59+02:00 EPO rules threaten biotech industryhttps://european-biotechnology.com/up-to-date/latest-news/news/epo-rules-threaten-biotech-industry.html2016-10-12T07:58:09+02:00 Roche’s NSLC mAb outperforms chemohttps://european-biotechnology.com/up-to-date/latest-news/news/roches-nslc-mab-outperforms-chemo.html2016-10-09T18:38:58+02:00 Synvina: BASF and Avantium join forceshttps://european-biotechnology.com/up-to-date/latest-news/news/synvina-basf-and-avantium-join-forces.html2016-10-07T12:21:58+02:00 CPhI sheds light on future marketshttps://european-biotechnology.com/up-to-date/latest-news/news/cphi-sheds-light-on-future-markets.html2016-10-07T11:23:19+02:00 EC delays bioeconomy strategy reviewhttps://european-biotechnology.com/up-to-date/latest-news/news/ec-delays-bioeconomy-strategy-review.html2016-10-06T09:07:40+02:00 Apeiron licences neuroblastoma antibodyhttps://european-biotechnology.com/up-to-date/latest-news/news/apeiron-licences-neuroblastoma-antibody.html2016-10-04T12:18:03+02:00 Diabetes giant cuts jobshttps://european-biotechnology.com/up-to-date/latest-news/news/diabetes-giant-cuts-jobs.html2016-09-30T15:46:55+02:00 Bluebird bio selects Medigene for TCR development https://european-biotechnology.com/up-to-date/latest-news/news/bluebird-bio-selects-medigene-for-tcr-development.html2016-09-29T14:02:06+02:00 Update: Immunic bags €17.5m https://european-biotechnology.com/up-to-date/latest-news/news/update-immunic-bags-eur175m.html2016-09-27T08:55:39+02:00 iOmx hits the ground runninghttps://european-biotechnology.com/up-to-date/latest-news/news/iomx-hits-the-ground-running.html2016-09-22T07:08:00+02:00 BioNTech teams up with Genentechhttps://european-biotechnology.com/up-to-date/latest-news/news/biontech-teams-up-with-genentech.html2016-09-21T11:18:34+02:00 With PhI win, Prexton targets Phase IIhttps://european-biotechnology.com/up-to-date/latest-news/news/with-phi-win-prexton-targets-phase-ii.html2016-09-20T11:12:00+02:00 Novozymes bags Organobalancehttps://european-biotechnology.com/up-to-date/latest-news/news/novozymes-bags-organobalance.html2016-09-15T11:15:00+02:00 AC Immune boldly prices Nasdaq IPOhttps://european-biotechnology.com/up-to-date/latest-news/news/ac-immune-boldly-prices-nasdaq-ipo.html2016-09-14T15:25:55+02:00 Sanofi, Google launch diabetes venturehttps://european-biotechnology.com/up-to-date/latest-news/news/sanofi-google-launch-diabetes-venture.html2016-09-13T00:00:00+02:00 Fresh French fund for healthcarehttps://european-biotechnology.com/up-to-date/latest-news/news/fresh-french-fund-for-healthcare.html2016-09-09T00:00:00+02:00 Bed and board go bio-basedhttps://european-biotechnology.com/up-to-date/latest-news/news/bed-and-board-go-bio-based.html2016-09-07T00:00:00+02:00 Boosting vaccines without the prickhttps://european-biotechnology.com/up-to-date/latest-news/news/boosting-vaccines-without-the-prick.html2016-09-06T00:00:00+02:00 Biomarker lifts a secret of old agehttps://european-biotechnology.com/up-to-date/latest-news/news/biomarker-lifts-a-secret-of-old-age.html2016-09-05T00:00:00+02:00 mAb ray of hope for Alzheimer’shttps://european-biotechnology.com/up-to-date/latest-news/news/mab-ray-of-hope-for-alzheimers.html2016-09-01T00:00:00+02:00 Ferring bags slipped disk pain drughttps://european-biotechnology.com/up-to-date/latest-news/news/ferring-bags-slipped-disk-pain-drug.html2016-08-30T00:00:00+02:00 Phase III washout for Adociahttps://european-biotechnology.com/up-to-date/latest-news/news/phase-iii-washout-for-adocia.html2016-08-26T00:00:00+02:00 AZ unloads antibiotics to Pfizerhttps://european-biotechnology.com/up-to-date/latest-news/news/az-unloads-antibiotics-to-pfizer.html2016-08-24T00:00:00+02:00 €87m for Cambridge Cluster fundhttps://european-biotechnology.com/up-to-date/latest-news/news/eur87m-for-cambridge-cluster-fund.html2016-08-23T00:00:00+02:00 Priority review for Genmab’s Darzalex?https://european-biotechnology.com/up-to-date/latest-news/news/priority-review-for-genmabs-darzalex.html2016-08-19T00:00:00+02:00 Post-Brexit EU funding securedhttps://european-biotechnology.com/up-to-date/latest-news/news/post-brexit-eu-funding-secured.html2016-08-17T10:55:00+02:00 Epigenomics considers US listinghttps://european-biotechnology.com/up-to-date/latest-news/news/epigenomics-considers-us-listing.html2016-08-15T13:53:00+02:00 Genmab in HIV antibody dealhttps://european-biotechnology.com/up-to-date/latest-news/news/genmab-in-hiv-antibody-deal.html2016-08-11T13:52:00+02:00 Ploughing ahead after Phase III setbackhttps://european-biotechnology.com/up-to-date/latest-news/news/ploughing-ahead-after-phase-iii-setback.html2016-08-09T13:50:00+02:00 Alzheimer’s vaccine clears Phase Ihttps://european-biotechnology.com/up-to-date/latest-news/news/alzheimers-vaccine-clears-phase-i.html2016-08-08T13:49:00+02:00 EMA keeps approval speedway openhttps://european-biotechnology.com/up-to-date/latest-news/news/ema-keeps-approval-speedway-open.html2016-08-04T13:47:00+02:00 Inflammation spin-off launchedhttps://european-biotechnology.com/up-to-date/latest-news/news/inflammation-spin-off-launched.html2016-08-01T13:45:00+02:00 GSK picks up asthma mAbhttps://european-biotechnology.com/up-to-date/latest-news/news/gsk-picks-up-asthma-mab.html2016-07-29T13:35:00+02:00 Brexit: calls for reassurancehttps://european-biotechnology.com/up-to-date/latest-news/news/brexit-calls-for-reassurance.html2016-07-27T13:28:00+02:00 Funds for MDx manufacturehttps://european-biotechnology.com/up-to-date/latest-news/news/funds-for-mdx-manufacture.html2016-07-20T00:00:00+02:00 IPO pay off for French biotechshttps://european-biotechnology.com/up-to-date/latest-news/news/ipo-pay-off-for-french-biotechs.html2016-07-19T14:31:39+02:00 Out of this world: UK tech in spacehttps://european-biotechnology.com/up-to-date/latest-news/news/out-of-this-world-uk-tech-in-space.html2016-07-18T00:00:00+02:00 Cell Medica picks up antibody techhttps://european-biotechnology.com/up-to-date/latest-news/news/cell-medica-picks-up-antibody-tech.html2016-07-13T00:00:00+02:00 Themis bags vaccine licensehttps://european-biotechnology.com/up-to-date/latest-news/news/themis-bags-vaccine-license.html2016-07-12T16:38:00+02:00 Medivation opens books to Sanofihttps://european-biotechnology.com/up-to-date/latest-news/news/medivation-opens-books-to-sanofi.html2016-07-07T00:00:00+02:00 Next chapter in Dx IP disputehttps://european-biotechnology.com/up-to-date/latest-news/news/next-chapter-in-dx-ip-dispute.html2016-07-06T00:00:00+02:00 Cinfa shows biosimilar equivalencehttps://european-biotechnology.com/up-to-date/latest-news/news/cinfa-shows-biosimilar-equivalence.html2016-07-04T00:00:00+02:00 An X-ray look at GPCR structurehttps://european-biotechnology.com/up-to-date/latest-news/news/an-x-ray-look-at-gpcr-structure.html2016-06-30T00:00:00+02:00 Partnership targets leukaemiahttps://european-biotechnology.com/up-to-date/latest-news/news/partnership-targets-leukaemia.html2016-06-28T00:00:00+02:00 Biotech responds to Brexit votehttps://european-biotechnology.com/up-to-date/latest-news/news/biotech-responds-to-brexit-vote.html2016-06-24T17:18:13+02:00 Malin hauls in €70m from EIBhttps://european-biotechnology.com/up-to-date/latest-news/news/malin-hauls-in-eur70m-from-eib.html2016-06-24T17:16:53+02:00 TxCell licenses CAR-T techhttps://european-biotechnology.com/up-to-date/latest-news/news/txcell-licenses-car-t-tech.html2016-06-22T17:15:00+02:00 Cat allergy setback for Circassiahttps://european-biotechnology.com/up-to-date/latest-news/news/cat-allergy-setback-for-circassia.html2016-06-21T17:13:00+02:00 Across the blood-brain barrier with ultrasoundhttps://european-biotechnology.com/up-to-date/latest-news/news/across-the-blood-brain-barrier-with-ultrasound.html2016-06-17T17:06:00+02:00 Novartis to develop new antimalarialhttps://european-biotechnology.com/up-to-date/latest-news/news/novartis-to-develop-new-antimalarial.html2016-06-16T17:12:00+02:00 Gilde closes €250m growth fundhttps://european-biotechnology.com/up-to-date/latest-news/news/gilde-closes-eur250m-growth-fund.html2016-06-14T00:00:00+02:00 EPO celebrates Europe’s top inventorshttps://european-biotechnology.com/up-to-date/latest-news/news/epo-celebrates-europes-top-inventors.html2016-06-09T18:26:00+02:00 Stratifying depression treatmenthttps://european-biotechnology.com/up-to-date/latest-news/news/stratifying-depression-treatment.html2016-06-08T18:33:00+02:00 Boost for bio-based isobutene planthttps://european-biotechnology.com/up-to-date/latest-news/news/boost-for-bio-based-isobutene-plant.html2016-06-07T18:35:00+02:00 EMA: Quick review for four medshttps://european-biotechnology.com/up-to-date/latest-news/news/ema-quick-review-for-four-meds.html2016-06-02T20:53:00+02:00 BioMérieux bags endotoxin detectorhttps://european-biotechnology.com/up-to-date/latest-news/news/biomerieux-bags-endotoxin-detector.html2016-06-01T18:38:00+02:00 EMA to make Phase I saferhttps://european-biotechnology.com/up-to-date/latest-news/news/ema-to-make-phase-i-safer.html2016-05-31T18:42:00+02:00 Award and €1m for engineering pioneerhttps://european-biotechnology.com/up-to-date/latest-news/news/award-and-eur1m-for-engineering-pioneer.html2016-05-27T18:44:00+02:00 BigDNA rebrands as Icenihttps://european-biotechnology.com/up-to-date/latest-news/news/bigdna-rebrands-as-iceni.html2016-05-26T18:58:00+02:00 Financing for the guthttps://european-biotechnology.com/up-to-date/latest-news/news/financing-for-the-gut.html2016-05-24T18:59:00+02:00 AMR Report: Test before you treathttps://european-biotechnology.com/up-to-date/latest-news/news/amr-report-test-before-you-treat.html2016-05-20T18:59:00+02:00 CRISPR patent deal for Bayerhttps://european-biotechnology.com/up-to-date/latest-news/news/crispr-patent-deal-for-bayer.html2016-05-18T19:12:00+02:00 €21.5m for Oxford stem cell spinouthttps://european-biotechnology.com/up-to-date/latest-news/news/eur215m-for-oxford-stem-cell-spinout.html2016-05-11T19:09:00+02:00 €39m for neurodegeneration therapieshttps://european-biotechnology.com/up-to-date/latest-news/news/eur39m-for-neurodegeneration-therapies.html2016-05-09T19:13:00+02:00 Ipsen and Oncodesign partner in R&Dhttps://european-biotechnology.com/up-to-date/latest-news/news/ipsen-and-oncodesign-partner-in-rd.html2016-05-03T19:20:00+02:00 US$471m for cancer research fundhttps://european-biotechnology.com/up-to-date/latest-news/news/us471m-for-cancer-research-fund.html2016-04-29T19:19:00+02:00 Clinical trial disaster: report blames drug’s toxicityhttps://european-biotechnology.com/up-to-date/latest-news/news/clinical-trial-disaster-report-blames-drugs-toxicity.html2016-04-21T19:16:00+02:00 Argenx in cancer drug licensing dealhttps://european-biotechnology.com/up-to-date/latest-news/news/argenx-in-cancer-drug-licensing-deal.html2016-04-21T19:14:00+02:00 Swiss biotech continues to do wellhttps://european-biotechnology.com/up-to-date/latest-news/news/swiss-biotech-continues-to-do-well.html2016-04-13T08:45:00+02:00 Recipharm in €68m Mitim takeoverhttps://european-biotechnology.com/up-to-date/latest-news/news/recipharm-in-eur68m-mitim-takeover.html2016-02-24T14:44:00+01:00